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NITRIC OXIDE MEDIATES THE NEUROPROLIFERATIVE EFFECT OF NPY 
By Angela Cheung 
 
Neuropeptide Y (NPY) is widely expressed in both the central and peripheral nervous system and 
has  an  important  role  in  the  regulation  of  adult  hippocampal  neurogenesis  by  mediating  the 
proliferation of neural precursor cells in both health and disease. The mechanisms underlying this 
neuroproliferative effect of NPY, however, are unknown. The aim of this project was to investigate 
these  cellular  pathways  and  the  possible  involvement  of  nitric  oxide  (NO)  in  NPY-mediated 
neuroproliferation using postnatal rat hippocampal cultures in vitro. 
 
      NPY was found to have a purely proliferative effect on hippocampal neural precursor cells. The 
role of NO was explored by inhibiting the NO synthesising enzyme, nitric oxide synthase (NOS), 
which abolished the proliferative effect of NPY and supported the involvement of NO in NPY-
mediated proliferation. Pharmacological analyses using subtype-selective inhibitors suggested that 
the neuronal isoform of NOS is the sole NOS subtype involved, which was expressed by both 
nestin
+ precursors and class III β-tubulin
+ neurons, the cell types previously shown to be responsive 
to NPY. The involvement of NO was further verified through loading hippocampal cells with an 
NO  indicator,  diaminofluorescein  diacetate,  where  an  increase  in  NO/N2O3  production  was 
observed in nestin
+ precursors and class III β-tubulin
+ neurons in response to NPY treatment.  
 
      The  downstream  signalling  pathways  coupling  NPY-mediated  NO  synthesis  to  cell 
proliferation were identified, through the use of selective pharmacological agonists and antagonists, 
as soluble guanylate cyclase, cGMP-dependent protein kinase (PKG) and the extracellular signal-
regulated kinases (ERK) 1/2. By assessing levels of NPY-mediated ERK 1/2 phosphorylation in 
response to NOS inhibition, it was found that ERK 1/2 activation was mediated only via NOS/NO 
mechanisms. This proliferative cGMP-PKG-ERK 1/2 signalling cascade appears to be mediated by 
intracellularly released NO, while on the other hand, the addition of extracellular NO through the 
application of NO donors exerted an inhibitory effect on neural precursor cell proliferation. In 
addition  to  demonstrating  the  dual  nature  of  NO,  this  is  the  first  time  that  the  signalling 
mechanisms  underlying  the  proliferative  effect  of  NPY  on  neural  precursor  cells  have  been 
described. Understanding the mechanisms underlying the proliferation of neural precursor cells will 
ultimately  be  beneficial  by  allowing  the  development  of  novel  therapeutic  interventions  for 
promoting hippocampal neurogenesis. 
      To analyse the role of NO in the NPY-mediated neuroproliferation of hippocampal cells in 
three-dimensional (3D) cultures, Laponite, a novel synthetic silica hydrogel, was used. Culture 
medium-based Laponite hydrogels were developed before cell viability within the hydrogels were 
assessed by culturing hippocampal monolayers under gel cover. Hydrogel cover, however, resulted 
in  cell  behaviour  reminiscent  of  preservation/fixation  as  monolayers  showed  no  spatial  or 
morphological changes over time, with one possible explanation being the high gel osmolarity. 
Although attempts at cell seeding showed more positive results, with cells adhering to a low heavy 
metal content variation of the hydrogel, determination of cell viability remained a problem due to 
prominent dye-gel binding. Although the rheological properties of Laponite make its use attractive, 
the biocompatibility of the hydrogels with hippocampal cells still require further optimisation if 
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Chapter 1 - General Introduction 
1.1 Adult hippocampal neurogenesis 
Neurogenesis is the process by which new neurons are generated (Altman & Das, 1965). 
Prominent  during  embryonic  development,  neurogenesis  had  long  been  considered  as 
restricted to neural development during the pre-natal period. The early theory of a fixed 
nervous system with “no new nerve cells after birth” and limited capacity for regeneration 
in the adult mammalian brain was well regarded by early neuroanatomists such as Ramón 
y Cajal (1928). This theory was widely accepted by the scientific community until around 
50 years ago when the first evidence for neurogenesis in the adult mammalian brain was 
published in the 1960’s by Altman and Das (1962, 1965). Since then, the existence of adult 
neurogenesis  has  been  confirmed  by  countless  studies  and  although  initially  met  with 
scepticism,  is  now  a  well-accepted  phenomenon  (Ehninger  &  Kempermann,  2008; 
Andersen et al., 2007).  
 
      Neurogenesis in adults has been confirmed in two regions of the brain, the subgranular 
zone  (SGZ)  of  the  dentate  gyrus  of  the  hippocampus  (Altman  &  Das,  1965),  and  the 
subventricular  zone  (SVZ)  of  the  anterior  lateral  ventricles  (Altman,  1969).  The  SGZ 
consists of a thin 2-3 cell layer which runs between the granule cell layer (GCL) and hilus 
of the hippocampus, while the new cells of the SVZ migrate via the Rostral migratory 
stream to the olfactory bulb (Altman & Das, 1965; Altman, 1969). These two regions 











Figure 1.1 Neurogenic regions of the rat brain. The subgranular zone (SGZ; yellow with black 
dotted line) of the dentate gyrus of the hippocampus which populates the granule cell layer (GCL; 
green),  and  the  forebrain  subventricular  zone  (SVZ)  which  lines  the  anterior  lateral  ventricles 







(orange) and provides new neurons for the olfactory bulb, are areas where adult neurogenesis have 
been confirmed.     
1.2 Process of adult hippocampal neurogenesis 
Adult hippocampal neurogenesis differs remarkably, in precursor cells, mechanism and 
regulation, from adult neurogenesis in the  SVZ/olfactory system (Abrous et al., 2005). 
Neural stem cells within the SGZ of the dentate gyrus of the hippocampus give rise to new 
granule  cell  neurons  that  populate  the  GCL.  Unlike  embryonic  neurogenesis,  adult 
neurogenesis  does  not  occur  in  the  manner  of  an  orchestrated  homogenous  population 
event.  Instead,  adult  neurogenesis  is  highly  individualistic,  heterogeneous  and  parallel 
neuronal  cells  can  be  found  at  all  developmental  stages  at  any  one  time  point.  Adult 
neurogenesis is a highly complex, dynamic and ongoing process in the brain which is 
interspersed with a range of other processes such as gliogenesis (Steiner et al., 2004).     
 
      Gerd  Kempermann  et  al.  (2004)  proposed  a  model  of  the  sequence  of  cellular 
differentiation during adult hippocampal neurogenesis based on cell morphology and the 
expression of key cell markers. This model is divided into six main stages of neuronal 
development (stages 1 to 6) and begins at stage 1 with the mitotic division of a neural stem 
cell (also called a type-1 cell). Type-1 cells have a radial-glia-like morphology with a 
roughly  triangular  soma  and  a  strong  lengthy  apical  process,  which  extends  into  the 
granule cell layer, and although abundant in the SGZ, they rarely divide. Intermediate 
filament nestin and the astrocytic marker GFAP (glial fibrillary acidic protein) are both 
expressed by type-1 cells (Filippov et al., 2003). The asymmetric division of a type-1 stem 
cell results in one identical type-1 cell and a daughter progenitor cell (Fukuda et al., 2003), 
whereby  neuronal  development  then  progresses  over  three  stages  (2  to  4)  which  are 
characterised by three distinct types of highly proliferative progenitor cells called type-2a, 
type-2b and type-3. The type-2 transiently amplifying progenitor cells are morphologically 
distinct from type-1 cells and do not express GFAP (Kronenberg et al., 2003). The two 
subtypes of type-2 cells are both positive for nestin, but while one, type-2a, is negative for 
doublecortin (DCX, an immature neuronal marker), type-2b is DCX
+ (Brown et al., 2003). 
Type-2 cells exhibit short tangentially orientated processes, a small soma and the nuclei are 
irregularly shaped (Kronenberg et al., 2003). On the other hand, type-3 cells are more 
advanced  with  regards  to  the  expression  of  neuronal  markers  and  are  nestin  negative, 
DCX
+,  and  express  PSA-NCAM  (polysialated  form  of  neural  cell  adhesion  molecule) 23 
 
(Filippov et al., 2003). Type-3 cells have a more variable morphology, generally with a 
rounder  nucleus  and  soma,  and  a  complex  array  of  processes  with  various  lengths 
(Ehninger & Kempermann, 2008). The radial migration of the type-3 cells into the GCL 
also occur at this stage (Kempermann et al., 2004). In the fifth stage of neurogenesis, the 
first postmitotic stage, cells are characterised by DCX, calcium binding protein calretinin 
and the mature neuron marker NeuN expression (Brandt et al., 2003). Similar to the late 
type-3  cells,  the  immature  granule  cell  neurons  have  a  rounded  nucleus  and  vertical 
morphology  with  an  apical  dendrite.  The  immature  granule  cells  at  this  stage  will  be 
subject to a selection process in which they are either recruited into long-term function or 
disposed of (where the majority of the new cells die by apoptosis) (Biebl et al., 2000; 
Kempermann et al., 2003). The final stage of adult hippocampal neurogenesis, stage 6, is 
where new granule cells integrate into the surrounding hippocampal network and circuitry 
and  mature  neuronally  (Jessberger  &  Kempermann,  2003).  Cells  at  this  stage  change 
expression from calretinin to calbindin (Brandt et al., 2003) and have the morphology of 
















Figure 1.2 Sequence of cellular differentiation during adult hippocampal neurogenesis. The six 
stages of neurogenesis are distinguished by the cellular morphology and expression of key markers 
nestin, GFAP (glial fibrillary acidic protein), DCX (doublecortin), calretinin, calbindin and NeuN. 
During stage 1, a type-1 stem cell divides to give rise to three consecutive stages (stages 2-4) of 
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granule cell 24 
 
transiently amplifying progenitor cells (type 2a, 2b and 3) which have different profiles of neuronal 
differentiation  and  proliferative  potential.  After  the  mitotic  stages  1-4,  stage  5  is  a  transient 
postmitotic stage characterised by selection for long-term survival and establishment of network 
connections.  Cells  which  survive  the  selection  process  develop  into  terminally  differentiated, 
mature  granule  cells  constituting  the  final  stage  of  adult  neurogenesis,  stage  6  (redrawn  from 
Kempermann et al., 2004).   
 
      It takes around 3 days  for cells to develop from stage 1 through to stage 5 of  the 
proposed  model,  whereby  cell  numbers  would  have  expanded  by  four  or  five  times 
(Kempermann et al., 2003). Two-thirds of the new cell population express post-mitotic 
markers on the third day. During stage 5, the numbers of new cells decrease dramatically 
as  result  of  the  post-mitotic  selection  process  and  2  to  3  weeks  is  required  for  the 
maturation  of  immature  granule  cells  to  mature  granule  cell  neurons  in  stage  6 
(Kempermann et al., 2003). Four to seven weeks is needed for functional integration of the 
new granule cells into the surrounding hippocampal environment, when they then become 
indistinguishable from older granule cells (Jessberger & Kempermann, 2003, van Praag et 
al., 2002). Approximately 9000 new granule cells are generated per day within the SGZ 
(Cameron & McKay, 2001), although most of these cells die (Biebl et al., 2001), leaving 
approximately ½ to 1/3 of new granule cells functionally integrated into the hippocampal 
environment after four weeks (Kempermann et al., 2003).  
1.3 Adult Neurogenesis in humans 
Adult  hippocampal  neurogenesis  is  well  established  in  mammalian  brains,  including 
humans,  and  rodents  in  particular  show  significant  amounts  of  adult  hippocampal 
neurogenesis (Andersen et al., 2007; Gould et  al., 1999; Altman & Das, 1965). In the 
seminal  study  by  Eriksson  et  al.  (1998),  adult  human  hippocampal  neurogenesis  was 
demonstrated in post-mortem brain tissue from cancer patients who had been treated, when 
they were alive, with the mitotic (S-phase) marker, bromodeoxyuridine (BrdU) (to assess 
the proliferative activity of tumour cells). Using immunohistochemistry, the presence of 
BrdU
+  cells  was  verified  in  both  the  dentate  gyrus  and  the  SVZ,  and  using  double 
immunostaining for BrdU and the neuronal markers NeuN or Calbindin, confirmed the 
generation of new neurons from dividing progenitor cells in the dentate gyrus of the adult 
human hippocampus (Eriksson et al., 1998). A different study has also shown that, similar 
to the course of adult hippocampal neurogenesis observed in rodents (Seki & Arai, 1995; 
Kuhn et al., 1996), there is a decrease in the generation of immature neurons in the dentate 25 
 
gyrus of the human brain, as demonstrated through assessing post-mortem human brain 
tissue ranging in age from fetal to 100 years for markers of cell proliferation and adult 
hippocampal neurogenesis (Knoth et al., 2010).     
 
1.4 Functional relevance of adult hippocampal neurogenesis  
The  hippocampus  plays  important  roles  in  the  consolidation  of  memory  and  spatial 
navigation (Squire & Cave, 1991). The functional integration of newly born cells into the 
hippocampal circuitry during adult hippocampal neurogenesis (van Praag et al., 2002) has 
lead  to  the  proposition  that  hippocampal  neurogenesis  may  be  important  in  learning 
processes  and  the  formation  of  hippocampal-dependent  memories  (Gould  et  al.,  1999; 
Snyder et al., 2001). Learning has been shown to promote adult hippocampal neurogenesis, 
which Gould et al. (1999) suggests is directly involved in the transient (temporary) storage 
of  hippocampus-dependent  memories.  Importantly,  the  ablation  of  adult  hippocampal 
neurogenesis through pharmacological, genetic or radiological procedures has been linked 
to the failure of certain hippocampal-dependent tasks (Ehninger & Kempermann, 2008). 
For example, Shors et al. (2001) ablated hippocampal precursor cells with the methylating 
agent methylazoxymethanol acetate (MAM) and found an impairment of a hippocampal-
dependent eye-blink task but not a hippocampal-independent version of the task. Other 
hippocampal-dependent tasks, however, were not affected by MAM treatment, suggesting 
that  adult  hippocampal  neurogenesis  is  functionally  required  for  only  some  forms  of 
hippocampal-dependent learning and memory (Shors et al., 2001, 2002).  Although our 
knowledge of the mechanisms are incomplete, adult hippocampal neurogenesis fluctuates 
in response to a plethora of extrinsic and intrinsic regulators including exercise (van Praag 
et al., 1999), age (Seki & Arai, 1995; Kuhn et al., 1996), stress (Gould & Tanapat, 1999), 
antidepressants (Malberg et al., 2000; Santarelli et al., 2003), neurodegenerative diseases 
(Thompson et al., 2008), brain injury including seizures (Bengzon et al., 1997; Parent et 
al., 1997; Gray and Sundstrom, 1998), traumatic brain injury (Dash et al., 2001) and stroke 
(Liu et al., 1998a), hormones (Gould et al., 2000) and growth factors (Cameron et al., 
1998),  to  name  but  a  few.  Although  increased  hippocampal  neurogenesis  does  not 
necessarily equate to enhanced hippocampal function, the possibility of manipulating adult 
neurogenesis  is  attractive  for  the  development  of  potential  therapeutic  treatments,  for 
example,  by  activating  endogenous  stem  cells  from  within  to  promote  repair  in  vivo 
(Shihabuddin  et  al.,  1999).  Neuropeptides,  in  particular,  are  emerging  as  significant 
modulators of adult neurogenesis, especially neuropeptide Y (NPY).  26 
 
1.5 Neuropeptide Y 
Following  its  isolation  from  the  porcine  hypothalamus  (Tatemoto  et  al.,  1982), 
determination of its amino acid sequence (Tatemoto, 1982) and distribution in the rat brain 
(Allen  et  al.,  1983),  NPY,  a  36  amino  acid  polypeptide,  has  been  implicated  in  the 
regulation of a range of physiological processes, including circadian rhythm (Albers & 
Ferris, 1984), feeding behaviour (Flood & Morley, 1989), memory processing (Redrobe et 
al., 1999), affective disorders (Heilig, 2004) and seizure control (Erickson et al., 1996; 
Vezzani et al., 1999). In the hippocampus, NPY is expressed by GABA(γ-aminobutyric 
acid)ergic interneurons of the dentate hilus and hippocampus proper (Kohler et al., 1986; 
Freund  &  Buzsaki,  1996),  and  acts  on  G-protein  coupled  receptors  (GPCR)  in  the 
rhodopsin-like GPCR family. Out of the five subtypes identified in mammals (NPY Y1, Y2, 
Y4,Y5 and Y6), four (Y1, Y2, Y4 and Y5) are functional in humans (Michel et al., 1998), and 
show tissue-specific expression patterns (Mullins et al., 2002). Although all five NPY Y 
receptors  appear  to  use  similar  intracellular  signalling  pathways,  no  one  Y  receptor  is 
consistently linked with any one distinct pathway (Michel et al., 1998). The signalling 
mechanisms through which NPY exerts its diverse range of effects have not yet been fully 
characterised or understood (Mullins et al., 2002), however, what is known is that the Y 
receptors show preferential coupling to G-proteins of the Gi and Go family (or the pertussis 
toxin-sensitive G-proteins) (Limbird, 1988).  
1.6 NPY and neurogenesis 
Hansel  et  al.  (2001)  first  demonstrated  the  proliferative  effects  of  NPY  on  neuronal 
precursor cells derived from the postnatal rat olfactory epithelium, which appear to be 
mediated via the NPY Y1 receptor. Since then, NPY has been shown to be able to stimulate 
the  proliferation  of  a  range  of  cell  types  including  neuronal  precursor  cells  from  the 
hippocampal SGZ (Howell et al., 2003), retinal glial  (Muller) cells (Milenkovic et al., 
2004), endothelial cells (Movafagh et al., 2006) and precursor cells from the SVZ (Agasse 
et al., 2008). Indeed, NPY plays a key role in regulating adult hippocampal neurogenesis 
under both normal and pathological conditions (Howell et al., 2005, 2007) and it has been 
proposed  that  NPY-releasing  interneurons  in  the  dentate  hilus  release  NPY  onto 
progenitors  within  the  SGZ  to  regulate  their  proliferation  and  adult  hippocampal 
neurogenesis (Gray, 2008). The neuroproliferative effect of NPY on SGZ precursor cells 
was shown to be Y1 receptor mediated (Howell et al., 2003) and adult NPY Y1
-/- receptor 
knock-out  mice  had  significantly  reduced  cell  proliferation  and  reduced  numbers  of 27 
 
immature DCX
+ neurons in the dentate (Howell et al., 2003). This correlates well with the 
predominant localisation of Y1 receptors to the dentate and SGZ (Kopp et al., 2002). The 
signalling mechanisms underlying the proliferative effect of NPY, however, are not yet 
fully understood. 
1.7 Nitric oxide  
Nitric oxide (NO) is a ubiquitous gaseous signalling molecule involved in mediating a vast 
range  of  intra-  and  intercellular  signalling  cascades  and  regulation  of  physiological 
processes (Garthwaite, 1991). Also known as endothelium-derived relaxing factor (EDRF) 
for its roles in mediating vasodilation (Furchgott & Zawadzki, 1980; Ignarro et al., 1987; 
Palmer et al., 1987), NO is synthesised by the enzyme nitric oxide synthase (NOS), which 
converts the amino acid L-arginine into NO and citrulline through sequential oxygenation 
reactions (Villalobo, 2006). In mammals there are three isoforms of NOS, neuronal NOS 
(nNOS or NOS-I), inducible NOS (iNOS or NOS-II) and endothelial NOS (eNOS or NOS-
III) (Alderton et al., 2001). The lipophilic and non-polar nature of NO allows it to diffuse 
rapidly  and  freely  through  barriers  and  lends  to  its  wide  ranging  physiological  effects 
(Philippides  et  al.,  2000).  Early  ideas  regarding  the  predicted  physiological  sphere  of 
influence of an NO source, initially thought to be up to ~200 µm for a single source of NO 
that emits for 1 - 10 s (Wood & Garthwaite, 1994), have now been substantially revised. 
Simulating a 7 x 7 array of simultaneously active nNOS molecules generating NO at the 
highest achievable rate (Santolini et al., 2001), the NO concentration is predicted to reach 
only 1 nM and 250 pM, 60 nm and 1 µm away from the central source, respectively, a 
sphere of influence much smaller than initially predicted (Hall & Garthwaite, 2009).  
 
      The  apparent  half-life  of  NO  varies  across  tissues  and  is  highly  dependent  on  its 
physiological  environment  and  the  presence  of  NO  consuming  pathways  or  enzymatic 
processes (Hall & Garthwaite, 2009). In the blood, for example, where the reaction of NO 
with oxyhaemoglobin to form methaemoglobin and nitrate in the blood is rapid (Liu et al., 
1998b; Tsoukias, 2008), NO has a half life of ~0.1 - 2 ms (Hall & Garthwaite, 2009). In 
contrast, NO consumption is slower in brain tissue (cerebellum), with a half life of ~6 - 60 
ms  (Hall  &  Garthwaite,  2006;  Hall  &  Attwell,  2008).  As  well  as  enzymatic  NO 
consumption, NO has also been shown to chemically react with radicals such as superoxide 
or lipid peroxyl (Kissner et al., 1997; Padmaja & Huie, 1993), and in the presence of 
molecular  oxygen,  give  rise  to  a  variety  of  nitrogen  oxides  including  NO2  (nitrogen 28 
 
dioxide),  N2O3  (dinitrogen  trioxide),  NO2
-  (nitrite),  NO3
-  (nitrate)  and  ONOO
- 
(peroxynitrite anion), depending on the concentration (Conner et al., 1996; Robbins & 
Grisham, 1997).  
 
      A key target of NO is the hemoprotein soluble guanylate cyclase (sGC) that mediates 
one  of  the  main  transduction  mechanisms  through  which  NO  exerts  its  physiological 
effects  (Waldman  &  Murad,  1988).  sGC  catalyses  the  conversion  of  guanosine  5'-
triphosphate (GTP) to the second messenger guanosine 3', 5'-monophosphate (cyclic GMP; 
cGMP), and the reaction between NO and the heme group of sGC increases this catalytic 
activity by 50 to 200-fold (Ignarro, 1990; Derbyshire & Marletta, 2009). In turn, signal 
transduction is transferred by cGMP onto three main effectors, including cGMP-dependent 
protein  kinases,  cGMP-gated  cation  channels  and  phosphodiesterases  (Garthwaite  & 
Boulton, 1995). cGMP-dependent protein kinases (PKG), of which there are two isoforms 
(PKG-I and PKG-II), are major cGMP effectors (Fiscus et al., 1983) and further mediate 
signalling transduction mechanisms through the phosphorylation of a variety of protein 
targets (Francis & Corbin, 1994). On the other hand, cGMP-gated cation channels have 
been shown to play a central role in visual (Yau & Baylor, 1989) and olfactory (Zufall et 
al., 1994) signal transduction, while cyclic nucleotide phosphodiesterases (PDEs) may be 
activated  or  inhibited  in  response  to  cGMP  depending  on  the  subtype  (Garthwaite  & 
Boulton, 1995) (Fig. 1.3). NO itself is also able to directly influence the activity of a range 






























Figure 1.3 The NO-cGMP signalling pathway. NO generated by nitric oxide synthase (NOS) from 
the amino acid L-arginine acts on soluble guanylate cyclase (sGC) to increase its production of the 
second messenger cGMP. The three main effectors of cGMP are cGMP-dependent protein kinases 
(PKG), cGMP-gated cation channels and phosphodiesterases (PDE).  
 
      NO has been implicated particularly, among others, in the regulation of cardiovascular, 
immunological  and  neurological  processes.  As  well  as  being  a  primary  mediator  of 
vasodilatory  actions,  which  are  important  in  the  regulation  of  blood  flow  and  blood 
pressure (Palmer et al., 1987), in penile erection for example (Burnett et al., 1992), NO is 
an important regulator of cardiac function and contractility (Kelly et al., 1996; Massion et 
al., 2003). In the immune system, NO production by iNOS acts as a cytotoxic mediator of 
macrophages (Hibbs et al., 1988) and may be a significant modulator of acute and chronic 
inflammatory  processes  (Moncada  &  Higgs,  1993).  The  role  of  NO  as  a 
neurotransmitter/neuromodulator  has  been  extensively  investigated  since  it  was  first 
implicated as an intercellular messenger in the central nervous system (Garthwaite et al., 
1988). NO mediates the action of glutamate on N-Methyl-D-aspartate (NMDA) receptors 
in  the  brain  (Garthwaite  et  al.,  1988)  and  contributes  to  the  maintenance  of  synaptic 
plasticity, including cerebellar long-term depression (Daniel et al., 1998) and hippocampal 
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faced  molecule  (Snyder,  1993)  for  its  role  in  mediating  both  neuroprotective  and 
neuropathological events.  
1.8 NO and neurogenesis 
NO  has  been  directly  implicated  in  the  mechanisms  underlying  both  the  early  stages 
(neurogenesis)  and  advanced  stages  (synaptogenesis  and  neural  map  formation)  of 
neuronal  differentiation  and  may  also  play  an  important  role  in  developmental 
neurogenesis  (Contestabile  &  Ciani,  2004).  Indeed,  NO  exerts  a  dual  role  in  cell 
proliferation by mediating both proliferative and antiproliferative effects (Villalobo, 2006). 
While NO exerts an antiproliferative effect on cells such as vascular smooth muscle cells 
(Garg & Hassid, 1989) and endothelial cells (RayChaudhury et al., 1996), it mediates a 
proliferative effect on fibroblasts (Du et al., 1997) and myoblasts (Ulibarri et al., 1999).  
Similarly,  NO  mediates  both  neuroinhibitory  and  neuroproliferative  effects  in  adult 
neurogenesis and observations have shown NOS localisation to neurogenic sites in the 
dentate gyrus of the hippocampus and SGZ (Islam et al., 2003), and the SVZ, olfactory and 
rostral migratory stream (Moreno-Lopez et al., 2000). In vivo investigations by Packer et 
al. (2003) showed that the chronic inhibition of NOS with L-NAME increased proliferation 
in neurogenic zones such as the SGZ and SVZ in rats. Similarly, there was an increase in 
proliferating cells in response to systemic administration of a different NOS inhibitor, 7-
nitroindazole,  in  mice,  although  this  was  observed  only  in  the  SVZ  and  not  the  SGZ 
(Moreno-Lopez et al., 2004). This disparity in region responses is probably due to the 
presence of specific cell types or sensitivity differences (Matarredona et al., 2005). These 
studies all support the idea that NO acts as a negative regulator of adult neurogenesis, 
although  it  must  be  noted  that  both  L-NAME  and  7-nitroindazole  are  relatively  non-
selective NOS inhibitors (Moore & Handy, 1997; Reiner & Zagvazdin, 1998). 
 
      Conversely, others have described NO as a positive regulator of adult neurogenesis. 
The administration of the NO donor, DETA/NONOate, increased cell proliferation in the 
SGZ and SVZ under both normal conditions and in response to stroke in young adult rats 
(Zhang et al., 2001). Likewise, the prior administration of 7-nitroindazole and the iNOS 
inhibitor  aminoguanidine  significantly  reduced  the  number  of  proliferating  cells  in  the 
dentate gyrus after pentylenetrazol-induced seizures in rats (Jiang et al., 2004), supporting 
a role for NO in brain repair after brain injury or seizures. DETA/NONOate has also been 
shown to produce antidepressant effects by promoting hippocampal neurogenesis in young 31 
 
adult mice (Hua et al., 2008). The explanation for these paradoxical effects of NO may lie 
in the differential effects of the NOS isoforms (Cardenas et al., 2005) and/or the opposing 
effects of intracellular and extracellular NO signalling (Luo et al., 2010). 
1.9 The aims of this project 
A decline in adult hippocampal neurogenesis and cell loss has been linked with  stress 
(Gould & Tanapat, 1999), depression (Malberg et al., 2000; Santarelli et al., 2003; Duman, 
2004) and neurodegenerative diseases such as Alzheimer's disease (Haughey et al., 2002). 
It  is  only  through  furthering  our  understanding  of  the  mechanisms  controlling  the 
proliferation  of  endogenous  neural  stem/precursor  cells  that  new  and  more  specific 
pharmacological  targets  can  be  identified  for  promoting  hippocampal  neurogenesis, 
neuronal regeneration and structural repair in the CNS in an attempt to alleviate these 
pathological conditions. 
 
      NPY  is  emerging  as  an  important  regulator  of  adult  hippocampal  neurogenesis 
although  the  mechanisms  underlying  this  effect  are  unknown.  Given  the  bifunctional 
effects of NO on neurogenesis and the localisation of NOS to NPY-responsive neurogenic 
areas, a key question to address is whether NO could be a mediator of NPY signalling. 
Indeed, a connection between NO and the physiological effects of NPY was previously 
described by Morley et al. (1991, 1999), who showed that a low dose of NPY was able to 
significantly  increase  NOS  expression  in  the  hypothalamus  and  that  an  NPY-induced 
increase in food intake was mediated via NOS. More recently, Alvaro et al. (2008) showed 
that NOS was involved in mediating the NPY-induced proliferation of retinal neural cells, 
further supporting this hypothesis.  
 
      The  aim  of  this  study  was  to  investigate  the  involvement  of  NO  in  mediating  the 
neuroproliferative  effect  of  NPY.  This  was  carried  out  using  an  established  in  vitro 
monolayer hippocampal cell culture system (Howell et al., 2003) upon which the survival, 
proliferation and differentiation of precursor and neuronal cells could be easily quantified. 
After  confirming  the  neuroproliferative  effects  of  NPY,  the  involvement  of  NO 
mechanisms and the key mediators of the signalling pathway involved in coupling NPY to 
cell, particularly nestin
+ stem/precursor cell, proliferation were investigated. Of particular 
interest  was  identifying  the  NOS  subtype  involved  and  the  effects  of  intracellular  or 32 
 
extracellular NO, both of which are factors involved in determining the dual proliferative 














































































































Chapter 2 - Neuropeptide Y promotes the proliferation of hippocampal precursor 
cells in culture  
2.1 Introduction 
NPY, named due to the many tyrosine (Y) residues within its structure (Tatemoto, 1982), 
has  been  implicated  in  the  regulation  of  a  series  of  physiological  processes  including 
memory processing, depression and seizures. In turn, these processes have been shown to 
influence, or be influenced by, fluctuations in levels of adult mammalian hippocampal 
neurogenesis. These initial observations suggest a role for NPY in the regulation of adult 
hippocampal neurogenesis. Using an in vitro primary cell culture system of hippocampal 
cells,  first  described  by  Brewer  (1997)  and  adapted  by  Howell  et  al.  (2003),  the 
physiological  effects  of  NPY  on  cell  proliferation,  phenotype  and  survival  were 
investigated. 
2.1.1 Neuropeptide Y 
In the peripheral nervous system, high levels of NPY-immunoreactivity are found in the 
sympathetic ganglia and in tissues innervated by the sympathetic system, including the 
heart, blood vessels, spleen and visceral smooth muscle (Lundberg et al., 1982, 1984a, 
1988). NPY is released by sympathetic nerves, the adrenal glands (Briand et al., 1990) and 
platelets  (Myers  et  al.,  1988),  and  is  also  co-released  with  catecholamines  such  as 
noradrenalin into the blood in response to strong sympathetic activation such as exercise or 
shock (Lundberg et al., 1984b, 1985; Pernow et al., 1986). In the central nervous system, 
NPY-immunoreactivity  is  abundant,  with  the  highest  concentrations  found  in  the 
paraventricular hypothalamic nucleus and hypothalamic arcuate nucleus (Chronwall et al. 
1985). In addition, NPY-immunoreactivity has been shown colocalised to catecholamine 
neurons  in  the  medulla  oblongata  and  with  a  range  of  other  neuropeptides  and 
neurotransmitters (Hökfelt et al., 1983, Everitt & Hökfelt, 1989, Lundberg et al., 1990). 
The abundant and widespread distribution of NPY, as well as its coexistence with other 
neurotransmitter systems, supports its role as a central and complex signaling agent which 
interacts with other transmitter systems.  
 
      In the hippocampus, NPY is largely localised within a subset of gamma-aminobutyric 
acid  (GABA)-ergic  interneurons  in  the  dentate  hilus  (Kohler  et  al.,  1986;  Freund  & 
Buzsaki, 1996), and similar to other secreted neuropeptides, is synthesised as an inactive 
pre-pro-peptide  (von  Hörsten  et  al.,  2004).  The  signal  peptide  of  the  pre-pro-NPY  is 36 
 
removed in the endoplasmic reticulum before pro-NPY is cleaved further by consecutive 
enzymes to generate the active amidated NPY which is released from cells via exocytosis 
(Silva  et  al.,  2005).  NPY  also  shares  close  homology  to  two  other  36  amino-acid 
polypeptides, pancreatic polypeptide (PP) and Peptide YY (PYY) (Michel et al., 1998).    
2.1.2 Neuropeptide Y receptors  
There are five NPY receptor subtypes (Y1, Y2, Y4, Y5 and Y6) which mediate the effects of 
NPY peptide. Activation of the GPCRs leads to the activation of intracellular signalling 
cascades (Michel et al., 1998). Following NPY binding and receptor phosphorylation, the 
Y1 receptor is internalised by endocytosis as part of the desensitisation process (Pheng et 
al., 2003). Significant differences in the expression and distribution of the neuropeptide Y 
receptors  in  the  brain  are  observed  across  species  (rodents,  guinea  pig  and  primates) 
(Dumont  et  al.,  1998),  although  regional  differences  are  less  pronounced.  Within  the 
hippocampus, high levels of the Y1 receptor are localised within the molecular layer of the 
dentate gyrus (Kopp et al., 2002), while Y2 is distributed predominantly in the CA3 region 
(Gustafson  et  al.,  1997).  One  function  of  the  Y1  receptor  is  to  mediate  the 
neuroproliferative effects of NPY on selected cell types (Hansel et al., 2001; Howell et al., 
2003). Y4, which shows higher affinity for PP and PYY, is expressed at very low levels in 
the hippocampus (Dumont et al., 1998) while low levels of Y5, which is implicated in 
feeding  behaviour  and  obesity,  is  expressed  in  the  Ammon’s  horn  of  the  ventral 
hippocampus and molecular layer of the dentate gyrus (Wolak et al., 2003). As well as 
being  highly  distributed  within  the  brain,  NPY  receptors  are  also  widely  distributed 
throughout the body due to its diverse physiological functions. 
2.1.3 The neuroproliferative effect of NPY 
Hansel et al. (2001) were one of the first to demonstrate the proliferative effects of NPY on 
neuronal  precursor  cells  derived  from  the  postnatal  rat  olfactory  epithelium.  NPY  at 
concentrations as low as 10 nM were sufficient to promote the proliferation of precursor 
cells and neuroproliferation increased in a dose-dependent manner (Hansel et al., 2001). 
NPY  is  able  to  stimulate  the  proliferation  of  a  range  of  cell  types  including  neuronal 
precursor cells from the hippocampal SGZ (Howell et al., 2003), retinal glial (Muller) cells 
(Milenkovic et al., 2004), endothelial cells (Movafagh et al., 2006) and precursor cells 
from the SVZ (Agasse et al., 2008), while inhibiting the proliferation of human retinal 
pigment epithelial cells (Troger et al., 2003).   37 
 
      Studies by Howell et al. (2003) have shown that NPY acts exclusively to increase the 
proliferation of nestin
+ precursor cells and class III β-tubulin
+ neuroblasts in post-natal in 
vitro rat hippocampal cultures. NPY was proliferative for nestin
+ precursor cells from both 
the  dentate  gyrus  and  the  rest  of  the  hippocampus,  but  only  for  class  III  β-tubulin
+ 
neuroblasts  from  the  dentate  gyrus,  suggesting  regional  specificities  in  proliferative 
responses to NPY in the hippocampal region (Howell at al., 2005; Gray, 2008). The small 
unipolar or bipolar nestin
+ proliferating precursor cells increased exponentially over time 
in  response  to  NPY  treatment,  as  shown  by  increases  in  total  cell  number,  BrdU 
incorporation  and  nestin  staining  (Howell  et  al.,  2003).  These  increases,  which  were 
mediated via the Y1 receptor, were purely neuroproliferative, as opposed to neurotrophic, 
as there was no difference in cell death between control and NPY-treated cultures (Howell 
et al., 2003). Furthermore, to assess the effects of NPY on neural stem cells, neurospheres 
(free-floating stem cell aggregates) were exposed to NPY in culture (Howell et al., 2007). 
NPY had a specific proliferative effect on neurosphere cultures, increasing both sphere size 
and  number,  while  the  phenotype  of  cells  within  the  spheres  remained  unchanged  in 
comparison  to  control  (Howell  et  al.,  2007).  When  plated  and  cultured  under 
differentiating  conditions,  the  neurospheres  gave  rise  to  neurones,  astrocytes  and 
oligodendrocytes  (Howell  et  al.,  2003).  The  proliferative  effect  of  NPY  has  also  been 
demonstrated in vivo, where Y1
-/- receptor knock-out mice show significantly reduced cell 
proliferation and decreased levels of DCX
+ immature neurons in the dentate gyrus (Howell 
et al., 2005).  
 
      In the dentate gyrus, NPY is present in a least four types of GABAergic interneuron 
(Sperk et al., 2007). These NPY-releasing interneurons receive numerous inputs (Miettinen 
& Freund, 1992), control the output of a number of excitatory pyramidal neurons, and 
innervate the dentate outer molecular layer (Knowles & Schwartzkroin, 1981; Sperk et al., 
2007). The hypothesis that GABAergic interneurons in the dentate hilus release NPY onto 
progenitors within the SGZ to control their proliferation (Gray, 2008) (Fig. 2.1.1) is further 
supported  by  studies  showing  that  Y1  receptors,  that  are  involved  in  mediating  the 







Figure  2.1.1  Schematic diagram  of  a  cross-section of  adult  hippocampus  showing  GABAergic 
NPY-releasing interneurons in the dentate gyrus. The dentate gyrus is made up of three main 
layers, the (A) molecular layer, (B) granular layer and (C) polymorphic layer. The subgranular 
zone (SGZ) runs between the granular and polymorphic layers. GABAergic interneurons in the 
dentate hilus modulate granule cell neuron excitability through feedback circuits from mossy fibre 
collaterals/CA3  region  and  feed  forward  circuits  from  the  entorhinal  cortex  (perforant  fibre 
pathway) and contralateral hippocampus (Freund & Buzsaki, 1996). Through sampling neuronal 
activity, GABAergic interneurons may release NPY onto progenitors within the SGZ to control 
their proliferation (Gray, 2008). HF, hippocampal fissure.      
2.1.4 The aims of this chapter 
The  aims  of  this  chapter  were  to  confirm  the  findings  of  Howell  et  al.  (2003,  2005) 
regarding the neuroproliferative effects of NPY on primary hippocampal cultures derived 
from the postnatal rat hippocampus. The effects of NPY on cell proliferation, phenotype 






Methodology and experimental aim 
The neuroproliferative effects of NPY on the proliferation, phenotype and survival of rat 
postnatal  hippocampal  cultures  (Howell  et  al.,  2003,  2005)  were  assessed  using  NPY 
peptide,  the  S-phase  marker  bromodeoxyuridine  (BrdU),  cell  death  markers  and 
immunocytochemistry for a range of cell type-specific markers.  
2.2.1 Primary hippocampal neuronal culture generation 
Primary hippocampal neuronal culture generation is a multi-step procedure consisting of 
hippocampi dissection, enzymatic dissociation, gradient isolation of cells and cell plating 
as described previously by Howell et al. (2003) and adapted from Brewer (1997). Cultures 
were  generated  from  early  post-natal  rats  because  the  granule  cell  layer  is  formed 
predominantly between post-natal days 5 and 20 (Altman & Bayer, 1990), thus allowing 
for the greatest yield of precursor cells in culture for studying effects on neuroproliferation.   
2.2.1.1 Hippocampi dissection 
Two sets of four (8 in total) Wistar rats of 7 to 10 post-natal day age were sacrificed by 
atlantoaxial  dislocation  followed  by  quick  decapitation  (Schedule  I  under  the  Animals 
Scientific Procedures Act 1986). Scissors were used to cut the skin and the skull, and 
forceps were used to remove the meninges. The whole brain was quickly transferred to a 
petri dish. Under sterile procedures, the hippocampi (two from each brain) were dissected 
and transferred onto a sterilised melinex strip on the stage of a MacIlwain tissue chopper 
with a small quantity of Gey’s balanced salt solution (Life Technologies, Paisley, UK) 
supplemented  with  4.5  mg  ml
-1  glucose  to  prevent  the  tissue  from  drying  out.  The 
hippocampi  were  cut  perpendicular  to  the  long  axis  into  slices  of  400  µm  thickness 
followed  by  rapid  transfer  into  a  petri  dish  containing  4  mls  of  Gey’s  solution 
supplemented with 4.5 mg ml
-1 glucose. The hippocampi were stored at 4°C for 5 min 
while the second set of hippocampi were dissected and cut.  
2.2.1.2 Enzymatic dissociation and cell release 
The Gey’s solution was aspirated and replaced with pre-warmed Neurobasal A (NBA-A) 
medium (Life Technologies, UK) supplemented with 2% B27 (Life Technologies) and 0.5 
mM Glutamine (Glu; Sigma Aldrich, UK) for 5 min at 37°C. Papain (22.0 U/mg; Sigma 
Aldrich, UK) at 2 mg/ml in NBA-A/B27/Glu was prepared at least 30 min before and pre-
warmed (37°C) before filter sterilisation through a 0.2 µm filter (0.22 µm pore, Millex-40 
 
GV, Millipore, USA). The filter sterilised pre-warmed papain solution was applied directly 
onto hippocampal slices for 30 min at 37°C to initiate enzymatic dissociation and cell 
release  from  hippocampal  slices.  After  30  min,  the  papain  solution  was  aspirated  and 
replaced with 4 ml of pre-warmed NBA-A/B27/Glu and further cell release was initiated 
by trituration. After trituration for about 10 times, the suspension was transferred into a 15 
ml centrifuge tube, further triturated if necessary and allowed to settle for about 1 min, 
after which a volume constituting half of the suspension (i.e. 2 ml from an original 4 ml) 
was removed from the top. The remaining sediment (2 ml) was further suspended in 2 ml 
of  fresh  pre-warmed  NBA-A/B27/Glu  for  further  trituration.  After  full  dissociation  by 
trituration,  a  cloudy  cell  suspension  in  6  mls  NBA-A/B27/Glu  per  four  animals  was 
obtained.  
2.2.1.3 Gradient isolation and enrichment of cells 
To purify cells from debris, the cell suspension was applied carefully onto the top of a two-
step density Optiprep (sterile solution of Iodixanol) gradient before centrifugation for 15 
min at 1900 rpm at room temperature. The Optiprep gradient was prepared by adding 2 ml 
10%  Optiprep  (Sigma  Aldrich,  UK)  in  NBA-A/B27/Glu  gently  on  top  of  2  ml  20% 
Optiprep in NBA-A/B27/Glu. After centrifugation, the fraction containing the cells was 
collected using a pipette and re-suspended into 2 ml of NBA-A/B27/Glu and centrifuged a 
second time for 2 min at 1100 rpm at room temperature to remove the Optiprep. After 
centrifugation, the supernatant was aspirated and the cell pellet re-suspended in 8 ml (1 
ml/animal) NBA-A/B27/Glu. 
 
      To determine the number of viable cells, 30 µl of cell suspension was mixed with 50 µl 
Trypan blue (Sigma Aldrich, UK), transferred onto a haemocytometer slide and live (dye-
excluding) cells counted. Cell suspension was typically diluted to a cell density of 100,000 
viable cells per ml for use. 
2.2.1.4 Cell plating  
Cells were plated onto 24 and 6 well polystyrene multiwell plates (Fisher Scientific, UK) 
which were pre-coated with poly-L-lysine. The coating of both 24 and 6 well multiwell 
plates involved the application of 250 µl and 800 µl of 50 µg/ml poly-L-lysine (Sigma 
Aldrich, UK) respectively, followed by incubation at room temperature for about 1 h, after 
which the poly-L-lysine was aspirated, allowed to dry, then rinsed with NBA-A/sterile 
distilled water to wash off any excess coating and warmed at 37°C before cell transfer. 41 
 
Viable cells were plated at a density of 100,000 cells/ml in NBA-A/B27/Glu at 500 µl/well 
in 24 well plates (260 cells/mm
2) and 1000 µl/well in 6 well plates (105 cells/mm
2). Cells 
were incubated under 5% CO2, 95% air (~20% O2), 37°C and 100% humidity incubator 
conditions.  
 
      2 h after plating, the medium in the wells were aspirated to remove any non-adherent 
cells  or  debris,  rinsed  with  pre-warmed  NBA-A/B27/Glu  and  replaced  with  fresh 
NBA/B27/Glu  medium  supplemented  with  1%  antibiotic/antimycotic  (Pen/Strep  and 
Fungizone,  Life  Technologies,  USA)  under  control  conditions.  Pharmacological  agents 
under study were also added at this time, for example, NPY (1 μM) (Sigma Aldrich, UK). 
Two-thirds of the growth media was replaced every three days for cultures longer than 
three days. 
2.2.1.5 Plating on coverslips 
Glass  coverslips  (13  mm  radius  borosilicate  glass,  VWR  International,  UK)  were 
transferred into 24 well polystyrene multiwell plates and coated with 300 μl of 50 µg/ml 
poly-L-lysine. After 1 h incubation at room temperature, the poly-L-lysine was aspirated, 
allowed to dry, rinsed with NBA-A/sterile distilled water and warmed at 37°C. Viable cells 
were  plated  at  a  density  of  100,000  cells/ml  NBA-A/B27/Glu  at  500  µl/well  (260 
cells/mm
2). Cells were incubated under 5% CO2, 95% air (~20% O2), 37°C and 100% 
humidity incubator conditions.  
 
      2 h after plating, the medium in the wells was aspirated to remove any non-adherent 
cells  or  debris,  rinsed  with  pre-warmed  NBA-A/B27/Glu  and  replaced  with  fresh 
NBA/B27/Glu  medium  supplemented  with  1%  antibiotic/antimycotic  (Pen/Strep  and 
Fungizone,  Life  Technologies,  USA)  under  control  conditions.  Pharmacological  agents 
under study were also added at this time. 
2.2.2 Measuring cell proliferation by incorporation of bromodeoxyuridine 
Proliferation in cultures was measured by the incorporation of bromodeoxyuridine (BrdU) 
(Sigma Aldrich, UK), a thymidine analogue, into dividing cells during the S-phase of the 
cell cycle (Cameron & McKay, 2001). Stocks of BrdU (1 mM in sterile water) were added 
directly to wells at a final concentration of 20 µM for 6 h before cell fixation. A 6 h 
exposure to BrdU was chosen because the S-phase is equal to a third to half of the total 
length of the cell cycle (12-14 h in progenitor cells (Hayes & Nowakowski, 2000)). During 42 
 
cell fixation, the growth media was aspirated and cells rinsed once in 0.1 M phosphate 
buffered  saline  (PBS)  for  3  min  (Sigma  Aldrich,  pH  7.4)  before  fixation  in  4% 
paraformaldehyde (PFA) for 20 to 30 min at 4ºC. Immunocytochemistry was used to label 
incorporated BrdU and was combined with 4’, 6-diamidino-2-phenylindole (DAPI) (Sigma 
Aldrich, UK) staining to derive the proliferation status of the cell population (number of 
BrdU
+ cells divided by the total cell count (DAPI)), otherwise known as the mitotic index. 
DAPI is a blue nuclear stain which binds to the double-stranded DNA of both healthy and 
dying cells. The combination of double staining with BrdU and cell phenotype specific 
markers (e.g. nestin for precursor cells) reveals the effect of treatments on the proliferating 
status of a specific cell type. 
2.2.3 Immunocytochemistry 
The fixed cultures were first washed in 0.1 M PBS 3 times to  remove PFA. Cultures 
treated  with  BrdU  underwent  an  additional  step  which  included  incubation  with  2  M 
hydrochloric acid (HCL) (Sigma Aldrich, UK) for 30 min at 37ºC. The HCL disrupts the 
nuclear envelope and unfolds the double stranded DNA to aid antibody binding to the 
nuclear incorporated BrdU antigen (Howell et al., 2003). Cells were then washed in PBS 3 
times before incubation in 5% donkey blocking serum (DBS) (Sigma Aldrich, UK) in 0.1 
M  PBS-0.1%  Triton  (PBS-T)  for  30  min  at  25°C  (room  temperature).  Triton  (X-100) 
(Sigma  Aldrich,  UK)  is  a  non-ionic  surfactant  used  to  permeabilise  eukaryotic  cell 
membranes. Cells were then incubated in 5% DBS in PBS-T with dilutions of primary 
antibodies (Table 2.2.1) overnight at 4ºC. The next day, cells were washed once in PBS 
before incubation with PBS-T containing dilutions of secondary antibodies (Table 4.2.1) 
for 2 h at room temperature (maintained under dark conditions to avoid bleaching). Cells 
were then washed once in PBS before being counterstained with the nuclear stain DAPI 
(20 µg/ml DAPI in distilled water) for 6 min. Cells were rinsed once in distilled water, 









Table 2.2.1 Primary and secondary antibody dilutions 
Primary antibodies  Company  Dilution 
Rat anti-BrdU  AbD Serotec, UK  1:500 
Mouse anti-rat nestin  BD Biosciences, UK  1:200 
Mouse anti-TUJ1  Cambridge Bioscience, UK  1:500 
Rabbit anti-TUJ1  Cambridge Bioscience, UK  1:500 
Rabbit anti-GFAP  Dako, UK  1:2000 
Isolectin B4 (IB4) 
AF555 conjugated 
Invitrogen  1:500 
Secondary antibodies  Company  Dilution 
Alexa Fluor donkey 
anti-rat 488   
Molecular Probes, Invitrogen, 
UK 
1:1000 
Alexa Fluor donkey 
anti-mouse 555 
Molecular Probes, Invitrogen, 
UK 
1:500 
Alexa Fluor donkey 
anti-rabbit 555 
Molecular Probes, Invitrogen, 
UK 
1:500 
Alexa Fluor donkey 
anti-mouse 488 
Molecular Probes, Invitrogen, 
UK 
1:500 
Alexa Fluor donkey 
anti-rat 594 





Millipore, UK  1:500 
 
      Coverslips  underwent  an  additional  mounting  step.  Immunostained  coverslips  were 
transferred (cell side down) onto mounting medium Mowiol (Sigma Aldrich, UK) on glass 
microscope slides. After a 40 min drying step, mounted coverslips were sealed with clear 
nail varnish which was allowed to dry before imaging.    
2.2.4 Cell counting and statistical analysis 
An inverted Leica DM IRB microscope (Leica Microsystems UK Ltd., Milton Keynes, 
UK) was used to capture fluorescent images for cell counting. Cell quantification was 
performed on 6 random 20X fields per well using the Volocity image capturing system 
version 4.2.0 (Improvision Inc., Lexington, USA). The area of a 20X field was previously 
measured using a 255 μm graticule slide. Raw data counts were averaged and expressed as 
cells/mm² per well or percentage of control, and plotted with the standard error of the mean 
(SEM). Plots were based on the mean of a sample of at least 4 wells per condition per 
experiment  from  a  minimum  of  three  independent  experiments  (n  ≥  3),  with  each 
experiment consisting of 16 hippocampi pooled from 8 animals. Data were plotted using 
GraphPad Prism data analysis software (GraphPad Software Inc., San Diego, CA, USA) 
and the appropriate statistical test (ANOVA with Dunnett's multiple comparison post-hoc 44 
 
test, ANOVA with Bonferonni’s post-hoc test or the Unpaired Students t-test) applied on 
the means. 
2.2.5 Culture characterisation 
The  phenotypic  characterisation  of  cells  was  carried  out  on  rat  primary  hippocampal 
cultures.  Hippocampal  cells  were  cultured  under  control  conditions  (NBA-A/B27/Glu 
medium plus 1% antibiotic/antimycotic) or in the presence of 1 μM NPY for 3 days in 
vitro (DIV) (Howell et al., 2003; Howell et al., 2005). On day 3, cells were pulsed with 20 
μM BrdU for 6 h before cell fixation in 4% PFA (Sigma Aldrich, UK). Fixed cultures were 
immunocytochemically  stained  for  the  S-phase  marker  BrdU,  the  stem/precursor  cell 
marker nestin, the astrocytic marker GFAP, the neuronal marker class III β-tubulin, the 
microglial marker isolectin IB4 and DAPI before imaging, cell quantification and analysis.  
2.2.6 Neuroproliferative effect of NPY on primary hippocampal neuronal cultures 
NPY has previously been shown to increase the proliferation of nestin
+ precursor cells in 
primary hippocampal neuronal cultures (Howell et al., 2003). This study was repeated to 
confirm the neuroproliferative effects of NPY (Sigma Aldrich, UK) as a control for further 
investigations. Hippocampal cells were cultured under control conditions or in the presence 
of 1 μM NPY for 5 DIV (Howell et al., 2003; Howell et al., 2005). Two-thirds of the 
growth media was replaced on day 3. On day 5, cells were pulsed with 20 μM BrdU for 6 h 
before cell fixation in 4% PFA. Fixed cultures were immunocytochemically stained for the 
S-phase marker BrdU, the stem/precursor cell marker nestin and DAPI before imaging, cell 
quantification and analysis.  
2.2.7 The acute neuroproliferative effect of NPY 
To assess the acute neuroproliferative effects of NPY, cells were grown under control 
conditions for 3 DIV before being pulsed with BrdU (20 μM) and either control medium or 
NPY (1 μM) for 6 h. Cells were fixed and cultures immunocytochemically stained for 
BrdU and nestin before cell imaging, quantification and analysis.   
2.2.8 Neurotrophic effect of NPY 
The neuroproliferative effects of NPY have been well demonstrated at a range of NPY 
concentrations (1 nM to 1 μM) (Howell et al., 2003). Howell et al. (2003) also showed that 
NPY was not neurotrophic and did not affect cell survival at 1 μM concentration using 
chromatin condensation as an assessment of cell death (Howell et al., 2003). To determine 
whether NPY has neurotrophic effects at lower concentrations, cell death was quantified in 45 
 
primary  hippocampal  cultures  in  the  presence  of  lower  concentrations  of  NPY. 
Hippocampal cells were cultured for 5 DIV in the absence of NPY (control) or in the 
presence  of  1  pM,  1  nM  or  1  μM  NPY.  On  the  fifth  day,  cell  death  in  culture  was 
quantified using the cell death marker Propidium Iodide (PI) and nuclear stain DAPI. PI, 
which is usually excluded from healthy cells with an intact membrane, binds to nucleic 
acids in dead or dying cells with a leaky membrane, emitting a fluorescence of about 590 
nm  wavelength.  PI  (Sigma  Aldrich,  UK)  was  added  directly  to  live  cultures  at  a 
concentration of 5 μg/ml (Eyupoglu et al., 2003) for 40 min at 37ﾰC. The PI-containing 
medium  was  then  aspirated  and  replaced  with  medium  (NBA-A/B27/Glu)  containing 
DAPI  (20  μg/ml)  for  40  min  before  aspiration,  and  replaced  with  fresh  medium  for 
imaging.  The  relative  proportion  of  dead  cells  (PI
+)  to  total  cell  count  (DAPI)  was 























2.3 Results  
2.3.1 Culture characterisation 
Primary  hippocampal  cultures  generated  from  postnatal  rats  resulted  in  mixed  cultures 
containing a variety of cell types. The cell types and proportions within the cultures were 
characterised using immunocytochemistry to cell type specific markers, as well as to the S-
phase marker BrdU, after 3 days in culture (Fig. 2.3.1A). There were cells immunopositive 
for the precursor cell marker nestin (Fig. 2.3.1B), the neuronal marker class III β-tubulin 
(Fig.  2.3.1C),  the  astrocytic  marker  GFAP  (Fig.  2.3.1D)  and  the  microglial  marker 

















Figure 2.3.1 Culture characterisation. Primary hippocampal cultures were stained for (A) the S-
phase cell marker BrdU (green), and a range of cell type-specific markers against (B) the precursor 
cell marker nestin (red), (C) the neuronal marker class III β-tubulin (red), (D) the astrocytic marker 
GFAP (red), and (E) the microglial marker isolectin IB4 (red). The cell nuclei were stained with 
DAPI (blue). Scale bar, 50 µm.   
 
      As well as uniform BrdU staining, speckled BrdU staining of cells was also observed 
(Fig. 2.3.1A bottom two cells). This speckled characteristic is representative of cells which 
(A)  (B)  (C) 
(D)  (E) 47 
 
have  entered  the  S-phase  later  or  when  a  labelled  cell  undergoes  cell  division,  which 
dilutes the amount of BrdU present (Raza et al., 1985). 
 
      The proportions of nestin
+, class III β-tubulin
+, GFAP
+ and IB4
+ cells were assessed in 
3-day-old  cultures.  Nestin
+  and  GFAP
+  cells  were  the  most  abundant  cell  phenotypes 
observed, with 40% and 41% proportions respectively, while just under a quarter of cells 
(24%) were class III β-tubulin
+. IB4
+ cells were in the minority (12%) (Table 2.3.1).  
 
Table  2.3.1  Proportions  of  specific  cell  phenotypes  and  BrdU  incorporation  in  hippocampal 
cultures after 3 d growth under control (NBA-A/B27/Glu medium plus 1% antibiotic/antimycotic) 
conditions
*.  The  cultures  were  exposed  to  the  S-phase  marker  BrdU  for  the  final  6  h  of  the 
experiment. n, number of wells sampled from at least 2 separate experiments. 
  BrdU (%)  Nestin (%)  Β-tubulin (%)  GFAP (%)  IB4 (%) 
Mean  10  40  24  41  12 
SEM  0.5  1.5  2.6  1.4  1.6 
n  48  29  6  6  5 
*The expression of cell markers overlap. 
2.3.2 NPY is neuroproliferative for hippocampal precursor cells 
To confirm that NPY is neuroproliferative for hippocampal precursor cells, 1 µM NPY 
was added to cultures over 5 DIV. Observations showed that NPY increased cell numbers 
as well as the number of BrdU
+ cells (Fig. 2.3.2). In response to NPY exposure, there were 
significant  increases  in  the  total  cell  count  (DAPI)  (196.3  ±  8.8  cells/mm
2  in  control 
condition compared to 255.5 ± 11.2 cells/mm
2 in NPY condition; Students unpaired t-test, 
p=0.0003, t=4.075, d.f.=30 and F=1.824) (Fig. 2.3.3A), BrdU
+ cell number (19.7 ± 1.5 
cells/mm
2  in  control  condition  compared  to  50.5  ±  9.3  cells/mm
2  in  NPY  condition; 
Students unpaired t-test, p=0.0044, t=3.084, d.f.=30 and F=42.64) (Fig. 2.3.3B) and the 
mitotic index (9.7 ± 2.5% in control condition compared to 20.7 ± 3.9% in NPY condition; 
Students unpaired t-test, p=0.0154, t=2.571, d.f.=30 and F=41.52) (Fig. 2.3.3E) of cultures. 
In  addition,  NPY  also  increased  the  numbers  of  nestin
+  precursor  cells  (95.4  ±  5.0 
cells/mm
2 in control condition compared to 121.0 ± 20.5 cells/mm
2 in NPY condition; 
Students unpaired t-test, p=0.0011, t=3.606, d.f.=30 and F=1.101) (Fig. 2.3.3C) and nestin
+ 
BrdU
+ precursor cells (12.1 ± 1.2 cells/mm
2 in control condition compared to 34.0 ± 5.7 
cells/mm
2  in  NPY  condition;  Students  unpaired  t-test,  p=0.0013,  t=3.534,  d.f.=30  and 48 
 
F=25.15) (Fig. 2.3.3D) as well as the mitotic index of the nestin
+ precursor cell population 
(12.3 ± 1.1% in control condition compared to 28.9 ± 4.7% in NPY condition; Students 










Figure 2.3.2 Exposure to NPY increased total cell counts. Hippocampal cultures treated under (A) 
control conditions (Neurobasal A/B27/glutamine) or (B) with NPY (1µM) at 5 DIV. The cultures 
were  exposed  to  the  S-phase  marker  BrdU  for  the  final  6  h  before  fixation  and 
immunocytochemistry for BrdU (green). The cell nuclei were stained with DAPI (blue). Scale bar, 
50 µm. 
2.3.4 NPY has an acute proliferative effect  
Hippocampal cultures (3 DIV) were exposed to a short 6 h pulse of 1 μM NPY to assess its 
acute neuroproliferative effects.  The proliferation of the cultures  increased over 6 h in 
response to NPY treatment. The total number of BrdU
+ cells was significantly increased 
(Students unpaired t-test, p=0.0026, t=3.339, d.f.=25 and F=1.399) (Fig. 2.3.4A), while the 
mitotic index of nestin
+ BrdU
+ precursors was also significantly enhanced by the presence 
of NPY (Students unpaired t-test, p=0.0016, t=3.548, d.f.=25 and F=1.054) (Fig. 2.3.4B).   
2.3.5 The effect of NPY on cultures is purely proliferative and not neurotrophic 
The increase in cell number in response to NPY treatment may be as a result of either 
proliferative or trophic effects. To clarify the effects of NPY on cell number, the effect of 
NPY concentration on cell survival was investigated. Hippocampal cultures were exposed 
to none (control), 1 pM, 1 nM or 1 μM NPY over 5 DIV before assessment of cell death by 
DAPI and PI staining. An increase in NPY concentration increased the total cell count, 
with a significant increase in response to 1 μM NPY (One-way ANOVA with Dunnett's 
post-hoc test, p<0.05, F=10.00 and d.f.=51) (Fig. 2.3.5A). On the other hand, increasing 
concentrations of NPY had no significant effect on the percentage cell death (PI
+ cells/total 
(A)  (B) 49 
 
cell count) of cultures (One-way ANOVA with Dunnett's post-hoc test, p>0.05, F=1.366 
and d.f.=50) (Fig. 2.3.5B). If NPY had a neurotrophic effect, the percentage of dead or 
dying cells compared to control would be significantly decreased. It can be concluded from 




































   
 






   
















Figure  2.3.3  NPY  was  neuroproliferative  for  nestin
+  hippocampal  precursor  cells.  Cells  were 
cultured under control conditions (Neurobasal A/B27/glutamine) or in the presence of 1 μM NPY 
for 5 DIV. BrdU was added for the final 6 h. (A) Total cell counts increased significantly with NPY 
treatment. (B) BrdU
+ cells, (C) nestin
+ precursor cells and (D) BrdU
+ precursor cells also increased 
significantly in response to NPY. The proliferation status or mitotic index of both (E) total cells 
(A)  (B) 
(C)  (D) 
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and (F) precursor cells was enhanced in the presence of NPY. Data represent mean ± SEM based 
on a sample that represents at least 15-17 wells per condition from three separate experiments. 













Figure 2.3.4 NPY had an acute proliferative effect on hippocampal cultures. Cells were cultured 
under control conditions (Neurobasal A/B27/glutamine) for 3 DIV before 20 μM BrdU and/or 1 
μM NPY was added for the final 6 h. (A) NPY significantly increased the number of BrdU
+ cells as 
well as (B) the mitotic index (proliferation status) of nestin
+ hippocampal precursor cells. Data 
represent mean ± SEM based on a sample that represents at least 12 wells per condition from three 














Figure 2.3.5 The effect of NPY was purely proliferative and not neurotrophic. Cells were cultured 
under control conditions (Neurobasal A/B27/glutamine) or in the presence of 1 pM, 1 nM or 1 μM 
NPY for 5 DIV. On day 5, cell death was assessed by PI and DAPI staining. (A) Total cell counts 
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were  increased  by  increasing  concentrations  of  NPY.  The  increase  in  total  cell  count  was 
significant  for  1  μM  NPY.  (B)  Increasing  NPY  concentration  had  no  significant  effect  of  the 
proportion of dead or dying cells. Data represent mean ± SEM based on a sample that represents at 
least 13 wells per condition from three separate experiments. One-way ANOVA with Dunnett’s 
































The neuroproliferative effect of NPY, first observed by Hansel et al. (2001) on postnatal 
precursor  cells  derived  from  the  olfactory  epithelium,  and  by  Howell  et  al.  (2003)  on 
postnatal hippocampal cultures, was also observed on primary hippocampal cultures in this 
study. It was important to verify these previous findings due to several reasons. Firstly, cell 
culturing techniques (adapted from Howell et al., 2003) often fluctuate between studies, so 
repetition allows for any major disparity to be identified, and secondly, it was important to 
validate these initial findings before carrying out further investigations into the actions of 
NPY.   
2.4.1 Culture characterisation 
The  relative  proportions  of  different  cell  phenotypes  within  cultures  were  assessed  by 
immunocytochemistry.  There  were  cells  immunopositive  for  the  precursor  cell  marker 
nestin,  the  astrocytic  marker  GFAP,  the  neuronal  marker  class  III  β-tubulin  and  the 
microglial  marker  isolectin  IB4.  These  results  can  be  compared  to  a  similar  study  by 
Howell et al (2003) who investigated the relative proportions of cell phenotype present in 
rat hippocampal cultures after 5 DIV (Table 2.4.1).  
 
Table 2.4.1 Cell phenotype after 5 DIV under control conditions (Howell et al., 2003). Proportions 
of specific cell phenotypes and BrdU incorporation in hippocampal cultures after 5 days growth 
under control (NBA-A/B27/Glu medium plus 1% antibiotic/antimycotic) conditions
*. The cultures 
were exposed to the S-phase marker BrdU for the final 24 h of the experiment. n, number of wells 
sampled  from  at  least  4  separate  experiments.  For comparison, the  mean  values  found in this 
present study (from Table 2.3.1) are shown in parentheses.  
  BrdU (%)  Nestin (%)  Β-tubulin (%)  GFAP (%)   










SEM  1.9  3.4  2.4  3.8   
n  54  22  29  14   
*The expression of cell markers overlap. 
†Cultures were exposed to BrdU for 6 h (instead of 24 h) in this study. 
 
      The relative proportions of nestin
+ cells (37.3%) and class III β-tubulin
+ cells (25.1%) 
obtained in Howell et al's study were similar to the proportions found here (40% and 24%, 
respectively), although Howell et al (2003) found the proportion of GFAP
+ cells to be 54 
 
slightly lower (around 10% lower). There was also a significantly higher proportion of 
proliferating cells (BrdU
+) observed by Howell et al. (2003), which is likely due to the 24 h 
(instead of 6 h) exposure to BrdU. 
2.4.2 The neuroproliferative effect of NPY 
As demonstrated by previous studies, NPY has a key role in modulating the proliferation 
of a range of cell types. Howell et al. (2003) have shown that the neuroproliferative effect 
of NPY on hippocampal neuronal cultures was primarily on nestin
+ hippocampal precursor 
cells and β-tubulin
+ neuroblasts. Similarly, my results confirm the proliferative effect of 
NPY (1 μM) on postnatal rat hippocampal neuronal cultures, as indicated by significant 
increases in total cell count, numbers of proliferating cells and mitotic indices (indicative 
of  proliferating status).  The neuroproliferation of nestin
+  precursor  cells also  increased 
significantly in response to 1 μM NPY treatment over 5 DIV. Indeed, previous studies 
have shown that even concentrations as low as 1 nM are proliferative for rat hippocampal 
cultures,  and  this  proliferative  effect  was  enhanced  with  an  increase  in  peptide 
concentration  (Howell  et  al.,  2003).  With  regards  to  whether  the  pharmacological 
concentrations used in vitro are representative of in vivo levels, a study by Nam et al. 
(2001) showed that the average concentration of NPY in the cerebrospinal fluid of normal 
weight  individuals  was  ~130  pg/ml,  equivalent  to  about  30  nM  free  NPY.  These 
concentrations are likely to be much higher at the site of NPY release  in vivo and are 
reflective of levels at which NPY was used in pharmacological studies. 1 μM NPY was 
chosen  for  further  studies  into  the  underlying  mechanisms  because  of  its  potent 
proliferative  effects  and  was  the  concentration  most  frequently  used  in  other  studies 
(Howell et al., 2003, 2005; Alvaro et al., 2008), thus allowing comparison between data 
sets.  In  addition  to  having  a  general  proliferative  effect  on  hippocampal  cultures,  a 
significant increase in proliferation was observed in response to an acute pulse of NPY for 
6 h. This acute effect of NPY had also been shown to be effective in response to a 4 h 
exposure (Howell et al., 2003). Results confirm that the proliferative effect of NPY was 
purely proliferative and not as a result of trophic mechanisms. Through an assessment of 
total cell count and cell death in response to increasing levels of peptide (1 pM, 1 nM and 1 
μM), no significant trophic effects were observed. Although there seemed to be a minor 
downward trend in cell death with increasing peptide concentration, this observation was 
not  significant.  In  similar  studies  which  used  nuclear  condensation  (pyknotic  nuclei) 
(Howell et al., 2003) or the TUNEL apoptosis assay (Hansel et al., 2001) as a marker of 55 
 
cell death, the effect of NPY was also confirmed to be purely proliferative as levels of cell 
death were comparable between control and NPY treated cultures. Results show that total 
cell  counts  increased  in  response  to  increasing  concentrations  of  NPY,  an  observation 
previously  confirmed  by  Howell  et  al.  (2003).  However,  in  comparison  to  that  study, 
although there was an increase in total cell counts at 1 nM NPY exposure compared to 
control (Fig. 2.3.5); current results did not show a significant proliferative effect at that low 
a concentration. One explanation may be a difference in the source of the NPY peptide.  
2.4.3 NPY in learning and memory 
Adult hippocampal neurogenesis is functionally required and important for some forms of 
hippocampal-dependent  learning  and  memory  (Shors  et  al.,  2001;  Shors  et  al.,  2002). 
Research has shown that NPY may play an important role in the modulation of learning 
and  memory  processes.  Flood  et  al  (1987)  have  shown  that  intracerebroventricular 
injections of porcine NPY fragments enhanced memory retention after training in mice and 
also  alleviated  amnesia  induced  by  anisomycin  (protein  synthesis  inhibitor)  and 
scopolamine (anticholinergic). Furthermore, NPY over-expressing transgenic mice show 
selective impairment of spatial memory acquisition in Morris water maze trials, which was 
associated with decreased hippocampal NPY-Y1 receptor binding in response to elevated 
NPY levels (Thorsell et al., 2000). The Y2 receptor subtype had also been implicated in 
cognitive  processing.  NPY  Y2  receptor-negative  mice  (NPY  Y2
−/−)  display  deficits  in 
Morris  water  maze  tasks  and  exhibit  significant  deterioration  in  object  memory  tests, 
supporting the possible involvement of NPY action on Y1 and Y2 receptors as a modulator 
of learning and memory (Redrobe et al., 2004).        
2.4.4 The role of NPY in depression  
Adult hippocampal neurogenesis is frequently linked to the pathogenesis of depression. 
Stress, a common prerequisite for depression, has been shown to decrease hippocampal 
neurogenesis (Gould et al., 1997), while hippocampal neurogenesis was increased in rats 
following  the  chronic  administration  of  antidepressants  (Malberg  et  al.,  2000).  This 
increase  in  dividing  hippocampal  neural  progenitor  cells  in  response  to  antidepressant 
treatment has also been observed post-mortem in the dentate gyrus of patients with major 
depressive disorder (Boldrini et al., 2009). There have been a range of animal and human 
studies implicating NPY in depression (Redrobe et al., 2002a). Electroconvulsive therapy 
(ECT) is a well established psychiatric therapy for depression and studies have shown that 
electroconvulsive shock stimulation (ECS), an animal model of ECT, increases NPY gene 56 
 
expression and NPY immunoreactivity in hippocampal and cortical homogenates (Stenfors 
et al., 1995). Moreover, decreased levels of NPY have been detected in the cerebrospinal 
fluid (CSF) of depressed patient compared to healthy controls (Widerlov et al., 1988). The 
action of NPY in regulating hippocampal neurogenesis has also been implicated in the 
mechanism  of  action  of  many  antidepressant  drugs  (Redrobe  et  al.,  2002a).  Lithium 
treatment, which was often used in the management of bipolar disorder, had been shown to 
increase  mRNA  and  peptide  levels  of  NPY  (Husum  et  al.,  2000),  while  chronic 
antidepressant  treatment  with  antidepressant  drugs  such  as  fluoxetine  and  imipramine 
increase mRNA levels of NPY peptide and NPY Y1 receptor (Caberlotto et al., 1998). In 
animal forced swimming tests, which are widely used for the screening of prospective 
antidepressant drugs, intracerebroventricular NPY and [Leu
31Pro
34]PYY (selective Y1/Y5 
agonist) administration significantly reduced the immobility time (time in which animal 
spends without moving). The immobility time tends to be decreased with antidepressants. 
Meanwhile, selective Y1 antagonists such as BIBP3226 blocked the anti-immobility effects 
of NPY, suggesting the possible involvement of the Y1 receptor in the pathogenesis of 
depression  (Redrobe  et  al.,  2002a).  With  further  understanding  of  the  mechanisms 
underlying  the  mediation  of  depression,  novel  pharmacotherapeutic  treatments  for 
depressive disorders, such as synthetic NPY Y1 agonists, may be developed (Redrobe et 
al., 2002b).  
2.4.5 NPY and temporal lobe epilepsy 
Seizures have been shown to increase neurogenesis in both the SGZ and SVZ (Parent et 
al., 1997; Bengzon et al., 1997; Parent et al., 2002), while NPY levels in the dentate gyrus 
and hippocampus have been shown to increase significantly in response to seizure activity 
(Marksteiner  et  al.,  1989).  A  study  by  Howell  et  al  (2007)  has  demonstrated  the  link 
between NPY and seizure-induced precursor cell proliferation in the hippocampus using 
NPY
-/- mice. Using BrdU as a marker of dividing cells in kainate-induced seizures, NPY
-/- 
mice  exhibited  a  41%  reduction  in  BrdU-immunopositive  cells  within  the  SGZ  in 
comparison  to  control  animals.  The  results  suggested  that  NPY  was  an  important 
modulator of precursor cell proliferation under both normal conditions and in response to 
seizure activity (Howell et al., 2007).   
 
      In conclusion, the neuroproliferative effects of NPY first observed by Hansel et al. 
(2001) and Howell et al. (2003) have been verified by this study. The effect of NPY was 57 
 
purely proliferative with no trophic effects on hippocampal cultures. This confirmation 
now allows us to further investigate this proliferative effect and the possible intracellular 




















































































































Chapter 3 – The proliferative effect of NPY is mediated via NOS and NO  
3.1 Introduction 
NPY  exerts  a  purely  proliferative  effect  on  postnatal  hippocampal  cultures  which  is 
mediated via its NPY Y1 receptor. The cellular mechanisms underlying this proliferative 
effect are not fully understood, although NOS and NO may be implicated.  
3.1.1 Nitric oxide synthase 
The  three  isoforms  of  NOS,  nNOS,  eNOS  and  iNOS,  first  identified  in  1989,  are 
individually  encoded  by  distinct  genes  and  have  differential  regulatory,  catalytic  and 
inhibitory properties and localisation profiles (Knowles et al., 1989; Knowles & Moncada, 
1994; Cardenas et al., 2005). nNOS was the first NOS isoform identified and predominates 
in  neuronal  tissue  (Bredt  & Snyder, 1990),  while iNOS  is  named due  to  its  inducible 
expression in a range of tissues and cells (Stuehr & Griffith, 1992). eNOS, on the other 
hand, was first identified in vascular endothelial cells (Pollock et al., 1991). Generally, the 
isoforms  are  further  categorised  based  on  their  constitutive  (nNOS  and  eNOS)  versus 
inducible  (iNOS)  expression,  and  calcium-dependence  (nNOS  and  eNOS)  or  -
independence  (iNOS)  (Bredt  &  Snyder,  1990;  Yui  et  al.,  1991).  There  is  a  51-57% 
homology between the NOS isoforms in humans (Alderton et al., 2001). Simply put, NOS 
catalyses a reaction between the substrates L-arginine, NADPH and oxygen to the reaction 
products citrulline, NADP and a free radical NO (Knowles et al., 1989; Knowles et al., 
1990). As well as the presence of calmodulin (CaM), other coenzymes or cofactors are also 
required, including iron protoporphyrin IX (haem), FAD, FMN and BH4, which are all 
relatively  tightly-bound  (Knowles  &  Moncada,  1994).  Structurally,  the  NOSs  have  a 
bidomain structure, consisting of an N-terminal oxygenase domain which is interconnected 
to  the  C-terminal  reductase  domain  through  a  CaM-recognition  site  (Ghosh  &  Stuehr, 
1995; Sheta et al., 1994). The oxygenase domain contains binding sites for haem, BH4 and 
L-arginine, while the reductase domain binds FMN, FAD and NADPH (Ghosh & Stuehr, 


















Figure  3.1.1  The  bidomain  structure  of  NOS.  NADPH  donates  electrons  (e
-)  to  the  reductase 
domain which flows through FAD and FMN before reaching the oxygenase domain and interacting 
with the haem iron and BH4. This active site then catalyses the reaction of L-arginine with oxygen, 
generating the reaction products citrulline and NO. Bound Ca
2+/CaM is required for electron flow 
(adapted from Alderton et al., 2001).     
 
      Subtype  specific  variances  at  the  primary,  secondary,  tertiary  and  even  quaternary 
structural level account for their distinct properties. In their active form, two monomers of 
NOS (dimeric form) associate with two CaMs, resulting in a tetrameric complex (Alderton 
et al., 2001). 
3.1.2 Regulation of NOS activity  
NO is important in mediating a variety of physiological roles, influenced in part by the 
localisation  of  the  NOS  subtypes  to  specific  cells  and  tissues  through  transcriptional 
regulation and the regulation of NOS activity by phosphorylation or proteins such as CaM 
(Gachhui et al., 1998), protein inhibitor of nNOS (PIN) (Jaffrey & Snyder, 1996), nitric 
oxide synthase interacting protein (NOSIP) (Dreyer et al., 2004) or heat-shock protein 90 
(Hsp90) (Garcia-Cardena et al., 1998), to name a few. Phosphorylation of NOS results in 
either an increase or decrease in NOS activity depending on the phosphorylation site and 
the NOS subtype. For example, while the NO production activity of eNOS is increased in 
response to the phosphorylation of Ser
1179 by protein kinase Akt (Dimmeler et al., 1999), 
nNOS  activity  is  decreased  in  response  to  Ser
847  phosphorylation  by  CaM-dependent 
kinases (Komeima et al., 2000) but increased in response to Ser
1412 phosphorylation (Adak 
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847 also increases nNOS activity, acting as a means by which to control nNOS activity 
(Rameau et al., 2004; Zhou & Zhu, 2009). Protein-protein interactions involving CaM are 
essential for the NOS activity of all three isoforms, although the Ca
2+ dependence may be 
different, and facilitates the electron flow from NADPH to the reductase domain (Gachhui 
et al., 1998). The proteins PIN and NOSIP have been shown to inhibit nNOS activity 
(Jaffrey & Snyder, 1996; Dreyer et al., 2004; Zhou & Zhu, 2009), while the heat-shock 
protein, Hsp90, is also a regulator of NOS, specifically eNOS, activity (Garcia-Cardena et 
al., 1998). Garcia-Cardena et al. (1998) showed that agonists, such as vascular endothelial 
growth factor, histamine and fluid shear stress, which stimulate NO production, increase 
the interaction between eNOS and Hsp90 and enhance eNOS activity. 
3.1.3 Galanin 
Galanin is a widely expressed 29-30 amino acid neuropeptide whose effects are mediated 
via  its  three  known  receptors  (GalR1,  2  and  3)  which  are  also  a  part  of  the  GPCR 
superfamily  of  receptors.  Like  NPY,  galanin  has  been  implicated  in  the  control  of 
physiological processes such as feeding behaviour, seizure activity, cognitive processes 
(learning and memory) and mood (Lundström et al., 2005; Hobson et al., 2008). Similarly, 
galanin has been shown to promote neurogenesis and is neuroprotective by acting through 
its GalR2/3 receptor (Hobson et al., 2008, Abbosh et al., 2011). During development and 
adulthood there are high levels of galanin peptide and GalR1/2 in the SVZ and SGZ (Shen 
et al., 2005) and, like NPY, galanin is proliferative for postnatal hippocampal precursor 
cells (Abbosh et al., 2011) and neurospheres derived from hippocampal precursor cells 
(Hawes et al., 2006).  
3.1.4 The aims of this chapter 
The aims of this chapter were to determine the involvement of NOS and NO in mediating 
the  neuroproliferative  effect  of  NPY  on  postnatal  hippocampal  cultures,  which  was 
explored  through  the  use  of  NOS  and  NO  selective  pharmacological  agonists  and 
antagonists,  fluorescent  NO  indicators  and  immunocytochemistry.  The  widespread 
physiological  effects  of  NO  can  be  attributable,  in  part,  to  the  existence  of  the  NOS 
isoforms, prompting further investigations into the NOS subtype involved. To determine 
whether  NOS  and  NO  signalling  is  common  in  the  proliferative  action  of  other 




Methodology and experimental aim 
The  NOS  and  NO  mechanisms  underlying  NPY-mediated  neuroproliferation  were 
investigated in an in vitro rat hippocampal cell culture system. A detailed description of 
primary  hippocampal  cell  culture  generation,  cell  plating,  the  assessment  of  cell 
proliferation  with  BrdU,  immunocytochemistry  and  cell  quantification  and  statistical 
analysis  is  provided  in  Chapter  2.  Unless  otherwise  stated,  a  one-way  ANOVA  with 
Dunnett's multiple comparison test was applied to the raw data to determine significance 
levels compared to control conditions (p = <0.05). The concentration of pharmacological 
agonists or antagonists were chosen based on published literature (Table 3.2.1).  
 
Table 3.2.1 Agonists and antagonists 
Agonists  Company  Concentration 
Y1 agonist [F7, P34]NPY  Prof. Dr A.G. Beck-
Sickinger, Universität 
Leipzig, Germany 
1 µM (Howell et al., 2003) 
L-arginine  Sigma Aldrich, UK  500 µM (Nakamura et al., 2006) 
Galanin 2-11  Sigma Aldrich, UK  100 nM (Abbosh et al., 2011) 
Antagonists  Company  Concentration 
N(ω)-Nitro-L-arginine 
methyl ester (L-NAME) 
Sigma Aldrich, UK  500 µM (Alvaro et al., 2008) 
N(ω)-Nitro-D-arginine 
methyl ester (D-NAME) 
Sigma Aldrich, UK  500 µM (used same concentration 
as active enantiomer L-NAME) 
3-Bromo7-nitroindazole 
(3B7N) 
Tocris Bioscience, UK  100 nM (Bland-Ward & Moore, 
1995) 




Sigma Aldrich, UK  200 nM (Hah et al., 2001) 
 
3.2.1 Effect of L-NAME on NPY-mediated neuroproliferation 
N(ω)-Nitro-L-arginine methyl ester (L-NAME) (Sigma Aldrich, UK) was used to study the 
involvement  of  NO  in  NPY-mediated  neuroproliferation.  L-NAME,  a  non-subtype 
selective inhibitor of NOS, is frequently used in the study of NO signalling. N(ω)-Nitro-D-
arginine  methyl  ester  (D-NAME)  (Sigma  Aldrich,  UK),  an  inactive  enantiomer  of  L-
NAME was used as a control and to test the specificity of L-NAME. Primary hippocampal 
cells  were  cultured  under  control  conditions  (NBA-A/B27/Glu  medium  plus  1% 
antibiotic/antimycotic) and in the presence of NPY (1 μM) and 500 μM L-NAME or D-
NAME (Alvaro et al., 2008) for 3 DIV. On day 3, cultures were pulsed with 20 μM BrdU 65 
 
for 6 h before cell fixation with 4% paraformaldehyde (PFA), immunocytochemistry for 
BrdU and nestin, cell imaging, quantification and analysis.  
 
      The  proliferative  effect  of  NPY  on  hippocampal  cultures  is  mediated  via  the  Y1 
receptor  (Howell  et  al.,  2003).  To  assess  the  involvement  of  NO  in  Y1-mediated 
proliferative  effects,  the  Y1  agonist  [F7,  P34]NPY  (courtesy  of  Prof.  Dr  A.G.  Beck-
Sickinger, Universität Leipzig, Germany) was used in the presence of L-NAME and D-
NAME. Primary hippocampal cells were cultured under control and in the presence of [F7, 
P34]NPY (1 μM) and/or 500 μM L-NAME or D-NAME for 3 DIV. On day 3, cultures 
were pulsed with 20 μM BrdU for 6 h before cell fixation, immunocytochemistry for BrdU 
and nestin, cell imaging, quantification and analysis.  
3.2.2 L-arginine effects on hippocampal cultures  
The amino acid L-arginine is a substrate used by NOS in the production of NO. L-arginine 
was added to cultures as a way of increasing the endogenous production of NO to assess 
the  involvement  of  NO  in  cell  proliferation.  D-arginine,  an  inactive  enantiomer  of  L-
arginine was used as a control. Hippocampal cells were cultured under control conditions 
and in the presence of 500 μM L-arginine or D-arginine (Sigma Aldrich, UK) for 3 DIV. 
On the third day, cultures were pulsed with 20 μM BrdU for 6 h before cell fixation. The 
cultures were then stained immunocytochemically for BrdU and nestin, imaged, quantified 
and analysed.  
3.2.3 Selective inhibition of NOS isoforms in vitro 
Subtype-selective  antagonists  were  used  to  identify  the  NOS  subtype  involved  in 
mediating the neuroproliferative effect of NPY. Potent and selective inhibitors of eNOS 
were not commercially available, so investigations were focused on either selective nNOS 
or  iNOS  inhibition.  The  subtype-selectivity  of  NOS  inhibitors,  however,  is  sometimes 
debated (Moore & Handy, 1997). 7-nitroindazole, for example, which is often used as a 
selective inhibitor of nNOS in a range of studies, and was originally thought to be very 
selective,  especially  in  vivo  (Moore  et  al.,  1993),  has  now  been  demonstrated  to  be 
relatively non-selective (Cholet et al., 1996; Zagvazdin et al., 1996). Indeed, the highly 
conserved  active  site  of  NOS  makes  the  design  of  selective  NOS  inhibitors  difficult 
(Garcin et al., 2008), the choice of inhibitors is often limited, and perfect inhibitors do not 
exist. Instead, caution must be made when interpreting the results of NOS inhibition when 
using any 'subtype-selective' inhibitors. 66 
 
      Hippocampal  cells  were  exposed  to  control  (NBA/B27/Glu  and  1% 
antibiotic/antimycotic), 1 µM NPY and/or 100 nM 3-Bromo7-nitroindazole (3B7N, Tocris 
Bioscience) or 100 nM EIT hydrobromide (EITH, Tocris Bioscience) for 3 DIV before a 6 
h 20 µM BrdU pulse and cell fixation. 3B7N is a nNOS and partial iNOS inhibitor (Bland-
Ward et al., 1994), while EITH is a selective iNOS inhibitor (Nakane et al., 1995). To 
further confirm the involvement of the nNOS isoform in mediating the effects of NPY, 
hippocampal cells cultured for 3 DIV were exposed to 1 µM NPY and/or N-(4S)-4-amino-
5-[aminoethyl]aminopentyl-N′-nitroguanidine (AAAN, 200 nM; Sigma  Aldrich) and 20 
µM BrdU for 6 h on the final day before cell fixation. AAAN is a selective inhibitor of the 
nNOS isoform, supposedly showing 2500- and 320-fold selectivity for nNOS over eNOS 
and  iNOS,  respectively  (Hah  et  al.,  2001).  The  cultures  were  stained 
immunocytochemically for BrdU, before they were imaged, quantified and analysed. 
3.2.4 Immunocytochemistry for nNOS and eNOS 
Hippocampal cells were cultured on poly-L-lysine-coated glass coverslips (13 mm radius 
borosilicate glass, VWR International, UK) under control or 1 µM NPY for 3 DIV before 
cell fixation. Chapter 2, section 2.2.3 outlines the detailed immunocytochemistry method. 
Immunocytochemistry was carried out using PBS-0.3% Triton (PBS-T) for better antibody 
permeability. The antibodies used and their dilutions are listed in Table 3.2.2. 
 
Table 3.2.2 Primary and secondary antibody dilutions 
Primary antibodies  Company  Dilution 
Rabbit anti-nNOS  Millipore, UK  1:250, 1:500, 1:1000 
Rabbit anti-eNOS  BD Transduction Laboratories, 
UK 
1:250, 1:500, 1:1000 
Mouse anti-eNOS  BD Transduction Laboratories, 
UK 
1:500 
Secondary antibodies  Company  Dilution 
Alexa Fluor donkey 
anti-rabbit 488   
Molecular Probes, Invitrogen, 
UK 
1:500 
Alexa Fluor donkey 
anti-mouse 555 
Molecular Probes, Invitrogen, 
UK 
1:500 
Alexa Fluor donkey 
anti-rabbit 555 
Molecular Probes, Invitrogen, 
UK 
1:500 
Alexa Fluor donkey 
anti-mouse 488 
Molecular Probes, Invitrogen, 
UK 
1:500 
       
      Immunostained coverslips were transferred (cell side down) onto mounting medium 
Mowiol (Sigma Aldrich, UK) on glass microscope slides. After a 40 min drying step, 67 
 
mounted coverslips were sealed with clear nail varnish which was allowed to dry before 
imaging. Confocal images were taken on a Nikon C1 Digital Eclipse Modular Confocal 
microscope system (Nikon UK Ltd., UK) using Nikon EZ-C1 Gold v3.70 software (Nikon 
Corporation, 2002). The appropriate immunocytochemical controls were used to ensure 
that there was no bleed-through (crossover or crosstalk) fluorescence and that any observed 
staining was real (Table 3.2.3). 
 
Table 3.2.3 Immunocytochemical staining controls 
Immunocytochemical controls  Antibodies 
Autofluorescence control  No primary or secondary 
Control for primary antibody 
autofluorescence 
Primary, no secondary 
Control for secondary antibody  Secondary, no primary 
Control for secondary antibody 
specificity during co-staining 
One primary, both secondary's or both primaries, one 
secondary 
 
3.2.5 Western blotting for nNOS in cell lysate  
Western blotting was used to verify nNOS protein expression in hippocampal cell lysate. 
3.2.5.1 Protein extraction 
Cells derived from the hippocampus were plated at a density of 10
6 cells/ml in 6 well 
plates and cultured for 3 DIV under control conditions (NBA-A/B27/Glu medium plus 1% 
antibiotic/antimycotic). On the final day, the cells were washed in ice-cold PBS for 1 min 
before they were lysed for ~5 min in 300 µl/well cold lysis buffer (25 mM NaCl, 2 mM 
EDTA, 0.5 mM dithiothreitol, 20 mM HEPES, 20 mM glycerophosphate, 50 mM NaF, 1 
mM  NaVO3  and  0.1%  Triton  X-100)  containing  a  phosphatase  inhibitor  cocktail  at 
10:1000  (phosphatase  inhibitor  cocktail  2,  Sigma  Aldrich,  UK)  and  protease  inhibitor 
mixture (1 tablet/10 ml) (Roche Diagnostics, Basel, Switzerland). During cell lysis, a cell 
scraper was used to scrape cells off of the well bottom and aid protein extraction. The 
buffer was collected from the wells into ependorfs and centrifuged (5000 rpm for 1 min) 
before  the  supernatant  was  collected  and  stored  as  frozen  aliquots.  Protein  content  of 
samples was determined using the Bradford assay protocol using Bradford reagent (Sigma 
Aldrich, UK) to ensure similar protein content across samples.  68 
 
3.2.5.2 Gel electrophoresis 
Glass electrophoresis plates were cleaned with distilled water and ethanol and secured into 
the casting stands before they were loaded with resolving gel (Table 3.2.4) and allowed to 
polymerise for ~30 min. After polymerisation of the resolving gel layer, the stacking gel 
layer (Table 3.2.4) was transferred over the top along with a 10 lane comb and allowed to 
polymerise for a further 30 min. The gel plates were then transferred into the running 
chamber and filled with electrophoresis buffer (25 mM Tris-HCl, 192 mM glycine, 0.1% 
sodium dodecyl sulphate (SDS), pH 8.3).      
 
Table 3.2.4 Resolving and stacking gel formulations (Burnette, 1981). 
Resolving Gel (10 ml – 12% gel)  Stacking Gel (5 ml – 3.75%) 
1.5 M Tris HCl  2.5 ml  1 M Tris HCl  1.25 ml 
Acrylamide 30%  4.0 ml  Acrylamide 30%  625 µl 
Distilled water  3.29 ml  Distilled water  2.825 ml 
10% SDS  100 µl  10% SDS  50 µl 
TEMED  10 µl  TEMED  3.75 µl 
10% APS*  100 µl  10% APS*  250 µl 
*APS is always made up fresh before each experiment and added last during gel formation 
 
      Protein aliquots were defrosted and 15 µl of the sample mixed with 15 µl SDS sample 
loading buffer (62.5 mM Tris-HCl, 2% w/v SDS, 10% glycerol, 50 mM DTT, 0.01% w/v 
bromophenol blue, pH 6.8). Samples were heated for 10 min at 99°C, followed by loading 
(20 µl/well – 4 µg/well) into the acrylamide gel along with a lane of (Amersham) full-
range rainbow molecular weight markers (5 µl; GE Healthcare Life Sciences, Bucks, UK) 
with the aid of fine pipette tips. The gel was run at 110 V at 25°C until the dye front 
reached the bottom of the gel (~1.5 h).  
3.2.5.3 Gel transfer 
After gel electrophoresis and protein separation, the proteins on the acrylamide gel were 
transferred to a polyvinylidene fluoride (PVDF) blotting membrane for easier handling. 
Blotting  cassettes  consisting  of  filter  paper,  the  acrylamide  gel,  PVDF  membrane  and 
sponge pads were constructed and soaked in blotting buffer (1 L working solution of 25 
mM Tris-HCl, 192 mM glycine, 0.02% SDS and 20% methanol at pH 8.3) before transfer 
into the blotting chamber. After the blotting cassettes were secured and ice block inserted, 
the chamber was filled with blotting buffer and run at 100 V at 25°C for 1 h.  69 
 
3.2.5.4 Immunodetection of proteins 
After transfer, the PVDF membrane was washed with tris-buffered saline (TBS; pH 7.6) 
for 5 min before incubation with blocking buffer (TBST (TBS with 0.1% Tween-20) with 
5% w/v non-fat dry milk) for 1 h with gentle agitation. The membrane was then washed 3 
x 5 min with TBST before it was incubated with the primary antibody, rabbit anti-nNOS 
(1:5000 in TBS-T 5% w/v non-fat dry milk; Millipore, UK), overnight at 4°C with gentle 
agitation. After overnight incubation, the primary antibody solution was discarded and the 
membrane washed for 3 x 5 min in TBST. The membrane was then incubated with the 
secondary antibody, anti-rabbit IgG horseradish peroxidase (HRP)-linked (1:2000 in TBS-
T 5% w/v non-fat dry milk; Cell Signaling Technology) in dilution buffer for 2 h at 25°C 
with gentle agitation. After incubation, the membrane was washed 3 x 5 min with TBST 
and 1 x 5 min with TBS.  
3.2.5.5 Enhanced chemiluminescence (ECL) 
The proteins on the membrane were detected via ECL, which relies on the conversion of  
the ECL substrate, i.e. luminol, into a sensitised reagent by the HRP-tethered onto the 
secondary antibody.  This reagent is then further oxidised by hydrogen peroxide into an 
excited  carbonyl  which  emits  light  when  it  decays.  The  membrane  was  exposed  to  a 
mixture of two ECL kit reagents, reagent A and reagent B (LumiGlo reagent and Peroxide; 
Cell Signaling Technology, New England Biolabs, UK) for 1 min before excess solution 
was  drained  and  the  membrane  wrapped  in  cling  film  (ensuring  all  air  bubbles  were 
brushed  out)  and  transferred  into  a  film  cassette.  In  a  dark  room,  the  membrane  was 
exposed to photographic film for different time periods, until optimal bands were obtained 
(not  under-  or  over-exposed),  before  the  film  was  developed  (1-2  min  in  developer 
followed by 5 min in fixative and a 15 min water rinse and then allowed to dry). The 
ladders  on  the  membrane  blot  were  recorded  onto  the  film,  the  film  scanned  into  the 
computer  and  the  data  analysed  with  ImageJ  analysis  software  (National  Institutes  of 
Health).  
3.2.5.6 Stripping of antibodies and re-probing of membrane  
After ECL and film exposure, the membrane was washed 4 x 5 min in TBST before it was 
incubated with 50 ml stripping buffer (62.5 mM Tris-HCl at pH 6.8, 2% SDS and 100 mM 
2-mercaptoethanol) for 30 min at 50°C. After incubation, the membrane was washed for 6 
x 5 min in TBST before the membrane was re-blocked with blocking buffer and reprobed 
(refer back to 3.2.5.4). Probed Western blots were stripped of antibody, re-blocked, then 70 
 
re-probed with rabbit anti-GAPDH (1:10000 in TBS-T 5% w/v non-fat dry milk; Abcam, 
UK) as a control for protein normalisation.  
3.2.6 Visualising NO using the fluorescent probe: Diaminofluorescein diacetate  
Diaminofluorescein diacetate (DAF-2 DA) is a cell permeable fluorescent indicator of NO 
first synthesised in 1998 (Kojima et al., 1998a). As one of the most widely utilised NO 
indicators, DAF-2 DA is frequently used to investigate NO levels in live cells (Kojima et 
al., 1998b) and many derivatives have been synthesised with selective properties. The non-
fluorescent DAF-2 is converted into its green-fluorescent triazole derivative, DAF-2T, by 
an N-nitrosation reaction with oxidised NO (N2O3), and is thus, an indirect NO indicator 












Fig. 3.2.1 Intracellular reactions of the indirect NO indicator, DAF-2 DA. The cell permeable 
DAF-2 DA traverses the cell membrane into the cell, whereby the diacetate groups are hydrolysed 
by  intracellular  esterases,  releasing  DAF-2.  DAF-2  is  converted  into  its  fluorescent  triazole 
derivative, DAF-2T, upon reaction with the oxidised form of NO, N2O3 (Kojima et al., 1998a). In 
this case, fluorescence intensity depends not only on the production of NO, but also the rate of NO 
oxidation, a reaction which requires oxygen.  
 
      DAF-2-DA is excited at 488 nm and emission is at 515 nm (fluorescein filter). DAF 
FM DA (Sigma Aldrich, UK), a more photo- and pH-stable variant of DAF-2 DA was used 
to  investigate  NO  production  in  response  to  NPY.  DAF  FM  DA  is  a  more  sensitive 
indicator than the conventional DAF-2 DA, with a NO/ N2O3 detection limit of 3 nM, 
compared to 5 nM. A range of DAF FM DA concentrations (0.1-10 µM) were tested and 
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      NO/N2O3  production  was  investigated  using  DAF  FM  DA  in  two  separate 
experimental  paradigms. The  first  involved pre-treating cultures  under  control  or  NPY 
conditions for 3 DIV before loading with DAF FM DA and live imaging to determine 
cellular  differences  in  DAF  FM  DA  fluorescence  due  to  NPY  treatment,  while  in  the 
second paradigm, cells were cultured under control conditions for 3 DIV before loading 
with DAF FM DA and use of time-lapse imaging to directly visualise the cellular response 
to a NPY pulse. For both paradigms, hippocampal cells were cultured on 23 x 23 mm 
photoetched coverslips (BellCo Glass, NJ, USA) in 6-well plates for 3 DIV under control 
conditions  (NBA/B27/Glu  and  1%  antibiotic/antimycotic)  or  1  µM  NPY.  Plates  were 
loaded with DAF FM DA (5 µM) in phenol red free-NBA/B27 (Life Technologies) for 30 
min at 37°C before the cells were rinsed 6 x with sterile PBS to remove the excess. All 
DAF FM DA loaded cells were imaged in 900 µl PBS under dimmed light conditions to 
avoid sample bleaching. Imaging was conducted on a Nikon Eclipse E800 Microscope 
(Nikon UK Ltd., UK) with a 40x water-dipping objective using MetaMorph® analysis 
software  (v6.2;  Universal  Imaging  Corporation,  Molecular  Devices,  USA).  In  the  pre-
treated investigation, the NPY group was exposed to 1 µM NPY throughout the whole 
loading and imaging process to ensure consistency. Pre-treated wells were imaged on a 
rota  of  3  grids/condition  until  there  were  at  least  12  grids/condition/experiment. 
Experimental settings and conditions were replicated across 4 independent experiments 
(Fig. 3.2.2A). The time-lapse investigation involved imaging select cells in DAF FM DA 
loaded cultures (cultured under control conditions) every 15 s over a time period of 20 min. 
The first 2 min served as a control period before 100 µl of sterile PBS or 10 µM NPY 
(final concentration in well) was added. Experimental settings were replicated across 4-5 





Figure 3.2.2 Visualising NO/N2O3 in hippocampal cells using diaminofluorescein diacetate (DAF-
FM DA). (A) In the first experimental paradigm, cells were pre-treated under control (Neurobasal 
A/B27/glutamine) or NPY conditions for 3 DIV before loading with DAF FM DA and the imaging 
of individual cells within each group. (B) In the second experimental paradigm, cells were cultured 
under control conditions for 3 DIV before loading with DAF FM DA and the use of time-lapse 
imaging to directly visualise the cellular NO/N2O3 response to a PBS or NPY pulse. 
       
      The  short-term  NO  donor  (S)-Nitroso-N-acetylpenicillamine  (SNAP;  Tocris 
Bioscience) was used as a positive control for DAF FM DA fluorescence. Imaged cells 
were fixed in 4% PFA and the cell phenotype (nestin
+ or class III β-tubulin
+) identified via 
immunocytochemistry.  The  fluorescence  intensity  of  cells  was  analysed  using  ImageJ 
analysis software whereby the average background intensity was subtracted from the cell 
intensity within each image. Time-lapse data of individual time points was normalised 
across experiments by plotting data relative to the cell intensity at time point 0 (T0). Linear 
regression analysis was used to test significance. 
3.2.7 Galanin-mediated neuroproliferation and NO 
To determine whether the proliferative effect of galanin was also mediated through NOS, 
hippocampal  cultures  were  exposed  to  control  conditions  or  100  nM  galanin  2-11 
(GALR2/3 agonist) (Sigma Aldrich, UK) in the presence of the NOS inhibitor L-NAME 
(500 µM) or its inactive enantiomer, D-NAME (500 µM). Cultures were exposed for 3 
DIV before cell proliferation was assessed on the final day with a 20 µM pulse of BrdU for 
6 h before cell fixation, immunocytochemistry, cell imaging, quantification and analysis.    73 
 
3.3 Results 
The involvement of NOS and NO mechanisms in mediating the proliferative effect of NPY 
in postnatal hippocampal cultures were investigated.  
3.3.1 L-NAME inhibits NPY-mediated neuroproliferation 
To  investigate  the  role  of  NOS  and  NO  in  NPY-mediated  proliferation,  hippocampal 
cultures were exposed for 3 DIV to 1 μM NPY and 500 μM of the (non subtype-selective) 
nitric oxide synthase inhibitor L-NAME or inactive enantiomer D-NAME. As expected 
from previous studies (Chapter 2), NPY induced a significant increase in total cell count 
(p<0.05, F=16.61 and d.f.=83) (Fig. 3.3.1A), the number of BrdU
+ cells (p<0.05, F=14.07 
and  d.f.=83)  (Fig.  3.3.1B),  nestin
+  precursor  cells  (p<0.05,  F=3.578  and  d.f.=56)  (Fig. 
3.3.1C)  and  BrdU
+  precursor  cells  (p<0.05,  F=11.16  and  d.f.=56)  (Fig.  3.3.1D).  In 
addition,  the proliferation status  (mitotic index) of the overall cell population  (p<0.05, 
F=5.754 and d.f.=80) (Fig. 3.3.1E) as well as the mitotic index of the nestin
+ precursor cell 
population (p<0.05, F=2.446 and d.f.=56) (Fig. 3.3.1F) was significantly enhanced by the 
presence of NPY.  
 
      On  the  other  hand,  the  addition  of  NPY  in  the  presence  of  L-NAME  reduced  the 
neuroproliferative  effects  of  NPY  back  down  to  control  levels.  Total  cell  counts  were 
comparable to control levels in the presence of L-NAME (p>0.05, F=16.61 and d.f.=83) 
(Fig. 3.3.1A), which was also reflected in the number of BrdU
+ cells (p>0.05, F=14.07 and 
d.f.=83) (Fig. 3.3.1B), nestin
+ precursor cells (p>0.05, F=3.578 and d.f.=56) (Fig. 3.3.1C) 
and BrdU
+ precursor cells (p>0.05, F=11.16 and d.f.=56) (Fig. 3.3.1D). The mitotic index 
of both the overall cell population (p>0.05, F=5.754 and d.f.=80) (Fig. 3.3.1E) and of the 
precursor cell population (p>0.05, F=2.446 and d.f.=56) (Fig. 3.3.1F) was also similarly 
reduced  to  control  levels.  With  regards  to  combined  NPY  and  D-NAME  treatment,  a 
significant increase was observed in the total cell count (p<0.05, F=16.61 and d.f.=83) 
(Fig. 3.3.1A), number of BrdU
+ cells (p<0.05, F=14.07 and d.f.=83)  (Fig. 3.3.1B) and 
number  of  BrdU
+  precursor  cells  (p<0.05,  F=11.16  and  d.f.=56)  (Fig.  3.3.1D),  which 
suggested  that  the  inactive  enantiomer  had  no  inhibitory  effect  on  NPY  action,  thus 
confirming  the  specificity  of  L-NAME  in  NOS  inhibition.  The  presence  of  D-NAME, 
however, reduced the effects  of NPY back down to  control  levels  with regards to  the 
number of precursor cells in culture (p>0.05, F=3.578 and d.f.=56) (Fig. 3.3.1C), as well as 
the mitotic indices of both the overall cell population (p>0.05, F=5.754 and d.f.=80) (Fig. 74 
 
3.3.1E) and precursor cell population (p>0.05, F=2.446 and d.f.=56) (Fig. 3.3.1F). This 
suggests  that,  under  certain  conditions,  D-NAME  exerted  an  inhibitory  effect  on  the 
enzyme NOS.  
3.3.2 L-NAME inhibits Y1 receptor-mediated proliferation 
The proliferative effect of NPY is mediated via its Y1 receptor (Howell et al., 2003). To 
confirm the involvement of NOS in mediating the proliferative effect of NPY through the 
Y1 receptor, primary hippocampal cells were cultured under control and in the presence of 
the Y1 agonist [F7, P34]NPY (1 μM) and/or 500 μM L-NAME or D-NAME for 3 DIV. 
The addition of a Y1 agonist significantly increased the total cell count (p<0.05, F=44.74 
and d.f.=87) and number of BrdU
+ cells (p<0.05, F=21.08 and d.f.=86), which was reduced 
back down to control levels by the presence of the NOS inhibitor L-NAME (Fig. 3.3.2A 
and Fig. 3.3.2B, respectively). The inactive enantiomer D-NAME had no inhibitory effect 
on the significant increase observed on the total cell count (p<0.05, F=44.74 and d.f.=87) 
and  the  number  of  BrdU
+  cells  (p<0.05,  F=21.08  and  d.f.=86)  in  response  to  NPY 
treatment  (Fig.  3.3.2A  and  Fig.  3.3.2B,  respectively).  Similarly,  the  NPY-mediated 
increase in the mitotic index of the cell population (p<0.05, F=4.172 and d.f.=86) was 
reduced to control levels in the presence of L-NAME, while D-NAME had no inhibitory 
effect on NPY action and the proliferation status remained high (p<0.05, F=4.172 and 
d.f.=86) (Fig. 3.3.2C). To determine the specificity of effects observed in response to L-
NAME  and  D-NAME  treatment  in  the  inhibition  of  NPY,  both  compounds  were  also 
exposed  to  cultures  individually.  L-NAME  and  D-NAME  had  no  significant  effect  on 
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Figure 3.3.1 The neuroproliferative effect of NPY was reduced by L-NAME. Cells were grown 
under control conditions (NBA-A/B27/glutamine) or 1 μM NPY and 500 μM L-NAME or D-
NAME for 3 DIV. BrdU was added for the final 6 h. NPY induced a significant increase in (A) 
total cell count, (B) BrdU
+ cells, (C) nestin
+ precursor cells, (D) BrdU
+ precursors, (E) overall 
mitotic index and (F) mitotic index of precursor cells, which was reduced by L-NAME back down 
(A)  (B) 
(C)  (D) 
(E)  (F) 76 
 


















































































to control levels, but unaffected by the inactive enantiomer D-NAME. Data represent mean ± SEM 
based on a sample that represents at least 15 wells per condition from three separate experiments. 
























   
 
 
Figure 3.3.2 L-NAME reduced the proliferative effects of the Y1 receptor agonist [F7, P34]NPY. 
Cells were grown under control conditions (NBA-A/B27/glutamine) or 1 μM [F7, P34]NPY and/or 
500 μM L-NAME or D-NAME for 3 DIV. BrdU was added for the final 6 h. The Y1 agonist 
significantly increased (A) the total cell count, (B) BrdU
+ cells and (C) the mitotic index. The 
addition of L-NAME completely abolished the proliferative effects of the Y1 agonist, while the 
inactive enantiomer D-NAME had no effect on Y1 agonist action. L-NAME and D-NAME had no 
effects on basal proliferation rates on their own. Data represent mean ± SEM based on a sample 
that represents at least 13 wells per condition from four separate experiments. One-way ANOVA 
with Dunnett’s multiple comparison test, compared to control condition. *p < 0.05. 
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3.3.3 L-arginine is proliferative for hippocampal cultures  
To analyse the role of endogenous NO in NPY-mediated proliferation, the amino acid L-
arginine, which is the substrate for NOS in the synthesis of NO, was exposed to cultures. A 
significant increase in the total cell count (p<0.05, F=12.09 and d.f.=49) and number of 
BrdU
+  cells  (p<0.05,  F=32.94  and  d.f.=49)  was  observed  in  response  to  L-arginine 
treatment, while treatment with the inactive enantiomer, D-arginine, had no effect on basal 
proliferation rates and levels were comparable to control (Fig. 3.3.3A and Fig. 3.3.3B, 
respectively). Similarly, L-arginine treatment significantly enhanced the mitotic index of 
the overall cell population compared to control (p<0.05, F=5.622 and d.f.=49) while D-




















Figure 3.3.3 L-arginine significantly increased the proliferation status of hippocampal cultures. 
Cells were grown under control conditions (NBA-A/B27/glutamine), 500 μM L-arginine and 500 
μM D-arginine for 3 DIV. BrdU was added for the final 6 h. L-arginine significantly increased the 
(A)  total  cell  count,  (B)  numbers  of  BrdU
+  proliferating  cells  and  (C)  the  mitotic  index.  The 
inactive enantiomer D-arginine had no effect on total cell count, numbers of BrdU
+ cells or basal 
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(C) 78 
 
proliferation rates. Data represent mean ± SEM based on a sample that represents at least 16 wells 
per  condition  from  five  separate  experiments.  One-way  ANOVA  with  Dunnett’s  multiple 
comparison test, compared to control. *p < 0.05. 
3.3.4 iNOS is not likely involved in mediating the proliferative effect of NPY 
Although  NOS  has  previously  been  shown  to  mediate  the  effects  of  NPY  on  feeding 
behaviour (Morley et al, 1999) and retinal neural cell proliferation (Alvaro et al., 2008), no 
attempts have yet been made to identify the subtype of NOS involved. The proliferation of 
hippocampal cultures in response to NPY was investigated in the presence of the selective 
iNOS inhibitor, EITH, and the partial iNOS/nNOS inhibitor, 3B7N. Over three days in 
culture, the presence of NPY significantly enhanced the total cell count (p<0.05, F=6.138 
and d.f.=80) (Fig. 3.3.4A), number of BrdU
+ cells (p<0.05, F=10.53 and d.f.=80) (Fig. 
3.3.4B) and mitotic index (p<0.05, F=8.054 and d.f.=80) (Fig. 3.3.4C). Similarly, NPY in 
the presence of EITH also produced a significant increase in the total cell count (p<0.05, 
F=6.138 and d.f.=80) (Fig. 3.3.4A), number of BrdU
+ cells (p<0.05, F=10.53 and d.f.=80) 
(Fig. 3.3.4B) and mitotic index (p<0.05, F=8.054 and d.f.=80) (Fig. 3.3.4C), reflective of 
levels induced by NPY alone. EITH did not affect levels of NPY-mediated proliferation, 
suggesting iNOS was not involved in the signalling process. On the other hand, 3B7N 
reduced the proliferation mediated by NPY. The total cell count (p>0.05, F=6.138 and 
d.f.=80) (Fig. 3.3.4A), number of BrdU
+ cells (p>0.05, F=10.53 and d.f.=80) (Fig. 3.3.4B) 
and mitotic index (p>0.05, F=8.054 and d.f.=80) (Fig. 3.3.4C) were comparable to control 
levels in the presence of NPY and 3B7N. Since the application of EITH indicated that 
iNOS was probably not involved in the proliferative process, the reduction caused by the 
application of 3B7N could be attributable to its action on nNOS. On their own, EITH and 










































Figure 3.3.4 iNOS is not likely involved in mediating the proliferative effect of NPY. Hippocampal 
cultures  were  exposed  to  control  (NBA-A/B27/glutamine),  1  μM  NPY  and/or  100  nM  EITH 
(selective iNOS inhibitor) or 100 nM 3B7N (partial iNOS/nNOS inhibitor) for 3 DIV. BrdU was 
added for the final 6 h. NPY significantly increased (A) the total cell count, (B) BrdU
+ proliferating 
cells and (C) mitotic index. The addition of 3B7N reduced the proliferative effect of NPY, while 
EITH showed no inhibitory effect on NPY action, suggesting only nNOS involvement. EITH and 
3B7N had no effects on basal proliferation rates on their own. Data represent mean ± SEM based 
on a sample that represents at least 13 wells per condition from three separate experiments. One-
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3.3.5 nNOS most likely mediates the proliferative effect of NPY 
To further verify the involvement of nNOS, a selective inhibitor of nNOS, AAAN, was 
added to hippocampal cultures for 6 h in the presence of NPY. NPY induced an increase in 
total  cell  count  (p<0.05,  F=16.86  and  d.f.=54)  (Fig.  3.3.5A),  number  of  BrdU
+  cells 
(p<0.05,  F=14.52  and  d.f.=54)  (Fig.  3.3.5B)  and  mitotic  index  (p<0.05,  F=3.404  and 
d.f.=54) (Fig. 3.3.5C), which was as expected from previous investigations. The presence 
of AAAN, however, significantly reduced the proliferative effect of NPY. The total cell 
count  (p>0.05,  F=16.86  and  d.f.=54)  (Fig.  3.3.5A),  number  of  BrdU
+  cells  (p>0.05, 
F=14.52 and d.f.=54) (Fig. 3.3.5B) and mitotic index (p>0.05, F=3.404 and d.f.=54) (Fig. 
3.3.5C) was reduced to levels comparable to control levels, while AAAN exerted no effect 

























































Figure 3.3.5 nNOS most likely mediates the proliferative effect of NPY on hippocampal cultures. 
Hippocampal cells were cultured under control conditions (NBA-A/B27/glutamine) for 3 DIV, 
before 1 μM NPY and/or 200 nM AAAN (selective nNOS inhibitor) and BrdU was added for the 
final 6 h. NPY significantly increased (A) the total cell count, (B) BrdU
+ proliferating cells and (C) 
the mitotic index, which was reduced to control levels by the presence of AAAN. Data represent 
mean ± SEM based on a sample that represents at least 13 wells per condition from three separate 
experiments.  One-way  ANOVA  with  Dunnett’s  multiple  comparison  test,  compared  to  control 















































(A)  (B) 
(C) 
Total cell count (DAPI)
Control
NPY















3.3.6 nNOS and eNOS are both expressed by precursor cells and neurons 
The proliferative effect of NPY is likely to be mediated principally through the nNOS 
subtype. In the CNS, nNOS expression was previously demonstrated in neurons (Bredt et 
al., 1990), astrocytes (Arbonés et al. 1996) and neural precursor cells (Wang et al., 1999a; 
Torroglosa et al., 2007; Luo et al., 2010). To further verify the involvement of nNOS in 
mediating the proliferative effect of NPY, immunocytochemistry was used to identify the 
cellular expression of nNOS in hippocampal cultures. Moreover, the involvement of eNOS 
was also assessed. Specifically, nNOS and eNOS expression was investigated in nestin
+ 
precursor cells and class  III β-tubulin (TUJ1)
+ neurons, the cell phenotypes previously 
shown by Howell et al (2003) to be responsive to NPY. A range of nNOS and eNOS 
antibody  dilutions  were  investigated  to  determine  the  optimal  concentration  for 
immunostaining. The ratio of immunostaining to background fluorescence was found to be 
best  within the dilution ranges  of 1:500-1:1000 for nNOS  and 1:250-1:500  for eNOS. 
Respective immunocytochemical  controls  were  carried out  (Table 3.2.3) to  ensure that 
there  was  no  background/antibody  autofluorescence  or  bleed-through,  confirming  the 
validity of any staining observed. 
 
      Both nNOS and eNOS were expressed in nestin
+ precursor cells and class III β-tubulin
+ 
neurons in hippocampal cultures (Fig. 3.3.6). All nestin
+ and class III β-tubulin
+ cells were 
immunopositive  for  nNOS  and  eNOS.  In  nestin
+  cells,  nNOS  immunoreactivity  was 
generally  evenly  distributed  across  the  whole  cell,  although  in  some  cases,  increased 
immunoreactivity was observed localised to the cell nucleus (Fig. 3.3.6A-C). Similarly, 
eNOS  immunoreactivity  in  nestin
+  cells  was  mostly  localised  to  the  nucleus,  while 
reactivity in the soma was comparatively low (Fig. 3.3.6G-I). nNOS immunoreactivity in 
class III β-tubulin
+ cells was also distributed across the cell, however, immunoreactivity 
varied, with some cells showing higher nNOS immunoreactivity in the nucleus, while in 
others nNOS was localised to the soma (Fig. 3.3.6D-F). Clear nNOS staining was also 
obtained using a 1:1000 dilution of the nNOS antibody. eNOS immunoreactivity in class 
III β-tubulin
+ cells, on the other hand, was distributed evenly across the whole cell (Fig. 
3.3.6J-L).  
 
      nNOS and eNOS immunocytochemistry was carried out using NOS antibodies raised 
in  rabbit,  combined  with  mouse  anti-nestin  or  mouse  anti-TUJ1  antibodies  for  cell 
phenotyping. As all nestin
+ and class III β-tubulin
+ cells were immunopositive for both 83 
 
nNOS and eNOS, this raised the question as to whether both subtypes were expressed 
together in the same cells or if this was as a result of non-specific NOS antibody binding to 
other subtypes. To answer this question a double immunostaining protocol with a rabbit 
anti-nNOS and mouse anti-eNOS was carried out to verify the expression profiles of each 
NOS subtype in the same sample. An nNOS and eNOS antibody dilution of 1:500, which 
is within the optimal immunostaining range of both antibodies, was chosen for consistency. 
Immunocytochemistry showed the expression of both subtypes in all the cells studied. All 
nNOS
+ cells were found to be also eNOS
+, and the distribution similar (Fig. 3.3.7). To 
further  reinforce  the  immunocytochemical  results  showing  the  presence  of  nNOS  in 
hippocampal  cultures,  a  different  method  for  quantifying  protein  expression,  Western 
blotting, was used. nNOS expression was identified in all three samples of hippocampal 



























































(B) nNOS 1:500  (C) nestin/nNOS 
(E) nNOS 1:1000  (F) TUJ1/nNOS 
(G) DAPI/eNOS  (H) eNOS 1:250  (I) nestin/eNOS 
(J) DAPI/eNOS  (K) eNOS 1:250  (L) TUJ1/eNOS 85 
 
Figure 3.3.6 Both nNOS and eNOS were expressed in nestin
+ precursor cells and class III β-tubulin 
(TUJ1)
+ neurons. nNOS/eNOS (green) and nestin/TUJ1 (red). All nestin
+ and TUJ1
+ cells were 
immunopositive for nNOS and eNOS, although not all cells were nNOS
+ or eNOS
+ (see DAPI 
(blue) staining for all cells). (A-C) nNOS immunoreactivity in nestin
+ cells was generally evenly 
distributed across cells, although in some cases increased localisation to the nucleus was observed 
(arrows).  Similarly,  (D-F)  some  TUJ1
+  cells  showed  increased  nNOS  immunoreactivity  in  the 
cytoplasm when compared to the nucleus (arrows). The optimal antibody dilution range for nNOS 
immunostaining  was  between  1:500-1:1000,  as  demonstrated  in  (B;  1:500)  and  (E;  1:1000), 
respectively. In the case of eNOS, immunoreactivity in (G-I) nestin
+ cells was largely localised to 
the nucleus (arrows), while in (J-L) TUJ1
+ cells, eNOS was evenly distributed throughout the cell 
(arrows).  The  optimal  antibody  dilution  range  for  eNOS  immunostaining  was  between  1:250-













Figure 3.3.7 nNOS and eNOS was expressed within the same cells.  A double immunostaining 
protocol was used to identify the expression profiles of nNOS and eNOS. All (A and B) nNOS
+ 
cells (green), were also (C and D) eNOS
+ (red). The cell nuclei were stained with DAPI (blue). The 
distribution of nNOS and eNOS was similar. Staining was specific as controls with the nNOS, but 








eNOS 1:500  DAPI/eNOS 
nNOS 1:500  (A) DAPI/nNOS 
(D) eNOS 1:500  (C) DAPI/eNOS 












Figure 3.3.8 nNOS expression was identified in hippocampal cell lysate. 3 day old hippocampal 
cultures were treated with control media (NBA-A/B27/Glu) before cell lysis and Western blotting. 
Immunoblots  were  probed  with  antibodies  against  nNOS  and  GAPDH.  All  three  samples  (S) 
showed nNOS expression.  
3.3.7 DAF FM DA fluorescence suggests increased NO production in response to NPY 
exposure 
To show a correlation between NPY and NO production, the intracellular release of NO in 
response to NPY was investigated using the fluorescent NO/N2O3 probe, DAF FM DA, 
which was combined with live cell imaging. Although some issues have been associated 
with the commonly used incubation concentration of 10 µM DAF FM DA, which can lead 
to intracellular DAF accumulation and a high autofluorescence background, thus limiting 
detection sensitivity (Rodriguez et al., 2005), a range of DAF FM DA concentrations was 
initially tested in this study before 5 µM was determined as the optimal concentration. A 
lower concentration of DAF FM DA was suggested by Rodriguez et al. (2005) for reliable 
measurement of NO/N2O3. However, low DAF FM DA concentrations tested at 1 µM 
required a high fluorescence exposure, which increased the risk of bleaching, while no 
detectable fluorescence was achieved with 0.1 µM even at the highest exposure settings.  
 
      As a positive control, the short-term NO donor, SNAP, was exposed to DAF FM DA-
loaded hippocampal cultures, whereby a significant increase in cell fluorescence intensity 
was observed, which continued to increase linearly over the exposure period of 10 min 
(Linear regression analysis *p<0.0001) (Fig. 3.3.9). Cultures were pre-treated under either 
control or NPY conditions before DAF FM DA fluorescence intensity in the nestin
+ and 
class III β-tubulin
+ cell populations was assessed. Hippocampal cells were cultured onto 
nNOS 
GAPDH 
S1  S2  S3  MW (kDa) 
165 -  
146 -  87 
 
photoetched  glass  coverslips  so  that  after  DAF  FM  DA  imaging  (Fig.  3.3.10A)  the 
respective  grid could  be relocated after immunocytochemistry for identification of cell 
phenotypes (Fig. 3.3.10B,C). In both nestin
+ and class III β-tubulin
+ populations, the NPY 
pre-treated group showed significantly enhanced DAF FM DA fluorescence compared to 
the untreated control group (Student's t-test, p=0.0003 and p=0.0324 for nestin
+ and class 
III  β-tubulin
+  cell  populations,  respectively)  (Fig.  3.3.11A,B),  indicative  of  increased 
NO/N2O3 production in response to NPY exposure. Similarly, in a second approach, a 10 
µM NPY pulse significantly enhanced the DAF FM DA fluorescence intensity of nestin
+ 
and  class  III  β-tubulin
+  cells  compared  to  a  control  pulse  of  PBS  (Linear  regression 
analysis  *p<0.0001)  (Fig.  3.3.11C-F),  which  suggests  the  involvement  of  NO  and  its 
production  within  the  intracellular  signalling  pathway  of  NPY.  Although  a  significant 
linear increase in DAF FM DA fluorescence was also observed in PBS treated cultures in 
both  nestin
+  and  class  III  β-tubulin
+  cells  (Linear  regression  analysis  *p<0.0001)  (Fig. 
3.3.11C,D), probably as a result of basal NO/N2O3 generation, the fluorescence increase in 
NPY-treated cultures was more remarked and still significantly increased after subtracting 













Figure 3.3.9 DAF FM DA fluorescence increased over time in response to the addition of a NO 
donor.  Hippocampal  cells  were  cultured  for  3  DIV  under  control  conditions  (NBA-
A/B27/glutamine) before they were loaded with 5 µM of the NO/N2O3 probe, DAF FM DA. The 
NO donor, SNAP, was added to the DAF loaded cells at T0 before imaging, which resulted in a 

































































Figure  3.3.10  Identification  of  cell  phenotype  was  attained  through  the  use  of  photoetched 
coverslips. Hippocampal cells were cultured on photoetched glass coverslips so that after (A) DAF 
FM DA imaging, the cells could be relocated after immunocytochemistry via the photoetched grid 
under (B) phase imaging, before (C) phenotype identification. Immunocytochemistry was carried 
out against the precursor cell marker nestin (red), the neuronal marker class III β-tubulin (green) 














































Figure 3.3.11 DAF FM DA fluorescence intensity in cells treated with NPY. Hippocampal cells 
were cultured under control conditions (NBA-A/B27/glutamine) or 1 μM NPY for 3 DIV before 
DAF  FM  DA  loading  and  imaging.  NPY  pre-treated  (A)  nestin
+  and  (B)  class  III  β-tubulin
+ 
(TUJ1
+) cell populations showed significantly increased fluorescence intensity compared to control 
treated cell populations (Student's t-test, p=0.0003 and p=0.0324 for nestin
+ and class III β-tubulin
+ 
cell populations, respectively). Cultures exposed to a pulse (time point indicated with arrows) of 
NPY or PBS under time-lapse studies showed a linear increase in DAF FM DA fluorescence over 
time, irrespective of the treatment condition, in both (C) nestin
+ and (D) class III β-tubulin
+ cells 
(Linear regression analysis *p<0.0001). The NPY pulsed cells, however, showed a significantly 
higher  cell  fluorescence  intensity  compared  to  the  control  pulse  in  both  cell  types  (Linear 
regression analysis, test for slope difference*p<0.0001). Subtraction of the control trace from the 
NPY trace for (E) nestin
+ and (F) class III β-tubulin
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in  cell  fluorescence  in  response  to  NPY  treatment  (Linear  regression  analysis  *p<0.0001). 
Experimental settings and conditions were replicated across 4-5 independent experiments for both 
the pre-treated culture and the time-lapse investigations.  
 
3.3.8 NOS is not required for mediating the proliferative effect of galanin 
Is signalling through NO-dependent mechanisms specific to NPY or do other proliferative 
neuropeptides  also  act  via  a  similar  pathway?  To  clarify  this  question,  galanin,  a 
neuropeptide  which  elicits  proliferative  effects  similar  to  that  of  NPY,  was  added  to 
cultures and the role of the NOS inhibitor L-NAME and its inactive enantiomer D-NAME 
assessed. Galanin induced a significant increase in the total cell count (p<0.05, F=9.792 
and d.f.=59) and BrdU
+ cell number (p<0.05, F=6.180 and d.f.=59), which was unaffected 
by the presence of  L-NAME or D-NAME  (p>0.05, F=9.792 and d.f.=59 for total  cell 
counts and p>0.05, F=6.180 and d.f.=59 for BrdU
+ cells) (Fig. 3.3.12A and Fig. 3.3.12B, 
respectively). In the case of the mitotic index, a small but significant increase in the mitotic 
index was observed with respect to galanin treatment in the presence of L-NAME (p<0.05, 









































































































Figure 3.3.12 NOS is not required for mediating the proliferative effect of galanin. Cells were 
cultured under control conditions (NBA-A/B27/glutamine) or 100 nM galanin in the presence of 
500 µM L-NAME or D-NAME for 3 DIV. BrdU was added for the final 6 h. Galanin increased (A) 
the total cell count and (B) the number of BrdU
+ cells, which were unaffected by the presence of L-
NAME or D-NAME. Galanin induced a significant increase in (C) the mitotic index in the presence 
of L-NAME, but not on its own or in the presence of D-NAME. Data represent mean ± SEM based 
on a sample that represents at least 15 wells per condition from four separate experiments. One-










The  involvement  of  NOS  and  NO  in  the  signalling  pathway  underlying  the 
neuroproliferative  effect  of  NPY  was  investigated  using  pharmacological, 
immunocytochemical and live cell imaging techniques. To my knowledge, this is the first 
time that these signalling mechanisms underlying the neuroproliferative effect of NPY on 
cultures from the postnatal rat hippocampus have been extensively explored.  
3.4.1 The neuroproliferative effect of NPY is mediated via NO 
Through the use of selective pharmacological agents, the involvement of NOS and NO in 
mediating the neuroproliferative effect of NPY was demonstrated in postnatal hippocampal 
cultures.  NPY-mediated  neuroproliferation  was  reduced  to  control  levels  through  the 
inhibition of NOS, the NO-synthesising enzyme, using the inhibitor L-NAME. As well as 
an inhibition of the overall proliferation rates of the total cell population (mitotic index), 
the proliferation status of the nestin
+ precursor cell population was also reduced. On the 
other hand, the inactive enantiomer of L-NAME, D-NAME, had no significant inhibitory 
effect on proliferation rates and both compounds had no effects on basal proliferation rates 
on their own. In some instances, however, such as under combined NPY and D-NAME 
treatment, NPY-mediated proliferation could not reach NPY-only levels, suggesting D-
NAME had a slight inhibitory effect. This observation could be explained by the presence 
of  impure  batches  of  the  inactive  D-NAME  enantiomer,  which  may  contain  minute 
proportions of the active L-NAME analogue. The supplementation of cultures with the 
precursor for NO synthesis, the amino acid L-arginine, significantly enhanced proliferation 
rates,  further  suggesting  the  involvement  of  NOS  and  NO.  The  fact  that  the  inactive 
enantiomer, D-arginine, had no effect on proliferation rates demonstrates the specificity of 
this system for L-arginine. What must be noted, however, is that Neurobasal A medium 
already contains around 398 µM L-arginine (Media Formulation, Life Technologies, UK), 
which  means  that,  with  an  apparent  Km  value  of  ~8.4  µM  of  nNOS  for  L-arginine 
(Todoroki et al., 1998), nNOS activity should already be saturated in culture even without 
additional L-arginine supplementation. Even so, 500 µM L-arginine supplementation had a 
clear  proliferative  effect  on  hippocampal  cultures,  which  may  have  been  because  the 
amount of L-arginine already present in the culture medium was not sufficient to support 
maximal nNOS activity over the full course of 3 days in culture without extra addition. For 
example,  the  relatively  high  hippocampal  expression  of  the  enzyme  arginase,  which 
metabolises L-arginine into L-ornithine and urea, may possibly contribute to the depletion 93 
 
of L-arginine in culture (Liu et al., 2003). One way of clarifying this would be to quantify 
levels  of  L-arginine  and/or  L-ornithine  in  hippocampal  culture  over  time,  possibly  via 
high-performance liquid chromatography (Volke et al., 2006).  
 
      The neuroproliferative effect of NPY is mediated via its Y1 receptor (Howell et al., 
2003,  Alvaro  et  al.,  2008).  The  link  between  Y1  receptor  activation  and  subsequent 
activation of NOS was confirmed by the inhibition of Y1 receptor agonist, [F7, P34]NPY, -
mediated proliferation of hippocampal cells by L-NAME. L-NAME significantly blocked 
the proliferative effects of the Y1 agonist while D-NAME had no significant effect, thus 
confirming the relationship between the Y1 receptor, NOS and proliferation.   
3.4.2 The nNOS isoform of NOS most likely mediates the proliferative effect of NPY 
and is expressed in precursor cells and neurons  
Through the use of subtype-selective antagonists, nNOS was identified as the most likely 
NOS subtype responsible for mediating the proliferative effect of NPY. Although earlier 
studies have demonstrated the importance of NOS in mediating NPY's effect (Morley et 
al.,  1999;  Alvaro  et  al.,  2008),  no  study  had  attempted  to  identify  the  NOS  subtype 
involved.  It  was  important  to  identify  the  NOS  subtype  because  the  subtype  and  its 
localisation  significantly  influences  the  physiological  effects  of  NO.  While  we  knew 
nothing of the NOS subtype in the hippocampus, Cordelier et al. (1999) showed in Chinese 
hamster ovary (CHO) cells that nNOS plays a role in proliferation. They showed that the 
cholecystokinin A receptor, a GPCR similar to the NPY Y1 receptor, activated nNOS via 
the  G-protein  βγ  subunit  and  the  tyrosine  phosphatase  SHP-2  in  the  cholecystokinin-
mediated  proliferation  of  CHO  cells.  While  Cordelier  et  al.  (1999)  demonstrated  the 
importance of the nNOS subtype in  mediating proliferative pathways, the proliferative 
agent and cell type studied were different. The present study is the first time that the NOS 
subtype  responsible  for  mediating  the  proliferative  effect  of  NPY  on  postnatal  rat 
hippocampal cultures has been explored. 
 
      The possible role of nNOS in mediating proliferative effects was further investigated 
through  immunocytochemistry.  Although  pharmacological  studies  eliminated  the  direct 
involvement of iNOS, the involvement of eNOS could not be ascertained due to a lack of 
selective inhibitors. Pharmacological studies, however, showed that the proliferative effect 
of NPY was completely reduced to control levels in the presence of the nNOS inhibitor, 94 
 
AAAN, which suggests that only nNOS was involved. If eNOS was also involved, AAAN 
may not have been able to fully reduce NPY's effects. To provide evidence for the role of 
nNOS, as well as eNOS, immunocytochemistry was carried out to analyse their expression 
profiles. Both nNOS and eNOS were expressed in all nestin
+ and class III β-tubulin
+ cells. 
As Howell et al. (2003) demonstrated previously, NPY exerts its proliferative effect on 
nestin
+ and class III β-tubulin
+ cells in rat hippocampal cultures. In addition, my own study 
has  also  confirmed  the  proliferative  effect  of  NPY  on  nestin
+  precursor  cells  and  the 
importance of NOS in mediating this effect. The distribution of both nNOS and eNOS 
varied widely within cells, although double immunostaining showed that all nNOS
+ cells 
were also eNOS
+. As well as the same expression profile, the distribution of both nNOS 
and eNOS within cells were identical, which could be either as a result of co-expression, or 
more  likely,  lack  of  antibody  specificity  to  a  select  NOS  subtype.  The  antibodies 
supposedly react specifically to subtype selective immunogens, such as the N-terminus of 
nNOS in the case of the nNOS-selective antibody, and for the eNOS-selective antibody, 
the  C-terminus  of  eNOS.  Although  eNOS  expression  had  previously  been  shown  in 
hippocampal pyramidal cells (Dinerman et al., 1994) and precursor cells (Wang et al., 
1999a), it is mainly associated with the brain vasculature (Dinerman et al., 1994; Seidel et 
al., 1997) and it is unlikely that both nNOS and eNOS immunoreactivity would be exactly 
the  same.  Most  probably,  the  57%  homology  between  the  nNOS  and  eNOS  isoforms 
(Alderton et al., 2001) resulted in some non-specific reactions of either the nNOS antibody 
with eNOS, the eNOS antibody with nNOS, or both. Although the involvement of eNOS 
could not be ruled out, the pharmacological results appear to support the contribution of 
nNOS in mediating the proliferative effect of NPY.  
 
      Using the same nNOS antibody, Luo et al. (2010) showed in their investigations that 
nNOS expression was localised to the nucleus in neural stem cells, while in neurons, nNOS 
was  localised  to  the  cytoplasm.  This  nNOS  distribution  pattern  was  also  present  in  a 
number  of  cells  in  the  immunocytochemistry  carried  out  in  this  study  and  may  be  an 
important  regulator  of  the  effects  of  NO.  I  also  demonstrated  nNOS  expression  in 
hippocampal cultures using a different method for examining protein expression, Western 
blotting, but  unfortunately, did  not  have time to  repeat  this  using the  eNOS antibody. 
Indeed,  the  demonstration  by  Islam  et  al.  (2003)  that  nNOS  was  localised  to  sites  of 
neuronal  proliferation  and  migration  in  the  hippocampal  dentate  gyrus  provides  a 95 
 
morphological basis which supports the involvement of only nNOS in mediating the effect 
of NPY.  
3.4.3 DAF FM DA fluorescence indicates increased NO production in response to 
NPY exposure  
DAF FM DA-loaded nestin
+ precursor cells and class III β-tubulin
+ neurons, which had 
either been pre-treated with or exposed to a pulse of NPY, showed significantly enhanced 
DAF FM DA fluorescence intensity compared to control (PBS)-treated cells, suggesting a 
link between NPY and NO production. Although the hippocampal cells were already DAF 
FM DA fluorescent before the NPY or PBS pulse, indicative of basal NO/N2O3 production, 
it is unlikely that this background NO was involved in mediating proliferative processes as 
the  pharmacological  control  investigations  with  only  L-NAME  had  no  effect  on  cell 
proliferation.  This  background  NO  is  probably  involved  in  mediating  other  cellular 
processes.  Indeed,  it  would  have  been  interesting  to  see  whether  DAF-FM  DA 
fluorescence would be completely eliminated by the prior incubation of tissue samples 
with the NOS inhibitor L-NAME, but unfortunately, due to time constraints, I was unable 
to investigate this further.  
 
      A plethora of fluorescent NO indicators exist, ranging from the o-Phenylenediamines 
to metal-based and genetically encoded fluorescent indicators for NO (Ye et al., 2008). The 
probe  used  within  this  study,  DAF  FM  DA,  falls  into  the  diaminofluorescein  (DAF) 
subgroup of the o-Phenylenediamine NO indicators. The DAFs are extremely sensitive 
NO/N2O3 probes, with DAF FM DA having an NO/N2O3 detection limit of 3 nM (Ye et 
al.,  2008).  Although  they  do  not  react  with  NO  directly,  the  use  of  fluorescence 
microscopy  combined  with  fluorescent  indicators  such  as  DAF  FM  DA  provides  a 
relatively simple method for estimating levels of NO production in single cells (Schuppe et 
al.,  2002).  These  probes,  however,  are  not  without  their  limitations.  The  formation  of 
N2O3, for example, is simple in air-equilibrated culture media containing NO, however, 
due  to  the  high  reactivity  of  the  NO2  precursor  with  antioxidants,  biological  N2O3 
formation is slow and inefficient, suggesting that the reaction of DAF FM DA with N2O3 is 
unlikely  (Wardman,  2007).  Instead,  it  is  more  probable  that  the  fluorescent  triazole 
derivative is formed as a result of a two stage reaction which first involves the oxidation of 
DAF to an intermediate DAF radical, before the subsequent addition of NO. This means 
that any event or reagent which interferes with DAF radical formation, such as oxidants, 96 
 
antioxidants (ascorbate) (Zhang et al., 2002), and even exposure to light (Broillet et al., 
2001), will ultimately affect DAF fluorescence, regardless of fluctuations in NO levels 
(Wardman, 2007). Although widely utilised for quantifying NO levels, the susceptibility of 
DAF  probes  to  diverse  environmental  factors  must  be  considered  when  interpreting 
experimental DAF fluorescence levels. Nevertheless, the quantification of NO in live cells 
is  difficult,  and  even  attempts  at  direct  NO  measurement  using  electrochemical 
microelectrodes (Shibuki, 1990) are not without their problems, with one being the huge 
variability in NO concentrations obtained by different groups (Hall & Garthwaite, 2009). 
Indeed, recent progress in the development of more sensitive techniques for the detection 
of  NO  levels  has  been  the  creation  of  NO  detector  cells  expressing  sGC  and 
phosphodiesterase-5 (Wood et al., 2011). These NO detector cells were able to sensitively 
monitor NO release from brain tissue slices and detected NO concentrations down in the 
pM  range.  The  further  development  of  techniques  such  as  these  will  allow  more 
physiologically representative concentrations of NO to be detected and measured (Wood et 
al., 2011).      
3.4.4 The proliferative effect of galanin is not mediated through NOS 
Of the three galanin receptors (GALR1, GALR2 and GALR3), only GALR1 and GALR2 
activate the MAPK pathway and GALR2/3 is responsible for the proliferative effect of 
galanin (Hobson et al., 2008; Abbosh et al., 2011). In the present study, galanin exerted a 
neuroproliferative effect similar to that of NPY, but did not require NOS to mediate its 
proliferative effect. The selective activation of the GALR2/3 receptor with the GALR2/3 
agonist (galanin 2-11) significantly enhanced the proliferation of hippocampal cultures, 
which was not reduced through NOS inhibition. Other studies have shown that GALR2 
activation  leads  to  the  stimulation  of  phospholipase  C  via  Gq/11,  resulting  in  calcium 
mobilisation, diacylglycerol formation and protein kinase C activation (Wang et al., 1998). 
The activation of NOS and NO mechanisms may not be a universal signalling mechanism 
in mediating the proliferative action of neuropeptides other than NPY, although, on another 
note, NOS/NO may be involved in mediating their other neurophysiological effects. For 
example, the binding of galanin to the N-methyl-D-aspartate receptor activates a NOS-NO-
cGMP pathway in the ventral hippocampus in vivo which may be important in memory 
processes (Consolo et al., 1998).  97 
 
3.4.5 The differential roles of NOS isoforms in adult neurogenesis 
Pharmacological  studies  have  shown  that  NO  initiates  both  neuroinhibitory  and 
neuroproliferative  effects  on  adult  neurogenesis  (Cardenas  et  al.,  2005).  These 
contradictory  effects  of  NO  can  be  explained  by  the  existence  of  the  different  NOS 
subtypes, which provided the basis for the subtype investigations covered in this chapter. 
To further evaluate the precise role in which NO and the subtypes of NOS confer on 
neurogenesis,  the  existing  literature  must  be  considered.  In  vivo  studies  using  NOS 
isoform-specific  knockout  mice  to  identify  the  contributions  by  each  NOS  to  adult 
neurogenesis offer higher specificity compared to using subtype-selective pharmacological 
inhibitors,  which  can  be  relatively  non-specific,  especially  in  the  case  of  the  eNOS 
inhibitors. In general, most studies suggest an inhibitory role for NO derived from nNOS, 
although the cellular mechanisms underlying this are not well understood. Packer et al. 
(2003), for example, showed that the number of BrdU
+ cells was significantly increased in 
the  neurogenic  regions  (olfactory  subependyma  and  dentate  gyrus)  of  the  adult  nNOS 
knockout mouse brain, implying that the endogenous action of nNOS negatively regulates 
adult neurogenesis. Similarly, Sun et al. (2005) showed that nNOS knockout mice showed 
reduced  infarct  size  in  response  to  transient  focal  cerebral  ischemia  and  increased 
neurogenesis under both basal and ischemia-induced conditions, while Zhou et al. (2007) 
found  that  nNOS-derived  NO  contributes  to  chronic  stress-induced  depression  by 
suppressing levels  of hippocampal neurogenesis. On the other hand, proliferative roles 
have  been  shown  by  the  eNOS  and  iNOS  isoforms,  which  seem  to  be  involved  in 
promoting adult neurogenesis under basal and ischemic conditions, respectively. eNOS-
deficient mice show a significant reduction in basal neuronal progenitor cell proliferation 
in the dentate gyrus (Reif et al., 2004), while ischemia-induced, but not basal, neurogenesis 
was significantly reduced in iNOS knockout rodents (Zhu et al., 2003). 
 
      The present study has identified the nNOS isoform as the most probable mediator of 
the neuroproliferative effect of NPY, which, considering the inhibitory role of nNOS on 
neurogenesis  suggested  in  the  literature,  is  contradictory  to  the  well-established 
proliferative  effect  of  NPY  on  neurogenesis.  NO  mechanisms,  however,  are  highly 
complex and still need further investigation. It would be simplistic to assume that nNOS-
derived  NO  can  only  be  inhibitory  in  adult  neurogenesis.  The  cell  type,  cell  source, 
reactive  status,  timing  of  synthesis  and  concentration  are  major  determinants  of  NO's 
effects (Cardenas et al., 2005). As suggested by Cardenas et al. (2005), while low levels 98 
 
and  early  synthesis  of  NO,  such  as  by  eNOS,  may  be  beneficial  through  a  local 
vasodilatatory effect, high and sustained levels of NO production by nNOS, for example, 
may  be  neurotoxic  by  contributing  to  oxidative  stress.  In  fact,  Park  et  al.  (2003)  also 
demonstrated that only chronic (15 days), and not acute, NOS inhibition had a stimulatory 
effect on neuronal stem cell proliferation.  
3.4.6 Conclusion 
I have shown, for the first time, that NOS and NO play an important role in mediating the 
proliferative effect of NPY on hippocampal cultures, especially on the nestin
+ precursor 
cell population. nNOS was identified as the most likely subtype involved, while live cell 
imaging using the NO/N2O3 indicator, DAF FM DA, suggests a link between NPY and 
increased NO production. Although NO mechanisms have been identified as a mediator of 
NPY, how do these processes translate to cell proliferation? The next chapter focuses on 





















































































Chapter 4 – Coupling NO mechanisms to cell proliferation 
4.1 Introduction 
I have shown that the proliferative effect of NPY is  most likely mediated through the 
nNOS subtype and that NO/N2O3 production significantly increased in response to NPY 
addition in hippocampal cells. Although I have identified NOS and NO as mediators of the 
proliferative  effect  of  NPY,  our  knowledge  of  the  underlying  signalling  pathways  are 
incomplete. To understand how NOS activation and NO synthesis may lead to an increase 
in  cell  proliferation,  the  signalling  pathway  of  NPY  was  further  investigated  in 
hippocampal cultures.   
4.1.1 Signalling mechanisms of the NPY receptors 
The expression patterns of the NPY Y receptors (Y1, Y2, Y4, Y5 and Y6) are tissue-specific, 
unlike  the  ubiquitous  expression  of  NPY,  which  probably  accounts  for  its  varied 
physiological effects (Gehlert, 2004). The Y receptors show preferential coupling to the G-
proteins of the Gi/Go class (Michel et al., 1998), which are inhibited by pertussis toxin 
(PTX) and show their own distinct response patterns (Gilman, 1987). The Gi pathway is 
mediated  by  its  βγ-subunit  and  is  dependent  on  phosphatidylinositol  3-kinase  (PI3K) 
activity, while being independent of protein kinase C (PKC) (Wettschureck & Offermanns, 
2005). A common target of the activated Gi subunit is adenylate cyclase, which it inhibits 
from producing the second messenger cAMP from ATP (Limbird, 1988). On the other 
hand, the Go pathway is mediated by its α-subunit and is dependent on the activity of PKC 
(Wettschureck & Offermanns, 2005). After activation of the G-proteins by NPY, signalling 
responses are restricted to tissue and cell type, with targets ranging from the regulation of 
Ca
2+ or K
+ channels and Ca
2+ release from intracellular stores (Herzog et al., 1992), to the 
control of cell proliferation and differentiation (Michel et al., 1998).  
4.1.2 NPY coupling to the ERK 1/2  
The  ERK  1/2  are  a  group  of  mitogen-activated  protein  kinases  (MAPK)  which  are 
activated via multistep protein kinase cascades by phosphorylation (Alvaro et al., 2008; 
Lopez-Ilasaca, 1998). In turn, the ERK 1/2 are involved in mediating intracellular signals 
which regulate the expression of genes controlling  cell proliferation and differentiation 
(Cano & Mahadevan, 1995). Studies have shown that the neuroproliferative effect of NPY, 
acting through the NPY Y1 receptor, is eliminated by the addition of an ERK 1/2 inhibitor, 
U0126.  ERK  1/2  phosphorylation  has  been  shown  to  be  involved  in  the  intracellular 
mechanisms  underlying  NPY-mediated  neuroproliferation  in  neuroblasts  from  the 102 
 
olfactory epithelium (Hansel et al., 2001), hippocampal precursor cells from the dentate 
gyrus (Howell et al., 2005), retinal neural cells (Alvaro et al., 2008) and SVZ stem cells 
(Agasse et al., 2008). 
  
      NPY receptor activation (Y1, Y2, Y4 or Y5) leads to the activation of ERK 1/2 by a 
PTX-sensitive mechanism i.e. through the involvement of the Gi/Go G proteins, in CHO 
cells (Mullins et al., 2002). However, while the NPY Y5 receptor seems to rely on PI3K 
and PKC for signalling in CHO cells, Y1, Y2 and Y4 act through a PKC- independent 
mechanism (Mullins et al., 2002). Mullins et al. (2002) suggest that the NPY Y5 receptor 
couple to Gi/Go proteins, while Y1, Y2 and Y4 use only Gi proteins (dependent on PI3K), to 
mediate the phosphorylation of ERK. These differences in the signalling mechanisms used 
to phosphorylate ERK may be due to structural differences between the NPY receptor 
subtypes (Mullins et al., 2002; Nie & Selbie, 1998).  
4.1.3 Coupling ERK 1/2 activation to proliferation 
The ERK 1/2 are critical components of mitogenic signalling and growth pathways and the 
activation of ERK 1/2 in response to NPY binding helps to initiate downstream signals 
which  coordinate  proliferative  processes  (Gutkind,  1998).  In  the  NPY-mediated 
proliferation of vascular smooth muscle cells (VSMC) through NPY Y1 receptors, Pons et 
al. (2008) showed that the mitogenic effects were blocked by pertussis toxin and inhibitors 
of  calcium/calmodulin-dependent  kinase  II  (CaMKII),  PKC  and  MEK  (MAPK/ERK 
kinase) 1 and 2. This suggests that the proliferative effect of NPY on VSMCs is mediated 
via a PKC, Ca
2+ (through increased intracellular Ca
2+) and CaMKII-dependent pathway(s) 
which results in the phosphorylation (activation) of ERK 1/2 by MEK 1/2 (Pons et al., 
2008).   
 
      NPY has been shown to regulate not only the proliferation of normal and healthy cells, 
but also cancerous cells (Ruscica et al., 2006). NPY regulates the proliferation of prostate 
cancer  cells  via  the  Y1  receptor  (Ruscica  et  al.,  2006).  Although  the  effects  of  NPY 
treatment varied across different strains of human prostate cancer cell lines, producing 
either inhibitory or proliferative effects, these responses were all inhibited by treatment 
with the Y1 receptor antagonist, BIBP3226. This direct regulation of cancerous cell growth 
by NPY, which also appeared to be related to ERK1/2 activation, was either long-lasting, 
or rapid and transient, depending on the strain (Ruscica et al., 2006).  103 
 
4.1.4 Intracellular and extracellular NO 
NO itself is a highly diffusible signalling molecule (Lancaster, 1997; Wood & Garthwaite, 
1994) which is  able to  mediate both  intracellular and intercellular signalling pathways 
through intracellular and/or extracellular release. This raises the question over whether NO 
may be synthesised and released from one cell, before diffusing to and exerting its effects 
on another cell. Is the NO synthesised in response to NPY stimulation released within the 
same cell, whereby proliferative processes are mediated intracellularly, or is NO released 
extracellularly before acting on cells within its proximity? In fact, a previous study by Luo 
et al. (2010) found that the source of NO (intracellular or extracellular) was important in 
determining  its  cellular  effects.  nNOS-derived  NO  from  neural  stem  cells  acted 
intracellularly  and  promoted  neural  stem  cell  proliferation  whereas  nNOS-derived  NO 
from  neurons  was  released  extracellularly  into  the  media,  where  it  exerted  anti-
proliferative effects on neural stem cell proliferation (Luo et al., 2010). In this case, could 
intracellularly  released  NO  be  involved  in  mediating  proliferative  effects,  while 
extracellularly  released  NO  be  a  negative  regulator  of  cell  proliferation  in  postnatal 
hippocampal cultures? 
4.1.5 The aims of this chapter 
NOS and NO mechanisms are significant players in mediating the proliferative effect of 
NPY on hippocampal cells, although how these mechanisms lead to an increase in cell 
proliferation is unknown. ERK 1/2 seem to be key mediators of proliferative pathways and 
have  been  shown  to  mediate  the  proliferative  effect  of  NPY  on  a  range  of  cell  types 
(Howell et al., 2005; Agasse et al., 2008; Alvaro et al., 2008), which brings into question 
whether NPY-mediated NOS/NO production could be linked to ERK 1/2 mechanisms, and 
if it is, how? The aims of this chapter, therefore, were to further investigate the signalling 
pathway of NPY and how the activation of NOS could lead to proliferative processes. 
Does  NO  produced  by  NOS  in  response  to  NPY  stimulation  act  intracellularly  or 
extracellularly,  and  what  are  the  consequences  of  the  NO  source?  The  most  common 
mediators of NO processes, sGC and cGMP, were investigated, as well as the ERK 1/2 





Methodology and experimental aim 
The  NOS  and  NO  signalling  cascade  underlying  NPY-mediated  cell  proliferation  was 
investigated in an in vitro rat hippocampal cell culture system. A detailed description of 
primary  hippocampal  cell  culture  generation,  cell  plating,  the  assessment  of  cell 
proliferation  with  BrdU,  immunocytochemistry  and  cell  quantification  and  statistical 
analysis  is  provided  in  Chapter  2.  Unless  otherwise  stated,  a  one-way  ANOVA  with 
Dunnett's multiple comparison test was applied to the raw data to determine significance 
levels compared to control conditions (p = <0.05). The concentration of pharmacological 
agonists or antagonists were chosen based on either published literature (where the chosen 
concentrations have already been tested on neuronal cells in a similar context) and/or by 
testing a range of different concentrations (Table 4.2.1).  
 
Table 4.2.1 Agonists and antagonists 
Agonists  Company  Concentration 
8-Bromo(Br)-cGMP  Tocris Bioscience, UK  20 µM (dose response and Alvaro 
et al., 2008) 
Antagonists  Company   
1H-[1,2,4]oxadiazolo[4,3-
a]quinoxalin-1-one (ODQ) 
Ascent Scientific, UK  50 µM (Alvaro et al., 2008) 
U0126  Ascent Scientific, UK  1 µM (Howell et al., 2005) 
KT5823  Tocris Bioscience, UK  1 µM (Reyes-Harde et al., 1999) 
Carboxy-PTIO  Tocris Bioscience, UK  10 µM (Luo et al., 2010) 
DETA/NONOate (NOC-18)  Calbiochem, Merck 
Biosciences, UK 
50, 100, 200 µM (Luo et al., 
2010) 
 
4.2.1 The effect of 8-Br-cGMP on hippocampal cultures 
The enzyme sGC is a common target of NO (Denninger & Marletta, 1999) which converts 
GTP  to  cGMP.  8-Bromo(Br)-cGMP  is  a  membrane-permeable  analogue  of  cGMP.  To 
assess the  effects  of the second messenger of  NO, cGMP,  on proliferation, cells  were 
cultured  under  control  conditions  (NBA-A/B27/Glu  medium  plus  1% 
antibiotic/antimycotic) and/or in the presence of 1 μM NPY or 10 μM, 20 μM or 50 μM 8-
Br-cGMP (Tocris Bioscience, UK) (Alvaro et al., 2008) for 3 DIV. Cells were pulsed with 
20 μM BrdU for 6 h on day 3, followed by cell fixation, immunocytochemistry for BrdU 
and DAPI, imaging, quantification and analysis.  105 
 
4.2.2 Inhibiting sGC on the neuroproliferative effect of NPY 
As well as using the cGMP analogue 8-Br-cGMP to study the mechanisms underlying 
NPY-mediated  neuroproliferation,  the  effect  of  sGC  inhibition  using  1H-
[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one  (ODQ)  was  also  explored.  ODQ  is  a  highly 
selective and potent inhibitor of the nitric oxide sensitive sGC. To investigate the effect of 
sGC inhibition on proliferation, hippocampal cells were cultured under control conditions 
and 1 μM NPY, 20 μM 8-Br-cGMP and/or 50 μM ODQ (Ascent Scientific, UK) (Alvaro et 
al., 2008) for 3 DIV. Cells were pulsed with 20 μM BrdU for 6 h on day 3 before cell 
fixation.  Fixed  cells  were  immunocytochemically  stained  for  BrdU  and  DAPI  before 
imaging, quantification and analysis.  
4.2.3 ERK 1/2 inhibition on NPY- and 8-Br-cGMP-mediated proliferation 
The ERK 1/2 kinases are involved in mediating a range of intracellular signalling cascades 
which regulate cell proliferation and differentiation (Cano & Mahadevan, 1995). U0126 
(Ascent Scientific, UK) is an inhibitor of MAP kinase kinase (MEK) 1/2, which are the 
upstream kinases involved in mediating the activation of ERK 1/2 by phosphorylation. 
Cells were cultured under control conditions and 1 μM NPY, 20 μM 8-Br-cGMP and/or 1 
μM U0126 (Howell et al., 2005) for 3 DIV. Cultures were pulsed with 20 μM BrdU for 6 h 
on  day  3  before  cell  fixation,  immunocytochemistry,  cell  imaging,  quantification  and 
analysis.  
4.2.4 The effects of ODQ and U0126 on the proliferative effect of L-arginine 
The pharmacological inhibitors of sGC and ERK 1/2, ODQ (50 μM) and U0126 (1 μM), 
respectively, were applied individually to hippocampal cultures in the absence or presence 
of 500 μM L-arginine for 3 DIV. Cultures were pulsed with 20 μM BrdU for 6 h on day 3 
before cell fixation, immunocytochemistry, cell imaging, quantification and analysis. 
4.2.5 cGMP-dependent protein kinase (PKG) and the proliferative effect of NPY 
PKGs are one of the most common targets of cGMP (Francis & Corbin, 1999). To assess 
the  involvement  of  PKG  in  mediating  the  proliferative  effect  of  NPY,  the  selective 
inhibitor  of  PKG,  KT5823  (Tocris  Biosciences,  UK),  was  used.  Hippocampal  cultures 
were exposed to control conditions, 1 µM NPY or 20 µM 8-Br-cGMP in the absence or 
presence of 1 µM KT5823 for 3 DIV. Cultures were pulsed with 20 μM BrdU for 6 h on 
day 3 before cell fixation, immunocytochemistry, cell imaging, quantification and analysis. 106 
 
4.2.6 Western blotting for ERK 1/2 activation 
Western blotting was used to determine the activation (phosphorylation) status of ERK 1/2 
in response to NPY (1 µM) treatment in the absence or presence of the NOS inhibitor L-
NAME and its inactive enantiomer D-NAME. Cells derived from the hippocampus were 
plated at a density of 10
6 cells/ml in 6 well plates and cultured for 3 DIV under control 
conditions  (NBA-A/B27/Glu  medium  plus  1%  antibiotic/antimycotic)  before  treatment. 
The treatment conditions were control, 1 µM NPY, 1 µM NPY and 500 µM L-NAME, 1 
µM NPY and 500 µM D-NAME, and 500 µM L-NAME or 500 µM D-NAME, for 8 min 
at 37°C. The wells that were treated with NAME were pre-treated with 1 mM L-NAME or 
D-NAME for 10 min in order to ensure adequate NOS inhibition (El Mabrouk et al., 2000). 
Treated  cells  were  immediately  washed  in  ice-cold  PBS  before  cell  lysis  and  protein 
extraction. The protocol for protein extraction and Western blotting is described in Chapter 
3, section 3.2.5. Immunodetection of protein was carried out with the aid of PhosphoPlus 
p44/42  MAP  kinase  (Thr202/Tyr204)  antibody  kit  (Cell  Signaling  Technology,  New 
England  Biolabs  Ltd.,  Hertfordshire,  UK)  containing  primary  antibodies  against 
phosphorylated  ERK  1/2  and  total  ERK  1/2,  and  horseradish  peroxidase  (HRP)-linked 
secondary antibodies (Table 4.2.2). 
 
Table 4.2.2 Primary and secondary antibodies used during Western blotting for assessing ERK 1/2 
activation (phosphorylation).  
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      The Western blots were analysed with ImageJ analysis software (National Institutes of 
Health)  and  because  there  are  two  distinct  ERK  kinases  (1  and  2,  or  p44  and  p42, 
respectively),  each  ERK  kinase  band  was  analysed  separately  to  determine  if  the 
contribution  by  each  ERK  was  different.  At  least  three  independent  experiments  were 
carried  out  before  the  data  was  plotted  using  GraphPad  Prism  data  analysis  software 
(GraphPad Software Inc., San Diego, CA, USA) and the unpaired Students t-test applied 
on the means.  
4.2.7 NPY-mediated NO release 
Hippocampal  cultures  were  exposed  to  control  conditions,  1  µM  NPY  and/or  10  µM 
Carboxy-PTIO (CPTIO; Tocris Bioscience), a cell membrane-impermeable NO scavenger, 
for 3 DIV. The NO scavenger inhibits any effects mediated by extracellularly released NO 
(Akaike et al., 1993). Cell proliferation was assessed via BrdU incorporation for 6 h on the 
final day. The cultures were fixed and stained immunocytochemically for BrdU and nestin 
before they were imaged, quantified and analysed. 
4.2.8 The role of extracellular NO 
To  assess  the  effect  of  extracellular  NO  on  cell  proliferation,  the  NO  donor, 
DETA/NONOate (NOC-18; Calbiochem, Merck Biosciences, UK), was added to cultures 
at 50, 100 or 200 µM (Luo et al., 2010) for 3 DIV. Cell proliferation was assessed via 
BrdU  incorporation  for  6  h  on  the  final  day.  The  cultures  were  fixed  and  stained 













4.3.1 8-Br-cGMP mimics the proliferative effect of NPY 
The effects of cGMP, a second messenger of NO, on hippocampal cell proliferation was 
investigated  to  determine  its  involvement  in  mediating  the  effect  of  NPY.  The  cGMP 
analogue, 8-Br-cGMP, was added to hippocampal cultures at concentrations of 10, 20 and 
50  μM  for  3  DIV  to  assess  the  dose-response  relationship.  8-Br-cGMP  induced  a 
significant increase in total cell counts at all concentrations tested (p<0.05, F=17.20 and 
d.f.=21) (Fig. 4.3.1), exhibiting an effect similar to that of 1 μM NPY. There were no 
significant differences between the proliferative effects induced by 1 μM NPY or 10, 20 
and 50 μM 8-Br-cGMP (p>0.05, F=17.20 and d.f.=21) (Fig. 4.3.1). 8-Br-cGMP at 20 μM 
concentration  was  chosen  for  further  investigations  into  cGMP  to  allow  comparison 













Figure 4.3.1 The c-GMP analogue 8-Br-cGMP induced a significant increase in total cell counts. 
Cells were grown under control conditions (NBA-A/B27/glutamine), 1 μM NPY or 10, 20 or 50 
μM 8-Br-cGMP for 3 DIV. The increase in total cell count induced by 8-Br-cGMP was similar to 
that of NPY. There were no significant differences between the proliferative effects induced by 
NPY or 10, 20 and 50 μM 8-Br-cGMP. Data represent mean ± SEM based on a sample that 
represents at least 4 wells per condition. One-way ANOVA with Dunnett’s multiple comparison 
test, compared against control condition. *p < 0.05.  
 
 






















4.3.2 ODQ inhibits the proliferative effect of NPY 
The enzyme sGC, which converts GTP into cGMP, is one of the most common targets of 
NO  and  a  potential  target  within  the  signalling  pathway  of  NPY.  To  investigate  the 
involvement  of  sGC,  ODQ,  a  selective  inhibitor  of  sGC,  was  added  to  cultures.  As 
expected from previous studies (4.3.1), individual NPY or 8-Br-cGMP treatment induced a 
significant  increase  in  the  total  cell  counts  (p<0.05,  F=31  and  d.f.=86)  (Fig.  4.3.2A), 
number of BrdU
+ cells (p<0.05, F=42.82 and d.f.=86) (Fig. 4.3.2B) and the mitotic indices 
(p<0.05,  F=23.50  and  d.f.=86)  (Fig.  4.3.2C).  Both  proliferative  compounds  exerted  a 
similar  magnitude  of  effect  as  the  increases  observed  were  not  significantly  different 
between NPY or 8-Br-cGMP conditions (p>0.05, F=23.50 and d.f.=86). Cultures were also 
simultaneously exposed to both NPY and 8-Br-cGMP to determine whether the combined 
treatment would result in a cumulative effect. Although combined treatment resulted in 
increased total cell count (p<0.05, F=31 and d.f.=86) (Fig. 4.3.2A), number of BrdU
+ cells 
(p<0.05, F=42.82 and d.f.=86) (Fig. 4.3.2B) and the mitotic index (p<0.05, F=23.50 and 
d.f.=86)  (Fig.  4.3.2C),  these  increases  were  not  significantly  different  to  the  levels 
observed with individual NPY or 8-Br-cGMP exposure, thus discounting any cumulative 
effects.  
 
      The addition of the sGC inhibitor, ODQ, significantly reduced the proliferative effect 
of  NPY  under  all  parameters  investigated.  The  effect  of  NPY  on  total  cell  count  was 
significantly reduced to control levels by the presence of ODQ (One-way ANOVA with 
Bonferroni's  Multiple  Comparison  Test  comparing  NPY  condition  to  NPY  +  ODQ 
condition,  p<0.05,  F=31  and  d.f.=86),  while  the  addition  of  ODQ  on  its  own  had  no 
significant effect (Fig. 4.3.2A). Similarly, the increase in BrdU
+ cell number by NPY was 
significantly  inhibited  by  the  presence  of  ODQ  (One-way  ANOVA  with  Bonferroni's 
Multiple Comparison Test comparing NPY condition to NPY + ODQ condition, p<0.05, 
F=42.82 and d.f.=86), although in this instance, ODQ itself also seemed to have a negative 
effect  when  added  on  its  own  by  significantly  reducing  BrdU
+  cell  number  to  below 
control levels (p<0.05, F=42.82 and d.f.=86) (Fig. 4.3.2B). With regards to the mitotic 
index, the presence of ODQ, both in the presence and absence of NPY, exerted a negative 
effect  which  reduced  the  mitotic  index  to  below  control  levels  (p<0.05,  F=23.50  and 
d.f.=86) (Fig. 4.3.2C). It was quite clear, however, that the proliferative effect of NPY on 
the mitotic index was significantly reduced by the presence of ODQ (One-way ANOVA 110 
 







































































with Bonferroni's Multiple Comparison Test comparing NPY condition to NPY + ODQ 






















Figure  4.3.2  ODQ  reduced  the  proliferative  effect  of  NPY.  Cells  were  grown  under  control 
conditions (NBA-A/B27/glutamine) and 1 μM NPY, 20 μM 8-Br-cGMP and/or 50 μM ODQ for 3 
DIV. BrdU was added for the final 6 h. NPY or 8-Br-cGMP both induced a significant increase in 
(A)  total  cell  count,  (B)  number  of  BrdU
+  cells  and  (C)  the  mitotic  index.  There  were  no 
cumulative effects from combined NPY and 8-Br-cGMP treatment. ODQ reduced the effect of 
NPY to control levels and also had negative effects on basal proliferation rates on its own. Data 
represent mean ± SEM based on a sample that represents at least 12 wells per condition from four 
separate experiments. One-way ANOVA with Dunnett’s multiple comparison test, compared to 
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4.3.3 U0126 inhibits the proliferative effect of NPY and 8-Br-cGMP 
The pharmacological compound U0126 is an inhibitor of the activation (phosphorylation) 
of ERK 1/2. The involvement of ERK 1/2 in mediating the effect of NPY had been shown 
by Hansel et al. (2001) and Howell et al. (2005) in postnatal precursor cells from the 
olfactory epithelium and hippocampus, respectively. The effects of U0126 on NPY and 8-
Br-cGMP action was investigated to confirm ERK 1/2 involvement and further determine 
its role within the signalling cascade of NPY. As expected, the presence of NPY or 8-Br-
cGMP induced a significant increase in total cell counts (p<0.05, F=17.14 and d.f.=84) 
(Fig. 4.3.3A), number of BrdU
+ cells (p<0.05, F=33.59 and d.f.=84) (Fig. 4.3.3B) and the 
mitotic  indices  (p<0.05,  F=20.48  and  d.f.=84)  (Fig.  4.3.3C),  reminiscent  of  previous 
studies. In the case of the total cell count and BrdU
+ cell numbers, the presence of U0126 
completely reduced the effects of NPY or 8-Br-cGMP back down to control levels (One-
way ANOVA with Bonferroni's Multiple Comparison Test comparing NPY condition to 
NPY  +  U0126  condition  or  8-Br-cGMP  condition  to  8-Br-cGMP  +  U0126  condition. 
p<0.05, F=17.14 and d.f.=84 for total cell counts and p<0.05, F=33.59 and d.f.=84 for 
BrdU
+ cells) (Fig. 4.3.3A and Fig. 4.3.3B, respectively). This reduction was also observed 
in the mitotic index and its response to NPY or 8-Br-cGMP, whose proliferative effects 
were  significantly  inhibited  by  the  presence  of  U0126  (One-way  ANOVA  with 
Bonferroni's  Multiple  Comparison  Test  comparing  NPY  condition  to  NPY  +  U0126 
condition;  and  8-Br-cGMP  condition  to  8-Br-cGMP  +  U0126  condition,  respectively, 
p<0.05, F=20.48 and d.f.=84) (Fig. 4.3.3C). On its own, U0126 had no effects on the total 
cell count, number of BrdU












































































































Figure 4.3.3 U0126 reduced the proliferative effect of NPY and 8-Br-cGMP. Cells were grown 
under control conditions (NBA-A/B27/glutamine) and 1 μM NPY, 20 μM 8-Br-cGMP and/or 1 μM 
U0126 for 3 DIV. BrdU was added for the final 6 h. NPY or 8-Br-cGMP both induced a significant 
increase in (A) total cell count, (B) number of BrdU
+ cells and (C) the mitotic index, which was 
reduced  back  down  to  control  levels  by  U0126.  On  its  own,  U0126  had  no  effect  on  basal 
proliferation rates. Data represent mean ± SEM based on a sample that represents at least 9-13 
wells per condition from four separate experiments. One-way ANOVA with Dunnett’s multiple 
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4.3.4 ODQ and U0126 inhibit the proliferative effect of L-arginine 
To  further  verify  the  interlinks  within  the  NPY  signalling  pathway,  cultures  were 
supplemented  with  L-arginine  to  stimulate  endogenous  NO  production  while  in  the 
presence of inhibitors of identified downstream targets of NO, including sGC and ERK 
1/2.  Primary  hippocampal  cultures  were  grown  under  control  conditions  and  in  the 
presence of L-arginine and ODQ or U0126 for 3 DIV.  
 
      As expected from previous studies (Fig. 3.3.3), stimulating endogenous NO production 
with L-arginine induced a proliferative effect in cultures. In the case of sGC inhibition with 
ODQ, the increase in total cell count (p<0.05, F=97.91 and d.f.=29) (Fig. 4.3.4A), BrdU
+ 
cell  number  (p<0.05,  F=89.63  and  d.f.=29)  (Fig.  4.3.4B)  and  mitotic  index  (p<0.05, 
F=17.47  and  d.f.=29)  (Fig.  4.3.4C)  observed  in  response  to  L-arginine  treatment  was 
significantly  reduced  in  the  presence  of  ODQ  (One-way  ANOVA  with  Bonferroni's 
Multiple Comparison Test comparing L-arginine condition to L-arginine + ODQ condition, 
p<0.05, F=97.91 and d.f.=29 for total cell counts, p<0.05, F=89.63 and d.f.=29 for BrdU
+ 
cells, and p<0.05, F=17.47 and d.f.=29 for the mitotic index) (Fig. 4.3.4). Similar to the 
results observed previously (4.3.2), ODQ exerted an inhibitory effect which significantly 
reduced the number of BrdU
+ cells (p<0.05, F=89.63 and d.f.=29) and the mitotic index 
(p<0.05, F=17.47 and d.f.=29) to below control levels, even in the presence of L-arginine 
(Fig. 4.3.4B and C).  
 
      Similarly,  with  regards  to  ERK  1/2  inhibition  with  U0126,  L-arginine  induced  a 
significant increase in the total cell count (p<0.05, F=8.111 and d.f.=40) (Fig. 4.3.5A), 
BrdU
+ cell number (p<0.05, F=9.789 and d.f.=40) (Fig. 4.3.5B) and mitotic index (p<0.05, 
F=4.454 and d.f.=40) (Fig. 4.3.5C). In the presence of U0126, however, the proliferative 
effect of L-arginine was reduced to levels comparable to control conditions (Fig. 4.3.5). 
The  total  cell  count  (p>0.05,  F=8.111  and  d.f.=40)  (Fig.  4.3.5A),  BrdU
+  cell  number 
(p>0.05,  F=9.789  and  d.f.=40)  (Fig.  4.3.5B)  and  mitotic  index  (p>0.05,  F=4.454  and 
d.f.=40) (Fig. 4.3.5C) were not  significantly different  to  control.  In line with  previous 

























































































Figure 4.3.4 ODQ reduced the proliferative effect of L-arginine. Cells were grown under control 
conditions  (NBA-A/B27/glutamine)  and  in  the  presence  of  500  µM  L-arginine  or  500  µM  L-
arginine  and  50  µM  ODQ  for  3  DIV.  BrdU  was  added  for  the  final  6  h.  L-arginine  induced 
proliferative effects which were reduced by the presence of ODQ. ODQ significantly reduced any 
increase in (A) total cell count, (B) number of BrdU
+ cells and (C) mitotic index mediated by L-
arginine. In the presence of L-arginine, ODQ also significantly reduced the (B) number of BrdU
+ 
cells and (C) mitotic index to below control levels. Data represent mean ± SEM based on a sample 
that represents at least 10 wells per condition from three separate experiments. One-way ANOVA 
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Figure 4.3.5 U0126 reduced the proliferative effect of L-arginine. Cells were cultured under control 
conditions  (NBA-A/B27/glutamine)  and  in  the  presence  of  500  µM  L-arginine  or  500  µM  L-
arginine and 1 µM U0126 for 3 DIV. BrdU was added for the final 6 h. The presence of L-arginine 
significantly increased (A) the total cell count, (B) number of BrdU
+ cells and (C) the mitotic 
index, which were all reduced to control levels by U0126. Data represent mean ± SEM based on a 
sample that represents at least 13 wells per condition from three separate experiments. One-way 
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4.3.5 PKG is involved in mediating the effect of NPY 
The kinase PKG was investigated to further explore the processes downstream of cGMP. A 
common target of cGMP, PKG is inhibited selectively by the compound KT5823 (Francis 
et  al.,  2010).  Individually,  NPY  and  8-Br-cGMP  exerted  proliferative  effects  which 
increased  total  cell  counts  (p<0.05,  F=27.02  and  d.f.=85)  (Fig.  4.3.6A),  BrdU
+  cell 
numbers  (p<0.05,  F=50.89  and  d.f.=85)  (Fig.  4.3.6B)  and  the  mitotic  indices  (p<0.05, 
F=15.37 and d.f.=85) (Fig. 4.3.6C). KT5823 significantly reduced the proliferative effects 
of NPY or 8-Br-cGMP on the total cell count and BrdU
+ cell number to control levels 
(One-way  ANOVA  with  Bonferroni's  Multiple  Comparison  Test  comparing  NPY 
condition to NPY + KT5823 condition or 8-Br-cGMP condition to 8-Br-cGMP + KT5823 
condition.  p<0.05,  F=27.02  and  d.f.=85  for  total  cell  counts  and  p<0.05,  F=50.89  and 
d.f.=85 for BrdU
+ cells) (Fig. 4.3.6A and Fig. 4.3.6B, respectively). On its own, KT5823 
had no effect on either the total cell count or BrdU
+ cell number (Fig. 4.3.6A and Fig. 
4.3.6B, respectively). The mitotic indices of both NPY and 8-Br-cGMP conditions were 
significantly reduced in the presence of KT5823 (One-way ANOVA with Bonferroni's 
Multiple Comparison Test comparing NPY condition to NPY + KT5823 condition or 8-Br-
cGMP condition to 8-Br-cGMP + KT5823 condition. p<0.05, F=15.37 and d.f.=85) (Fig. 
4.3.6C), while combined 8-Br-cGMP and KT5823 treatment, as well as KT5823 treatment 
on  its  own,  significantly  reduced  the  mitotic  indices  to  below  control  levels  (p<0.05, 












































































































Figure 4.3.6 KT5823 reduced the proliferative effects of NPY and 8-Br-cGMP. Cells were grown 
under control conditions (NBA-A/B27/glutamine) and/or 1 µM NPY or 20 µM 8-Br-cGMP in the 
presence of 1 µM KT5823 for 3 DIV. BrdU was added for the final 6 h. The presence of NPY or 8-
Br-cGMP  induced an increase in (A) total cell counts, (B) number of BrdU
+ cells and (C) the 
mitotic indices, which were significantly reduced by KT5823. In the case of the mitotic indices, 
both treatment with KT5823 on its own and combined 8-Br-cGMP and KT5823 treatment resulted 
in a significant decrease to below control levels. Data represent mean ± SEM based on a sample 
that represents at least 13 wells per condition from four separate experiments. One-way ANOVA 
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4.3.6 ERK 1/2 activation by NPY is reduced by inhibiting NOS 
The proliferative effect of NPY has been shown to require, and induce, ERK 1/2 activation 
(phosphorylation) (Hansel et al., 2001; Howell et al., 2005; Alvaro et al. 2008). To assess 
whether  NPY  mediates  ERK  activation  through  a  NOS  and  upstream  NO  signalling 
pathway, ERK 1/2 phosphorylation was assessed via Western blotting in response to NPY 
treatment  in  the  presence  of  the  active  inhibitor  of  NOS,  L-NAME,  or  its  inactive 
enantiomer, D-NAME. The Western blots showed two bands against ERK, an upper and 
lower band, which were representative of ERK 1 (p44) and 2 (p42), respectively. There 
was increased phosphorylation of ERK 1 (p44) and 2 (p42) in response to NPY treatment, 
detected as increased band intensity, which was reduced by the presence of L-NAME and 
D-NAME (Fig. 4.3.7). To account for variability in protein loading, α-tubulin or GAPDH 












Figure 4.3.7 ERK 1/2 activation by NPY was reduced by inhibiting NOS. Western blots showing 
bands obtained in response to treatment of 3-d hippocampal cultures with control media (NBA-
A/B27/glutamine), 1 µM NPY or 1 µM NPY in the presence of 500 µM L-NAME or D-NAME for 
8 min. NAME treatment wells were pre-treated with 1 mM L-NAME or D-NAME for 10 min 
beforehand.  Immunoblots  were  probed  with  antibodies  against  phosphorylated  and  total  ERK, 
while GAPDH was used as a loading control. ERK 1 (p44) and 2 (p42) showed distinct bands. The 
addition of NPY increased the phosphorylation levels of ERK 1/2, while the presence of L-NAME 





















































































      Treatment  with  NPY  increased  the  phosphorylation  levels  of  ERK  1  (p44)  (Fig. 
4.3.8A) which, in the case of ERK 2 (p42), showed a significant increase (p<0.05, F=7.497 
and d.f.=11) (Fig. 4.3.8B). The increased phosphorylation levels of ERK 1/2 induced by 
NPY were significantly decreased by the presence of L-NAME and D-NAME (p<0.05, 
F=9.077  and  d.f.=11,  and  p<0.05,  F=7.497  and  d.f.=11,  for  ERK  p44  and  p42, 
respectively) (Fig. 4.3.8A and B). L-NAME and D-NAME alone had no significant effect 
on ERK 1/2 phosphorylation levels (p>0.05, F=0.2727 and d.f.=8, and p<0.05, F=0.3420 
























Figure 4.3.8 ERK 1 (p44) and 2 (p42) activation by NPY was reduced by inhibiting NOS. ERK 1/2 
phosphorylation in response to NPY, L-NAME and D-NAME treatment. 3 d hippocampal cultures 
were treated with (A and B) control media (NBA-A/B27/glutamine), 1 µM NPY or 1 µM NPY in 
(A)  (B) 

































the presence of 500 µM L-NAME or D-NAME, or (C and D) 500 µM L-NAME or D-NAME, for 8 
min.  NAME  treatment  wells  were  pre-treated  with  1  mM  L-NAME  or  D-NAME  for  10  min 
beforehand. (A and B) ERK 1 (p44) and 2 (p42) showed an increase in phosphorylation levels in 
response to NPY treatment, which was significant with ERK 2 (*), while the presence of L-NAME 
and D-NAME significantly reduced ERK 1/2 phosphorylation levels compared to NPY treatment 
(
+). (C and D) L-NAME or D-NAME treatment alone did not affect ERK 1/2 phosphorylation 
levels. Data represent mean ± SEM based on three separate experiments. One-way ANOVA with 
Dunnett’s (*) or Bonferroni’s (+) multiple comparison test. *p < 0.05. 
 
4.3.7 The proliferative effect of NPY is mediated via intracellular NO signalling and 
not by extracellular release and stimulation 
To determine the precise NO signalling cascade (intracellular or extracellular) involved in 
mediating the proliferative effect of NPY, hippocampal cultures were exposed to NPY in 
the presence of the cell membrane-impermeable NO scavenger, CPTIO, for 3 DIV as a 
means to reduce any extracellularly released NPY.  
 
      On  its  own,  NPY  exerted  a  proliferative  effect  on  cultures  which  significantly 
increased  the  total  cell  count  (p<0.05,  F=20.84  and  d.f.=46)  (Fig.  4.3.9A),  number  of 
BrdU
+ cells (p<0.05, F=21.43 and d.f.=46) (Fig. 4.3.9B) and the mitotic index (p<0.05, 
F=8.659 and d.f.=46) (Fig. 4.3.9E). Similarly, this effect was also observed with regards to 
the  nestin
+  precursor  cell  population,  with  significantly  enhanced  nestin
+  cell  (p<0.05, 
F=8.999 and d.f.=47) (Fig. 4.3.9C) and nestin
+ BrdU
+ cell numbers (p<0.05, F=14.02 and 
d.f.=47) (Fig. 4.3.9D) and mitotic index of nestin
+ precursor cells (p<0.05, F=6.206 and 
d.f.=47) (Fig. 4.3.9F). The proliferative effect of NPY was unaffected by the presence of 
the NO scavenger CPTIO, as demonstrated by the significantly increased total cell count 
(p<0.05, F=20.84 and d.f.=46) (Fig. 4.3.9A) and number of BrdU
+ cells (p<0.05, F=21.43 
and d.f.=46) (Fig. 4.3.9B), nestin
+ cells (p<0.05, F=8.999 and d.f.=47) (Fig. 4.3.9C) and 
nestin
+ BrdU
+ cells (p<0.05, F=14.02 and d.f.=47) (Fig. 4.3.9D). Likewise, the increased 
proliferation status in response to NPY and CPTIO treatment was reflected in the mitotic 
indices of the overall cell population (p<0.05, F=8.659 and d.f.=46) (Fig. 4.3.9E) and the 
nestin
+ precursor cell population (p<0.05, F=6.206 and d.f.=47) (Fig. 4.3.9F), supporting 
the  involvement  of  intracellular  NO  signalling  pathways  in  mediating  the  proliferative 
effect of NPY.  
































Figure 4.3.9 The proliferative effect of NPY is mediated via an intracellular NO signalling pathway 
and not by extracellular release and stimulation. Cells were cultured for 3 d under control (NBA-
A/B27/Glu), 1 µM NPY and/or 10 µM CPTIO (NO scavenger) conditions, before BrdU was added 
for the final 6 h. A significant increase was observed in (A) the total cell count, (B) numbers of 
(A) 
(F)  (E) 
(D)  (C) 












































































































































































+ cells, (C) nestin
+ cells, (D) nestin
+ BrdU
+ cells, and the mitotic indices of the (E) overall and 
(F) nestin
+ cell population in response to NPY exposure, which was still significantly increased in 
the presence of CPTIO, suggesting an intracellular, rather than extracellular, signalling pathway in 
the NPY bound cell. Data represent mean ± SEM based on a sample that represents at least 12 
wells per condition from at least three separate experiments. One-way ANOVA with Dunnett’s 

































4.3.8 The extracellular application of NO is inhibitory for cell proliferation 
If NO is released intracellularly in response to NPY stimulation and mediates proliferative 
processes, does extracellular NO, as described previously by Luo et al. (2010), exert anti-
proliferative  effects?  To  answer  this  question,  hippocampal  cells  were  cultured  in  the 
presence of the NO donor, DETA/NONOate (NOC-18), for 3 DIV to determine the effect 
of extracellular NO on cell proliferation. NOC-18 at concentrations of 50, 100 and 200 µM 
were  investigated  to  explore  the  dose-response  relationship.  NOC-18  at  the  lowest 
concentration of 50 µM exerted no effect on cell proliferation. The total cell count (p>0.05, 
F=0.2692 and d.f.=44), number of BrdU
+ cells (p>0.05, F=46.66 and d.f.=44), nestin
+ cells 
(p>0.05, F=44.90 and d.f.=45), nestin
+ BrdU
+ cells (p>0.05, F=16.19 and d.f.=45) and the 
mitotic  indices  of  the  overall  (p>0.05,  F=44.39  and  d.f.=44)  and  nestin
+  cell  (p>0.05, 
F=5.321 and d.f.=45) population were unchanged from control levels (Fig. 4.3.10A-F). At 
100  µM  concentration,  however,  a  negative  effect  on  cell  proliferation  was  observed. 
Although  total  cell  counts  in  response  to  100  µM  NOC-18  were  unchanged  (p>0.05, 
F=0.2692 and d.f.=44) (Fig. 4.3.10A), the number of BrdU
+ cells (p<0.05, F=46.66 and 
d.f.=44) (Fig. 4.3.10B) and the overall mitotic index (p<0.05, F=44.39 and d.f.=44) (Fig. 
4.3.10E) were significantly reduced to below control levels. The number of nestin
+ cells 
(p<0.05, F=44.90 and d.f.=45) (Fig. 4.3.10C) and nestin
+ BrdU
+ cells (p<0.05, F=16.19 
and d.f.=45) (Fig. 4.3.10D) were also significantly reduced, however, the mitotic index of 
nestin
+ precursor cells was not different to control levels (p>0.05, F=5.321 and d.f.=45) 
(Fig.  4.3.10F).  NOC-18  at  the  highest  concentration  tested,  200  µM,  fully  reduced 
proliferation to well below control levels. The number of BrdU
+ cells (p<0.05, F=46.66 
and d.f.=44), nestin
+ cells (p<0.05, F=44.90 and d.f.=45), nestin
+ BrdU
+ cells (p<0.05, 
F=16.19 and d.f.=45) and the mitotic indices of the overall (p<0.05, F=44.39 and d.f.=44) 
and nestin
+ cell population (p<0.05, F=5.321 and d.f.=45) were significantly decreased 
compared to  control  levels,  although the total  cell count was  also  unchanged (p>0.05, 
F=0.2692  and  d.f.=44)  (Fig.  4.3.10A-F).  The  inhibition  of  basal  cell  proliferation, 
especially of nestin
+ precursor cells, increased in response to NOC-18 concentration, with 
higher concentrations exerting a more prominent inhibitory effect. The negative effect of 
NOC18 on the numbers of BrdU
+ cells (Fig. 4.3.10B), nestin
+ cells (Fig. 4.3.10C), nestin
+ 
BrdU
+ cells (Fig. 4.3.10D) and the mitotic index (Fig. 4.3.10E) was significantly more 
pronounced  with  100  µM,  compared  to  50  µM  NOC18  (One-way  ANOVA  with 
Bonferroni's Multiple Comparison Test comparing 50 µM NOC18 condition to 100 µM 
NOC condition, p<0.05). Similarly, 200 µM NOC18 significantly reduced the numbers of 124 
 
BrdU
+ cells (Fig. 4.3.10B) and nestin
+ cells (Fig. 4.3.10C), as well as the mitotic indices of 
the overall (Fig. 4.3.10E) and nestin
+ cell (Fig. 4.3.10F) population, compared to 100 µM 
NOC18 (One-way ANOVA with Bonferroni's Multiple Comparison Test comparing 100 
µM NOC18 condition to 200 µM NOC condition, p<0.05). Interestingly, however, there 
were  no  significant  changes  in  the  total  cell  count  in  response  to  any  NOC-18 
concentration tested, which could be explained by the fact that the proportion of cells 





























































Figure 4.3.10 Extracellular NO exerts a negative effect on basal proliferation rates. Hippocampal 
cells  were  cultured  under  control  conditions  (NBA-A/B27/glutamine)  or  50,  100  or  200  µM 
DETA/NONOate (NOC-18) for 3 DIV before BrdU was added for the final 6 h. NOC-18 at 50 µM 

































































































































































































































had no effect on basal proliferation rates (A-F). 100 µM NOC-18 exerted a negative effect on 
proliferation rates by reducing the number of (B) BrdU
+ cells, (C) nestin
+ cells, (D) nestin
+ BrdU
+ 
cells and (E) the mitotic indices of the overall cell population to below control levels, although it 
showed no effect on (A) the total cell count or (F) the mitotic index of nestin
+ precursor cells. 200 





+ cells and the mitotic indices of the overall and nestin
+ cell population 
(B-F), although, similar to the treatment with 100 µM NOC-18, the total cell count was unaffected. 
Data represent mean ± SEM based on a sample that represents at least 11 wells per condition from 
three  different  experiments.  One-way  ANOVA  with  Dunnett’s  and  Bonferroni's  multiple 
comparison test, compared to control condition (ns, not significant). *p < 0.05.  
 
 























Chapter 3 had identified NOS and NO mechanisms as mediators of the NPY signalling 
pathway, but how this ultimately results in an increase in cell proliferation was unknown. 
The aim of this chapter was to decipher the signalling pathway downstream of NOS/NO 
responsible  for  mediating  the  proliferative  effect  of  NPY  in  postnatal  hippocampal 
cultures.   
4.4.1 Involvement of sGC and PKG 
The most common target of NO, sGC, activates a variety of intracellular kinase pathways 
through  the  synthesis  of  cGMP  (Denninger  &  Marletta,  1999;  Derbyshire  &  Marletta, 
2009). A heterodimeric protein, sGC consists of two homologous subunits, α and β, for 
which two isoforms of each subunit have been identified (α1/α2 and β1/β2) (Harteneck et 
al., 1991; Yuen et al., 1990). Although this gives rise to a variety of sGC isoforms, only the 
α1β1  and  α2β1  isoforms  are  active  (Russwurm  et  al.,  1998).  The  α1β1  isoform 
predominates in all other tissues except for the brain, where levels of α1β1 and α2β1 are 
comparable  (Mergia  et  al.,  2003).  The  sGC  inhibitor,  ODQ,  which  inhibits  both  sGC 
isoforms (Nimmegeers et al., 2007), reduced the proliferative effect of NPY, while the 
cGMP  analogue,  8-Br-cGMP,  mimicked  the  proliferative  response,  supporting  the 
involvement  of  both  sGC  and  cGMP  in  mediating  the  proliferative  response  of  NPY. 
Combined  treatment  with  NPY  and  8-Br-GMP  was  not  accompanied  by  any  further 
increase in proliferation (as a result of cumulative effects) compared to NPY-only or 8-Br-
cGMP-only conditions, possibly due to saturation of the signalling system. The addition of 
ODQ on its own was found to have an inhibitory effect on basal proliferation, suggesting a 
role for sGC in maintaining basal proliferation rates, however, ODQ at sufficiently high 
concentrations (above 10 µM) have been shown to inhibit the proliferation of prostate cell 
lines, independent of its effects on sGC (Haramis et al., 2008). The inhibitory effect of 
ODQ  in  this  study  may  be  partly  explained  by  the  high  50  µM  concentration  used, 
although  nevertheless,  in  the  presence  of  ODQ,  NPY  was  still  unable  to  restore 
proliferation back to basal rates. On a side note, it would also have been interesting to see 
whether the decreased proliferation in response to ODQ would have been restored by the 
addition of 8-Br-cGMP, which would have strengthened the results.     
 
      The second messenger of NO, cGMP, exerts its effects through three main cellular 
targets: the PKGs, cGMP-gated cation channels and cyclic nucleotide phosphodiesterases 128 
 
(PDEs)  (Garthwaite  &  Boulton,  1995).  PKGs  are  activated  on  cGMP  binding,  which 
results in the phosphorylation of serines and threonines on different cellular protein targets 
(Francis et al., 2010). This phosphorylation of proteins by PKG changes their activation 
status,  function  or  subcellular  localisation,  leading  to  a  range  of  physiological  effects 
ranging  from  the  regulation of calcium  homeostasis  and smooth  muscle contraction to 
controlling the expression of select genes or negative feedback back onto the NO pathway 
(Francis et al., 2010). Two isoforms of PKG exist, PKG-I and PKG-II (Uhler, 1993). Both 
are individually encoded by distinct genes (Uhler, 1993) and widely expressed within the 
mammalian  brain  (Feil  et  al.,  2005).  Of  the  PKG-I  isoform,  which  can  be  further 
subdivided into PKG-Iα and PKG-Iβ, Feil et al. (2005) showed that the PKG-Iβ subtype 
predominates in the hippocampus of the mouse brain. The expression of distinct PKG 
isoforms/subtypes  in  specific  brain  regions  contribute  to  the  selective  control  of  PKG 
activity (Feil et al., 2005). The involvement of PKG in the NPY signalling pathway was 
confirmed  by  the  addition  of  KT5823,  a  selective  PKG  inhibitor,  which  significantly 
reduced the proliferative effects mediated by both NPY and 8-Br-cGMP. This inhibition of 
both  upstream  factors suggested that PKG was the next  intermediary step after cGMP 
during the cellular signalling mechanisms of NPY. In addition, like sGC, PKG may have a 
role in maintaining basal proliferation rates. 
 
      The importance of PKG in signalling pathways is evident for the neural cell adhesion 
molecule  (NCAM),  which  has  important  roles  in  regulating  neuronal  development, 
synaptic plasticity and regeneration (Ditlevsen et al., 2007). In NCAM-mediated neurite 
outgrowth and neuroprotection of primary neurons, Ditlevsen et al. (2007) showed that 
NCAM binding leads to the activation of NOS, which results in NO synthesis and cGMP 
production through the NO-mediated activation of sGC. In turn, the increased synthesis of 
cGMP leads to the activation of PKG. In addition, PKG has been shown to activate ERK 
1/2 in adult smooth muscle cells by stimulating the activity of MEK (the kinases upstream 
of ERK 1/2) (Komalavilas et al., 1999). 
4.4.2 ERK 1/2 mediates the proliferative effect of NPY 
The ERK 1/2 have been shown by Hansel et al. (2001), Howell et al. (2005) and Alvaro et 
al. (2008) to be involved in mediating the effect of NPY in postnatal precursor cells from 
the olfactory epithelium, hippocampus and retina, respectively. My results also confirm 
ERK 1/2 involvement, showing a reduction in NPY-mediated proliferation upon ERK 1/2 129 
 
inhibition.  The  pharmacological  compound  U0126  completely  reduced  the 
neuroproliferative effects of NPY and 8-Br-cGMP on hippocampal cultures back down to 
control levels and had no effect on basal proliferation rates on its own. The inhibition of 8-
Br-cGMP activity allows us to conclude that ERK 1/2 activation was downstream of both 
sGC and cGMP, demonstrating interlinks within the pathway which had not been shown 
previously.  
4.4.3 NPY activates the ERK pathway through NOS 
The phosphorylation (activation) of ERK 1/2 is required for mediating the proliferative 
effect of NPY (Hansel et al., 2001; Howell et al., 2005). The signalling pathways initiated 
by the NPY Y receptors are diverse and activation of ERK 1/2 may be possible by acting 
through  NO-independent  mechanisms  (Mullins  et  al.,  2002).  Levels  of  ERK  1/2 
phosphorylation  were  assessed  by  Western  blotting  in  response  to  NOS  inhibition  to 
determine the importance of the NO pathway in mediating the proliferative effect of NPY. 
As expected, ERK phosphorylation was increased in response to NPY treatment, especially 
in the case of ERK 2 (p42). On the other hand, inhibition of NOS by L-NAME treatment 
reduced NPY-mediated ERK phosphorylation back down to control levels, confirming the 
importance of NO in mediating ERK 1/2 activation by NPY. Unexpectedly, the inactive 
enantiomer  D-NAME  also  had  a  significant  inhibitory  effect  on  ERK  phosphorylation 
levels induced by NPY. Similar to the pharmacological results in the last chapter, this may 
be explained by the presence of minute amounts of the active enantiomer, L-NAME, in the 
D-NAME, although it is unlikely that such small amounts would be able to cause such 
significant  inhibition.  Indeed,  L-NAME or D-NAME treatment alone had no effect  on 
basal  levels  of ERK  phosphorylation. Some studies,  however, have reported the chiral 
conversion of similar L-arginine derivatives (such as nitro-D-arginine (D-NA) into nitro-L-
arginine (L-NA; the active enantiomer for inhibiting NOS)) in vivo (Wang et al., 1999b), 
which may be one explanation, as L-NAME/D-NAME are methyl ester prodrugs which are 
hydrolysed by intracellular esterases into L-NA/D-NA, although it is unknown whether 
this may also be present in in vitro systems. Wang et al. (1999b) also showed that D-NA, 
although  400 times less potent than  L-NA, still caused a dose-dependent  inhibition  of 
nNOS in vitro at sufficient concentrations (EC50 = 200 µM), which may possibly explain 
the inhibitory effect of 500 µM D-NAME observed in this current study. 
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      Another conclusion drawn from the Western blotting investigations was that the whole 
signalling cascade from NPY to ERK 1/2 occurs in a matter of seconds to minutes. NPY 
was  able  to  increase  ERK  1/2  phosphorylation  in  hippocampal  cultures  in  less  than  8 
minutes (treatment time), while even earlier observations on olfactory cultures by Hansel 
et  al.  (2001)  demonstrated  increased  ERK  1/2  phosphorylation  30  seconds  after  NPY 
treatment. ERK 1/2 signalling is a key regulator of cell proliferation. After activation, ERK 
can either regulate targets in the cytosol by phosphorylation or translocate to the nucleus of 
the  cell  to  regulate  gene  expression  through  the  phosphorylation  of  a  variety  of 
transcription factors, such as c-Myc and c-Fos, which have important roles in controlling 
cell proliferation and the cell cycle (Roux & Blenis., 2004). Although the pharmacological 
profile of NPY in the dentate gyrus, for example, the rate of NPY release from GABAergic 
interneurons, is unknown, NPY acts quickly to exert its physiological effects.  
4.4.4 The proliferative effect of NPY is mediated through a NO-cGMP-PKG and 
ERK 1/2 pathway 
From what has been identified so far, the proliferative effect of NPY is mediated via a NO-
cGMP-PKG and ERK  1/2  pathway  (Fig. 4.4.1). The activation  order  within this  NPY 
signalling  pathway  was  further  reinforced  by  combined  pharmacological  investigations 
with L-arginine, ODQ and U0126. The proliferative effect mediated by L-arginine, which 
promotes intracellular NO production and the signalling pathway upstream at NOS, was 
inhibited when the sGC inhibitor, ODQ, or the ERK 1/2 inhibitor, U0126, was present. 
This addition of ODQ or U0126 blocks the signalling pathway downstream of L-arginine 



























Figure 4.4.1 The proliferative effect of NPY is mediated through a NO signalling cascade. NPY 
most likely activates neuronal nitric oxide synthase (nNOS) which synthesises NO. NO in turn 
induces the conversion of GTP into cGMP by soluble guanylate cyclase (sGC), upon which cGMP 
binds to and activates cGMP-dependent protein kinase (PKG). PKG stimulates a range of protein 
targets, ultimately resulting in the phosphorylation of the extracellular-regulated kinases (ERK) 1/2 
of the mitogen activated protein kinase (MAPK) pathway. ERK 1/2 direct the expression of genes 
involved in regulating cell proliferation and differentiation.    
 
      The  NO-cGMP-PKG  pathway  is  a  common  signalling  mechanism  utilised  by 
physiological  processes  (Garthwaite  &  Boulton,  1995)  and  the  ERK  1/2  mediate 
intracellular signals which regulate the expression of genes controlling cell proliferation 
and  differentiation  (Cano  &  Mahadevan,  1995).  The  importance  of  a  NO-cGMP-PKG 
pathway  in  mediating  the  activation  of  ERK  1/2  was  demonstrated  previously  in  rat 
cerebellar Purkinje cells, where the use of NO donors combined with the simultaneous 
application of high potassium and glutamate induced ERK 1/2 phosphorylation, which was 
important in enhancing the declustering of the ionotropic glutamate receptor subunit 2/3 
(Endo  &  Launey,  2003).  Declustering  of  the  glutamate  receptor  is  thought  to  be  a 
preliminary step in glutamate receptor internalisation, an important part of the molecular 
mechanisms of early-phase long-term depression. The pharmacological inhibitor KT5823 
was similarly used to inhibit PKG (Endo & Launey, 2003).  
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4.4.5 The proliferative effect of NPY is probably mediated via intracellular NO 
signalling 
The proliferative effect of NPY was probably mediated via an intracellular NO signalling 
pathway which involved NO release inside the cell, as the membrane-impermeable NO 
scavenger, CPTIO, had no effect  on NPY action.  Although other studies  typically use 
higher levels of CPTIO (~200-300 µM) (Griffiths et al., 2003; Onitsuka et al., 1998; Podda 
et al., 2004), as CPTIO reacts slowly with NO (rate constant of 1.01 x 10
4 M
-1s




-1 at 25°C and 37°C, respectively) (Akaike et al., 1993; Griffiths et al., 2003) and 
so may not be able to inhibit very local effects, 10 µM CPTIO was used in this study to 
maintain consistency and allow comparison with Luo et al's (2010) study. Extracellular 
NO, on the other hand, exerted a negative effect on basal proliferation rates. The addition 
of  the  NO  donor,  DETA/NONOate  (NOC-18),  induced  a  dose-dependent  decrease  in 
proliferation rates which also inhibited the proliferation of nestin
+ precursor cells. Similar 
to the CPTIO investigation, the same concentrations of DETA/NONOate as Luo et al's 
study  were  used  to  allow  comparison  of  results.  The  50  to  200  µM  DETA/NONOate 
concentration was based on the fact that the estimated physiological concentration of NO 
in the normal brain ranges between 10 and 100 nM (Shibuki, 1990), and that the lowest 
concentration of DETA/NONOate, 50 µM, was approximately equivalent to physiological 
levels (Luo et al., 2010). However, as mentioned previously, huge variations in in vivo NO 
concentration have been obtained by different groups (Hall & Garthwaite, 2009), casting 
doubt  over  whether  the  levels  of  DETA/NONOate  used  are  physiologically  relevant. 
Moreover,  a  review  of  independent  studies  conducted  by  Hall  and  Garthwaite  (2009) 
suggests that the physiological concentration of NO is more likely to be 100 pM (or below) 
up  to  ~5  nM,  much  lower  than  initially  thought.  If  these  levels  are  indeed  more 
representative of endogenous NO levels, then the concentrations of DETA/NONOate used, 
in not only this but also other studies, may be too high for NO levels to be physiologically 
representative. In fact, in the study by Covacu et al. (2006), who Luo et al. (2010) based 
their choice of DETA/NONOate concentrations on, ~500 nM NO was found to be released 
from 0.1 mM DETA/NONOate at the peak of NO release (~2 h) using a NO-selective 
microelectrode  (NO  release  was  measured  over  a  period  of  24  h).  If  0.1  mM 
DETA/NONOate releases ~500 nM NO at its peak, then 50 µM, 100 µM, and 200 µM 
DETA/NONOate would release ~250 nM, ~500 nM, and ~1 µM NO, respectively (Covacu 
et al., 2006), far exceeding the physiological concentration of NO proposed by Hall & 
Garthwaite  (2009)  of  100  pM  (or  below)  up  to  ~5  nM.  Increased  cell  death  usually 133 
 
associated with high NO levels (Beckman & Koppenol, 1996), however, was not observed 
in hippocampal cultures (please refer to Appendix A; page 195), and DETA/NONOate 
clearly had only an inhibitory effect on the mitotic index, which decreased with an increase 
in donor concentration, reflective of the results by Luo et al. (2010). 
 
      This  dual  effect  of  NO,  with  intracellular  NO  mediating  proliferative  effects  while 
extracellular NO exerted anti-proliferative effects, as previously described by Luo et al. 
(2010), demonstrates a way in which the actions of NO may be regulated. In this case, the 
source of NO (intracellular or extracellular) dictates the effect of NO on the proliferation of 
nestin
+  precursor  cells.  Although  the  mechanisms  underlying  the  inhibitory  effect  of 
extracellular NO on my own cultures is unknown, the study by Luo et al. (2010) showed 
that the NO produced by nNOS in neurons deceased the proliferation of neural stem cells 
by exerting a negative control, possibly through cAMP-dependent protein kinase (PKA), 
on cAMP response element-binding (CREB) phosphorylation. This in turn inhibited nNOS 
expression and intracellular NO production in the neural stem cell, resulting in reduced cell 
proliferation. In fact, the negative role of nNOS in regulating adult neurogenesis in vivo, as 
described previously, could be as a result of the inhibitory effect mediated via the release 
of, possibly high concentrations, of extracellular NO by nNOS in neurons, which, due to 
the predominant  expression of nNOS in neurons, may have surpassed the proliferative 
effect of intracellular NO from nNOS in neural stem cells (Luo et al., 2010). Indeed, a 
transient decrease in the proliferation of neural precursor cells during the early postnatal 
period is observed in the olfactory epithelium of nNOS knockout mice (Chen et al., 2004), 
which  supports  the  involvement  of  nNOS  in  mediating  neural  stem/precursor  cell 
proliferation.  
4.4.6 Conclusions  
For  the  first  time,  NPY  has  been  shown  to  exert  a  neuroproliferative  effect  on  rat 
hippocampal  cells  through  a  NO-cGMP-PKG  and  ERK  1/2  signalling  pathway.  This 
signalling pathway is possibly mediated entirely intracellularly with a localised release of 
NO.  On  the  contrary,  extracellular  NO  exerted  anti-proliferative  effects,  a  clear 
























































































Chapter 5 - A novel synthetic silica hydrogel for culturing rat hippocampal neuronal 
cells in three-dimensions 
5.1 Introduction 
Cell culture is an important tool for studying living cells under controlled conditions which 
would otherwise not be possible in intact tissues in vivo. Cell culture is frequently used to 
produce enriched or homogenous populations of desired cell types for ease of study and to 
decrease  the  uncertainty  associated  with  interpreting  the  cellular  target  of  a  variety  of 
experimental conditions or substances (Bottenstein & Sato, 1985). Advantages to cultured 
cells are that isolated cells allow for simple in vitro access for the direct application of 
pharmacological  agents  or  electrophysiological  studies  and  allows  for  morphological 
studies into cellular characteristics because of easy visual access (Brewer, 1997). An in 
vitro environment allows better control and maintenance of variables, producing uniform 
conditions  which  allow  greater  reproducibility  to  be  obtained  in  physiological 
measurements and recordings than studies in vivo (Bottenstein & Sato, 1985). Although 
biomedical  research  is  currently  dominated  by  the  growth  of  cells  in  conventional 
monolayers, where cells propagate in a two-dimensional (2D) environment on the surface 
of glass or plastic vessels, whether this is a true representation of the in vivo environment is 
uncertain (Xu et al., 2009). The in vivo extracellular environment, the extracellular matrix 
(ECM),  is  a  dynamic  and  highly  specialised  three-dimensional  (3D)  environment 
containing diverse structures, molecules and components (Alberts et al., 2002). Specific 
cellular interactions exist between cells with other cells and their environment, which are 
important  for  regulating  cell  growth,  migration  and  differentiation  (Buck  &  Horwitz, 
1987).  Studies  have  shown  that  removing  cells  from  their  natural  environment  and 
culturing them in a restrictive 2D environment is linked with unnatural behaviour, as many 
features and interactions characteristic of their original environment are lost (Cukierman et 
al.,  2002;  Tibbitt  &  Anseth,  2009).  Real-time  fluorescence  imaging,  for  example,  has 
illustrated distinct differences in the behaviour of lymphocytes under in vitro conditions 
compared to their natural 3D environment of the intact lymph nodes, with lymphocytes 
showing significantly enhanced cellular movements in vivo (Miller et al., 2002). Similarly, 
Petersen et al. (1992) showed that human breast epithelial cells cultured in 2D developed 
like tumour cells, while normal growth behaviour was exhibited when cultured in a 3D 
reconstituted basement membrane. 3D cultures offer many advantages over conventional 
2D  cultures  by  allowing  the  combination  of  a  controllable  in  vitro  environment  with 
features more representative of an in vivo environment. 138 
 
      I have shown that NOS and NO signalling pathways mediate the neuroproliferative 
effect of NPY on hippocampal cells cultured in conventional monolayers. It would be 
intriguing,  however,  to  determine  whether  hippocampal  neuronal  cultures  would 
proliferate,  differentiate  and  interact  differently  to  NPY  in  an  environment  which  was 
much more comparable to  an  in  vivo  environment. One of the most common scaffold 
materials used for creating 3D cultures are hydrogels (Hoffman, 2002). These extremely 
hydrated  hydrophilic  polymeric  matrices  contain  abundant  amounts  of  water  (typically 
more than 30% by weight), and in some instances, can absorb up to thousands of times 
their dry weight in water while still maintaining a stable 3D network (Hoffman, 2002; 
Kopecek, 2007). Indeed, the proposition that NPY-releasing interneurons in the dentate 
hilus  interact  with  progenitors  within  the  SGZ  by  releasing  NPY  to  control  their 
proliferation  and  adult  hippocampal  neurogenesis  in  vivo  (Gray,  2008),  could  be 
investigated in vitro, as the unique rheological properties of many hydrogels will allow the 
assembly of complex 3D cultures incorporating multiple sectors consisting of different cell 
types  i.e.  NPY-releasing  interneurons  and  nestin
+  precursor  cells,  and/or  chemical  or 
biological factors. With this in mind, attempts were made to develop viable 3D cultures of 
hippocampal cells in hydrogel matrices. 3D cell cultures using conventional hydrogels, 
such as collagen or polymer-based hydrogels, are frequently used for culturing a myriad of 
cell  types,  which  made  it  appealing  to  try  a  novel  synthetic  silica  hydrogel  known  as 
Laponite as the 3D matrix material.  
5.1.1 Three-dimensional cell cultures 
There are three main types of 3D culture, organ culture, organotypic culture and histotypic 
culture (Freshney, 1987). In organ culture, small fragments of organ are cultured at an air-
fluid interface (to optimise gas and nutrient exchange). These tissues retain a 3D structure 
and possibly most of their in vivo functional features as the relationship and interactions 
between cells are still intact (Browning & Trier, 1969). This type of culture is often used to 
study the effect of exogenous stimuli on development, as demonstrated by Lasnitzki & 
Mizuno (1979), who showed the importance of the mesenchyme tissue in the induction of 
the rat prostate gland by androgens. Most types of organ culture are developed for the 
study of fragmented or whole organs and recombined tissues. Organotypic cultures, on the 
hand,  involve  the  recombination  of  isolated  cells  of  different  lineages  to  recreate 
components  of  a  particular  organ  of  study  (Freshney,  1987).  Previous  attempts  to 
regenerate tissue-like architecture from isolated monolayer cell cultures include efforts by 139 
 
Kruse & Miedema (1965), who showed that perfused monolayers could form dense multi-
layers which were more than ten cells deep, whilst, in the presence of endothelial growth 
factor and tumour cell conditioned medium, Folkman & Haudenschild (1980) showed that 
capillary  tubules  formed  in  vascular  endothelial  cell  cultures.  In  contrast  to  organ  or 
organotypic  cultures,  histotypic  cell  culture  is  a  technique  where  isolated  cells  are 
reassociated and grown to high density in an artificial 3D matrix to generate an architecture 
which resembles a tissue of the studied organ (Freshney, 1987). As the focus of this study, 
the ability to manipulate the 3D scaffold of histotypic cultures allows for unprecedented 
possibilities  for  investigating  the  effect  of  different  environmental  parameters  on  cell 
response.  3D  histotypic  cultures  tend  to  show  superior  physical  properties,  higher 
complexity  and  enhanced  cell  survival  compared  to  monolayer  cultures.  Additionally, 
advantageous aspects typical of traditional 2D cultures are retained in histotypic cultures, 
including  the  ability  to  control  the  attachment,  proliferation,  pharmacological  and 
electrophysiological properties of dissociated cells, which may prove difficult under in vivo 
conditions because of the many influencing factors in situ. 
5.1.2 Basic requirements of a 3D histotypic cell culture system 
Most  cells  in  conventional  2D  culture  are  anchorage-dependent  cells  which  grow  as 
monolayers on the surface of a vessel, often helped by attachment factors such as poly-L-
lysine for adherence (Brewer et al., 1997). In their natural 3D environment, the ECM is 
present not only as a scaffold to support cells, but is also important for regulating cellular 
interactions which ultimately determine the survival and development of the cell and tissue 
as a whole (Buck & Horwitz, 1987). An important requirement of a 3D histotypic culture 
system is the presence of a matrix which is sufficient to support the cells growing within 
(Hubbell,  2003).  It  is  hard  to  mimic  the  ECM  due  to  its  highly  complex  nature,  but 
attempts have been made to reproduce a similar environment in vitro for 3D cell culture. 
This biomimicry is mainly focused on reproducing the biochemical composition, fibrillar 
structure  and  viscoelastic  gel-like  properties  (Hubbell,  2003).  This  has  been  achieved 
through the use of both naturally-derived and or synthetic materials to varying degrees of 
success.   
 
      Gas and nutrient exchange is relatively efficient in 2D cultures due to the organisation 
of isolated cells into monolayers, although this becomes more complicated in 3D cultures 
due to the presence of a 3D matrix. Depending on the type of scaffold material used, 140 
 
gaseous diffusion, metabolite and nutrient exchange may be either sufficient or limited 
(Amsden, 1998). Gas and nutrient exchange issues have typically affected organ cultures, 
where  large  explants  show  central  necrosis  due  to  limited  gas  diffusion  and  nutrient 
exchange  (Browning  &  Trier,  1969),  although  this  would  not  be  an  issue  in  a  living 
organism  due  to  the  diffuse  vasculature  present  throughout  tissues,  which  constantly 
regulate gas and nutrient exchange in metabolising cells (Hoffman, 2002). The ECM is 
also composed predominantly of hydrophilic glycosaminoglycans (GAGs) or unbranched 
polysaccharide chains which form a highly hydrated porous gel-like matter which permits 
the rapid diffusion of gases, nutrients and metabolites (Trowbridge & Gallo, 2002). These 
GAG  gels  are  able  to  withstand  vast  compressive  forces  and  form  gels  at  low 
concentrations. In this aspect, hydrogels are very similar to the GAG gels making up the 
ECM.  
5.1.3 Hydrogels as synthetic extracellular matrices 
Hydrogels show properties similar to those of GAG gels in that many form gels at low 
concentrations, permit the rapid diffusion of gas and nutrients due to its highly hydrated 
nature, are non-toxic and are able to withstand compressive forces (Kopecek, 2007). In this 
sense, hydrogels are one of the best candidate materials for replacing the ECM in 3D 
histotypic  cultures.  Indeed,  hyaluronic  acid  (HA),  the  simplest  GAG,  is  used  to  form 
naturally-derived  hydrogels  for  a  range  of  applications  (Vercruysse  et  al.,  1997).  An 
additional benefit to HA hydrogels is the natural degradation by hyaluronidase in the body, 
allowing regulation of hydrogel clearance from the body when used as tissue engineering 
matrices (Drury & Mooney, 2003).  
 
      Collagen, a major constituent of the mammalian ECM, is also one of the polymers 
most frequently used for the synthesis of hydrogels. These collagen hydrogels have been 
extensively used for the study of cell migration, motility and contraction (Hubbell, 2003). 
Elsdale & Bard (1972) were one of the first to describe a collagen substrata containing 1% 
collagen by weight. These 3D hydrated collagen lattices synthesised from polymerised 
collagen I matrices were similar to tissue matrices and induced morphological changes in 
fibroblasts  (Elsdale  &  Bard,  1972).  Yang  et  al.  (1979,  1980)  also  demonstrated  the 
sustained growth of primary mouse mammary tumour epithelial cells embedded within 
collagen hydrogels. These epithelial cells were shown to form duct-like structures which 141 
 
extended into the matrix (Yang et al., 1979). Although naturally-derived hydrogels have 
many advantages to their use, they are limited to only a partial reconstitution of the ECM.  
5.1.4 Mimicking the fibrillary and viscoelastic nature of the ECM 
The  reconstitution  of  specific  mechanical  properties  of  the  ECM  through  the  use  of 
biosynthetic or synthetic materials in the hope to produce 3D matrices which are more 
representative of the natural  ECM have been well attempted (Hubbell, 2003). Fibrillar 
matrices with fibre diameters in the order of tens of micrometers have been synthesised 
from synthetic polymers, while the process of electrospinning has been used to generate 
fibrillar  matrices  composed  of  even  thinner  fibres  with  diameters  which  are  several 
microns down to 100 nm or less (Sun et al., 2007). This fabrication process involves the 
control of polymer fibre deposition through an electric field, which produces fibres with 
diameters more representative of those in the ECM (Matthews et al., 2002). It is possible to 
fabricate either random or highly complex and ordered 3D matrices. Classic polymers used 
for the synthesis of fibrillar matrices include synthetic aliphatic polyesters and even natural 
materials such as collagen and fibrinogen (Sun et al., 2007; Matthews et al., 2002; Wnek et 
al.,  2003).  Matthews  at  al.  (2002)  showed  that  collagen  matrices  produced  from 
electrospinning promoted cell penetration, integration and growth within the matrix. To 
replicate the viscoelastic nature of the ECM, naturally elastic hydrogels such as alginate 
and the temperature-sensitive synthetic polymers poly(ethylene glycol) and poly(propylene 
glycol) have been extensively investigated (Cellesi et al., 2002). 
5.1.5 Mimicking the molecular recognition properties of the ECM 
In living organisms, there are both bi-directional and dynamic interactions between cells 
and the ECM. Many of these interactions, such as cell adhesion, influence of bound growth 
factors and proteolytic sensitivity, are important for normal cellular development (Alberts 
et al., 2002). In 2D systems these interactions may be considerably reduced, prompting 
research not only into the biomimicry of the ECM structure but also into the challenge of 
replicating the molecular recognition properties (Hubbell, 2003).  
 
      Many groups have tried to replicate the cell adhesion properties of the ECM, which is 
important  for  regulating  a  range  of  physiological  responses  such  as  cell  growth  and 
migration (Cukierman et al., 2002). Schense et al. (2000) used the enzymatic activity of 
Factor XIIIa to covalently incorporate exogenous bioactive peptides (adhesion domains) 
from laminin and N-cadherin into fibrin hydrogels. It was shown that neurite extension in 142 
 
vitro and the regeneration of severed dorsal root axons in animal models was enhanced 
(with a maximal improvement of 75% and 85% respectively) in the presence of these 
peptides (Schense et al., 2000).  
 
      The presentation of growth factors is another key function of the ECM. These bound 
growth factors may partition from the ECM into a soluble phase to regulate an array of 
cellular processes (Alberts et al., 2002). Efforts to reproduce bound growth factors include 
the work by Sakiyama-Elbert and Hubbell (2000), in which a heparin-containing fibrin-
based  cell  ingrowth  matrix  consisting  mainly  of  fibrin,  immobilised  heparin-binding 
peptides,  heparin  and  basic  fibroblast  growth  factor  (b-FGF)  was  investigated.  The 
immobilised heparin-binding peptides contained a factor XIIIa substrate which interacts 
with heparin to immobilise it within the matrix, allowing heparin in turn to interact with b-
FGF. This model system showed a slow, controlled local release of b-FGF by passive 
diffusion  or  enzymatic  factors  (e.g.  heparinase  or  plasmin)  released  from  cells,  which 
enhanced neurite extension from dorsal root ganglia by up to 100% relative to neurite 
extension in fibrin matrices which were not modified. Without this delivery system, neurite 
extension in fibrin matrices was not enhanced by the presence of free b-FGF (Sakiyama-
Elbert & Hubbell, 2000). 
 
      Homeostatic regulation in vivo may also be lost in an in vitro environment. Efforts to 
replace homeostasis include hormone supplements in the culture medium (Yang et al., 
1981).  In  the  context  of  3D  cultures,  studies  on  the  effects  of  hormones  (insulin  and 
cortisol)  and  growth  factors  (epidermal  growth  factor)  on  primary  human  mammary 
epithelial cells in collagen hydrogel culture by Yang et al. (1981) showed that hormone 
and growth factor supplement sustained growth over the first 2 to 3 weeks which lead to a 
10- to 30-fold increase in cell number.  
 
      The  proteolytic  sensitivity  of  the  ECM  is  important  in  permitting  cell  migration. 
Materials  which  are  sensitive  to  proteases  expressed  by  migrating  cells  have  been 
developed, including a synthetic hydrogel system incorporating the ability to present bound 
growth factors, adhesion peptides and show proteolytic sensitivity (Lutolf et al., 2003). In 
this  system  created  by  Lutolf  et  al.  (2003),  multifunctional  poly(ethylene  glycol)  is 
crosslinked  with  a  di-cysteine  peptide  containing  a  proteolytically  sensitive  sequence 
through a Michael-type addition reaction to form a synthetic hydrogel network. Adhesion 143 
 
peptides  and  growth  factors  were  incorporated  through  reaction  via  cysteine  residues 
(adhesion  peptides  and  growth  factors)  or  entrapment  (growth  factors)  and  cells 
incorporated  within  the  synthetic  matrix  were  viable  and  able  to  migrate  three-
dimensionally via proteolytic degradation of the hydrogel (Lutolf et al., 2003).  
 
      These materials demonstrate the remarkable ability by which we can now imitate the 
many properties of the ECM, but by no means are these synthetic imitations complete. 
Through greater understanding of the biology and mechanisms of the ECM and further 
development  of  synthetic  or  biomaterials,  we  will  ultimately  be  able  to  generate  3D 
matrices which replicate more fully the unique ECM.   
5.1.6 The aims of this chapter 
3D cell culture models truly reflective of in vivo environments will be valuable for future 
biomedical research, however, 3D hydrogel cultures are currently dominated by the use of 
only  a  handful  of  hydrogels  (e.g.  collagen),  although  there  are  a  vast  range  of  other 
hydrogels  which  may  provide  far  superior  properties  to  those  at  current.  Laponite,  a 
synthetic silica hydrogel, is an attractive alternative because of its appealing rheological 
properties. Laponite dispersions are thixotropic (Martin, 2002), which means they show 
time-dependent  changes  in  viscosity.  The  rheological  characteristics  and  handling 
properties  of  the  Laponite  hydrogels,  as  well  as  their  potential  for  creating  3D  multi-
layered or multi-sectored matrices, were investigated prior to this chapter and covered in 
detail in Appendix B (pages 199 to 230). Furthermore, in order to optimise the survival of 
hippocampal cultures in Laponite, thixotropic culture medium-based Laponite hydrogels 
were also developed (please refer to Appendix B; pages 199 to 230). The aims of this 
chapter were to determine the viability of hippocampal cells in this novel culture medium-










5.2.1 Methodology and experimental aim  
Laponite RDS (rapid diffusion sol) is one of a variety of Laponite formulations (Rockwood 
additives Ltd.). Thixotropic culture medium-based Laponite RDS hydrogels were the key 
findings of previous investigations (please refer to Appendix B; pages 199 to 230). 16% 
w/v  Laponite  RDS  produced  the  optimal  culture  medium-based  hydrogel,  which  was 
investigated in the present study for its potential as a cell culture matrix for hippocampal 
cells. Laponite XLS, the low heavy metal content variation of RDS, was also explored. A 
range of dyes  and staining techniques  was used to  determine whether  Laponite was  a 
biocompatible hydrogel. A brief description of the fluorescent dyes and abbreviations used 
are listed in Table 5.2.1.  
 
Table 5.2.1 Fluorescent dyes and stains  




















5 μl/ml  Red-fluorescent 
lipophilic 
membrane dye: live 
cell 







nucleic acid stain: 
dead cell 
Sytox green  Life Technologies, 
Paisley, UK 
50-500 nM  Green-fluorescent 










nucleic acid stain: 
live and dead cells 
 
5.2.2 Primary hippocampal neuronal culture generation 
The generation of primary hippocampal monolayer cultures is provided in Chapter 2.  
5.2.2.1 Neurosphere generation 
Neurospheres are free-floating non-adherent spherical aggregates of neural stem cells (Bez 
et al., 2003). 6-well polystyrene multiwell plates were used to cultivate neurospheres. 2 145 
 
ml/well of cell suspension in NBA-A/B27/Glu at a cell density of 100,000 cells/ml were 
transferred into non-surface treated 6-well plates (210 cells/mm
2). The cell suspension was 
supplemented with 1% antibiotic/antimycotic, 20 ng/ml EGF and 20 ng/ml bFGF. Cells 
were incubated under 5% CO2, 95% air (~20% O2), 37°C and 100% humidity conditions.  
 
      After 7-10 d, half of the neurosphere growth media was changed. Neurosphere cultures 
from a 6-well plate (12 ml) were collected into a 15 ml centrifuge tube and centrifuged for 
5 min at 200g at room temperature. After centrifugation, half of the medium was carefully 
aspirated  and  discarded  and  replaced  with  fresh  pre-warmed  NBA-A/B27/Glu  medium 
supplemented with 1% antibiotic/antimycotic, 20 ng/ml EGF and 20 ng/ml bFGF. The 
neurospheres were gently triturated back into suspension and re-plated onto a new plate. 
Thereafter, half of the neurosphere culture medium was changed every 2-3 d.  
5.2.2.2 Passaging neurospheres  
After  14  d  of  culture,  neurospheres  were  passaged  to  expand  cultures.  Neurosphere 
cultures from a 6-well plate (12 ml) were collected into a 15 ml tube and centrifuged for 5 
min  at  200g  at  room  temperature.  After  centrifugation  the  supernatant  was  aspirated, 
leaving only 1 ml of supernatant and the cell pellet. Using a 1 ml pipette, the cell pellet was 
broken up with gentle trituration. Trituration was repeated several times to dissociate the 
neurospheres into single cells until a cloudy suspension was obtained.  
 
      To determine the number of viable cells, 30 µl of cell suspension was mixed with 50 µl 
Trypan blue (Sigma Aldrich, UK), transferred onto a haemocytometer slide and live (dye-
excluding) cells counted. The cells were re-plated at 2 ml/well of cell suspension in NBA-
A/B27/Glu at a cell density of 100,000 cells/ml (210 cells/mm
2). supplemented with 1% 
antibiotic/antimycotic, 20 ng/ml EGF and 20 ng/ml bFGF. 
5.2.2.3 Cryopreservation of neurospheres 
Neurosphere cultures from a 6-well plate (12 ml) were collected into a 15 ml centrifuge 
tube and centrifuged for 5 min at 200g at room temperature. The supernatant was removed 
and discarded and the cell pellet gently re-suspended in 10 ml NBA-A/B27/Glu serum-free 
medium containing 15 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) 
buffer (Sigma Aldrich, UK) and 15% dimethyl sulfoxide (DMSO) (Sigma Aldrich, UK). 
The  neurosphere  suspension  was  aliquoted  into  1.5  ml  aliquots  per  2  ml  capacity 
polypropylene cryovials and transferred to a -80°C freezer.  146 
 
5.2.2.4 Monolayer dissociation from multiwell plates using Trypsin-EDTA 
The culture medium was carefully aspirated off the plates before addition of 500 μl (24-
well plate) or 1 ml (6-well plate) Trypsin-EDTA (ethylenediaminetetraacetic acid) (Sigma 
Aldrich, UK) to each well. After 5 min, the Trypsin-EDTA was stopped with the addition 
of 10% FBS (50 μl in a 24 well plate or 100 μl in a 6-well plate) (Sigma Aldrich, UK). The 
cells were gently rinsed off the plate (3/4 times per well) before transfer to a 15 ml tube. 
The cell suspension was centrifuged at 1100 rpm for 5 min followed by removal of the 
supernatant  and  Trypsin-EDTA.  Fresh  medium  (about  2  ml)  was  added  and  the  cells 
released from the pellet by gentle trituration. The cellular density was determined by using 
a haemocytometer and Trypan blue, diluted as required and used immediately.   
5.2.3 Laponite RDS and Laponite XLS hydrogel formation - Sterile conditions 
Laponite  RDS  and  Laponite  XLS  (low  heavy  metal  content  version  of  RDS)  powder 
(courtesy of Mr Patrick Jenness, Rockwood Additives Ltd.) was autoclaved before use 
(autoclaving does not affect hydrogel formation). The balance was wiped down with 70% 
ethanol,  glass  weighing  boats  and  spatulas  used  for  measuring  out  the  powder  were 
autoclaved, and all procedures carried out in sterile hoods. All equipment brought into the 
sterile hoods was disinfected using 70% ethanol spray. To keep the measured Laponite 
powder sterile during transitions between hoods, measured powder was transferred into 
sterile 15 ml centrifuge tubes. After the addition of Laponite powder to culture medium 
(NBA-A/B27/Glu medium supplemented with 1% antibiotic/antimycotic), the sample was 
quickly vortexed for at least 10 s outside the hood. To ensure sterility during this process, 
the  sample  was  made  up  in  15  ml  or  50  ml  (depending  on  the  amount  of  hydrogel) 
centrifuge tubes and the lid tightly screwed onto the top of the tube before transferring the 
tube out of the sterile hood for vortexing. After vortex, the tube was disinfected with 70% 
ethanol  before  transfer  back  into  the  sterile  hood.  The  hydrogel  setting  times  differed 
depending on the concentration (% w/v) and type of Laponite (RDS or XLS).  
 
Different thicknesses of gel could be achieved by using the formula:  
π x radius
2 (mm) x height (mm) = volume required (μl), with details of the well diameter or 
radius. For example, to create a 2 mm thick hydrogel layer in a 6-well plate which has a 
diameter of 34.8 mm (17.4 mm radius) the volume required is 3.14 x 17.4
2 x 2 mm = 
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5.2.4 pH of Laponite RDS culture medium hydrogels 
The  pH  of  Laponite  hydrogels  was  measured  using  a  pH  meter  (pH  210  advanced 
microprocessor based bench pH meter, Hanna Instruments, Norway). HEPES buffer (pKa 
= 7.55) (Sigma Aldrich, UK), an organic zwitterionic buffer (pH range 7-8) widely used in 
cell culture, was chosen as the buffering agent for 16% Laponite RDS culture medium 
hydrogels.  To  find  the  optimum  concentration  of  HEPES  for  buffering,  a  range  of 
concentrations of HEPES (0, 10, 15, 20, 25, 30, 35, 40, 45 mM final concentration in 
hydrogel) was prepared. The pH of the culture medium was measured before and after the 
addition of 16% Laponite RDS at room temperature. The pH probe was calibrated and 
rinsed carefully between each use and each measurement was repeated 5 times. 
5.2.5 Laponite RDS culture medium hydrogels 
Laponite RDS/XLS culture medium hydrogels were prepared by adding 12-16% Laponite 
RDS/XLS powder (w/v) to neat culture medium (NBA/B27/Glu) supplemented with 35 
mM  HEPES,  1%  antibiotic/antimycotic  and/or  growth  factors/serum  (EGF/FGF/FBS). 
Although Laponite RDS/XLS preparations below 15% did not form full hydrogels, a range 
of  Laponite  RDS/XLS  concentrations  were  investigated  to  test  the  biocompatibility  of 
Laponite.  The  preparations  were  vortexed  to  ensure  thorough  dispersion  of  Laponite 
powder before use and transferred via pipettes with cut pipette tips to overcome blockage. 
5.2.6 Seeding and embedding cells on and in Laponite RDS hydrogels 
Cells  were  seeded  onto  and  embedded  within  Laponite  RDS  hydrogels  to  assess  the 
potential for Laponite as a cell culture material. For cell seeding, 1 to 2 mm thick 16% 
Laponite RDS culture medium hydrogels were layered in 6- or 24-well multiwell plates 
and  allowed  to  set.  Hippocampal  cells  obtained  through  either  primary  hippocampal 
culture generation or Trypsin dissociation of existing monolayer cultures were seeded onto 
the top of Laponite RDS hydrogels at different cell densities (ranging from 100,000 to 
300,000 cells/ml) and followed over time.  
 
      For cell embedding, 16% Laponite RDS powder (w/v) was added to culture medium 
containing  hippocampal  cells  (100,000  cells/ml)  obtained  through  either  primary 
hippocampal culture  generation or Trypsin  dissociation  of existing monolayer cultures. 
The preparation was vortexed for about 5 s to ensure thorough dispersion of Laponite 
powder before the  hydrogel/cells  were transferred to  6- or 24-well multiwell plates  to 148 
 
create  gels  of  about  1-2  mm  thickness.  500  μl  of  growth  media  (NBA/B27/Glu)  was 
transferred on top of the gels to minimise gel desiccation.  
 
      All seeded and embedded cultures were maintained at 37ºC, 100% humidity, 5% CO2 
and  95%  air  (~20%  O2).  A  variety  of  fluorescent  dyes  were  used  to  help  with  cell 
visualisation (Table 3.2.1). Fluorescence cell visualisation was performed on an inverted 
DM IRB microscope (Leica Microsystems UK Ltd, Milton Keynes, UK) and analysed 
using Volocity imaging software 4.2.0 (Improvision, Lexington, MA, USA). 
5.2.7 Laponite hydrogel autofluorescence 
Laponite hydrogels were tested for autofluorescence. 5% Laponite RD (rapid diffusion) 
water-based  hydrogels,  16%  Laponite RDS  Neurobasal  A medium  hydrogels  and 16% 
Laponite RDS culture medium (NBA/B27/Glu) hydrogels were prepared and layered in a 
24-well plate at thicknesses of 1-2 mm. The hydrogels were then exposed to a range of 
fluorescent excitation wavelengths (456 nm, 520 nm and 640 nm) at different intensities 
(50 msec to 1 sec exposure) to test for autofluorescence. 
5.2.8 Staining and embedding neurospheres in hydrogels 
Neurosphere cultures were stained with one of two fluorescent dyes, DAPI or CM-DiI. 
After 40 min incubation time, the neurospheres were transferred to individual 15 ml tubes 
and allowed to settle. The liquid medium above the settled neurospheres was  carefully 
aspirated  and  replaced  with  pre-warmed  culture  medium  (NBA/B27/Glu).  After  gentle 
inversion of the tubes to mix the neurospheres, they were allowed to settle before the liquid 
medium was removed and replaced with fresh media. This rinsing process was repeated 3 
times to remove excess dye.  
 
      Subsequently, 1% antibiotic/antimycotic and 35 mM HEPES buffer was added to the 
neurosphere suspension before the addition of 16% Laponite RDS powder (w/v) followed 
by vortexing for 10 s. The preparation was quickly plated at 1 mm hydrogel thickness in 6-
well (1000 μl) and 24-well (200 μl) multiwell plates and covered with 1000 μl or 500 μl 
culture medium respectively to avoid gel desiccation. Neurosphere in hydrogel cultures 
were maintained at 37ºC, 100% humidity, 5% CO2 and 95% air (~20% O2). Fluorescence 
cell visualisation was performed on an inverted Leica DM IRB microscope and analysed 
using Volocity imaging software. 
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 5.2.9 Seeding neurospheres onto semi-set Laponite hydrogels  
Neurospheres  were  stained  with  DAPI  or  CM-DiI  following  the  protocol  described  in 
section  5.2.8.  Laponite  RDS  culture  medium  hydrogels  with  1%  antibiotic/antimycotic 
were prepared at the concentration and vortex times shown in table 5.2.2. Similarly, a 
range of Laponite RDS concentrations were used to investigate Laponite biocompatibility 
regardless of hydrogel formation.  
 
Table 5.2.2 Laponite RDS concentration and vortex times for neurosphere seeding 
Laponite RDS concentration (w/v)  Vortex times 
-  10% RDS 
 
-  12% RDS 
 
-  14% RDS 
 
-  16% RDS 
-  30 s 
-  2 min 
-  30 s 
-  2 min 
-  30 s 
-  2 min 
-  30 s 
-  2 min 
 
      The prepared hydrogels were plated in 24-well multiwell plates at 200 μl per well (1 
mm hydrogel thickness) and, before the hydrogels were set, 100 μl of stained neurospheres 
were transferred on top. Culture medium with no cells/neurospheres was transferred onto 
the top of control cultures. All seeded neurosphere cultures were maintained at 37ºC, 100% 
humidity, 5% CO2 and 95% air (~20% O2). PI and MTG staining was used to investigate 
cell death and survival. Fluorescence cell visualisation was performed on an inverted Leica 
DM IRB microscope and analysed using Volocity imaging software. 
5.2.10 Layering Laponite hydrogels over hippocampal monolayers 
Hippocampal monolayer cultures were pre-stained with CM-DiI or MTG. After 40 min 
incubation, monolayers were rinsed 3 times with fresh medium before all the medium was 
carefully aspirated and a 1 mm layer of Laponite hydrogel (with 1% antibiotic/antimycotic) 
transferred over the top.  The  hydrogel  was  allowed to  set  before culture medium  was 
transferred over the top of the hydrogels to prevent gel desiccation. The medium in control 
cultures were changed with fresh medium but had no hydrogel transferred over the top. A 





1.  16% Laponite RDS or XLS culture medium hydrogels 
2.  Buffered (35 mM HEPES) and non-buffered hydrogels 
3.  Varying Laponite concentration (2-16% w/v) to investigate biocompatibility. 
4.  Cultures of different age (1 d to 7 d plus) 
5.  Incorporation of growth factors (EGF/FGF) 
6.  Staining cultures before or after hydrogel application or after a period of time (h to 
d). 
 
      All monolayer cultures were maintained at 37ºC, 100% humidity, 5% CO2 and 95% air 
(~20% O2). Accounting for the hydrogel volume, MTG, Sytox green and PI were used to 
investigate cell viability and cell death, respectively. Fluorescence cell visualisation was 
performed on an inverted Leica DM IRB microscope and analysed using Volocity imaging 
software. 
5.2.11 PI incorporation into hydrogels to assess cell death in hydrogel-covered 
monolayers 
PI (5 μl/ml) was incorporated into 16% Laponite hydrogels by prior addition to culture 
medium (NBA/B27/Glu) supplemented with 1% antibiotic/antimycotic, EGF/FGF and 35 
mM HEPES buffer before the addition of Laponite powder. The PI containing hydrogels 
were  transferred  onto  hippocampal  monolayer  cultures  at  1  mm  thickness  in  24-well 
multiwell plates. The parameters were as follows: 
 
1.  PI incorporated into hydrogel transferred over hippocampal monolayers 
2.  Control: hydrogel with no PI transferred over hippocampal monolayers 
3.  Control: PI in culture medium over hippocampal monolayers 
4.  Control: hippocampal monolayers in culture medium with no hydrogel or PI addition 
5.  Control: PI incorporated into hydrogel – no cells 
6.  Control: hydrogel with no PI – no cells 
 
      Culture  medium  (500  μl/well)  was  transferred  over  hydrogels  after  setting  and  the 
cultures  followed  over  time.  Fluorescence  visualisation  was  performed  on  an  inverted 
Leica DM IRB microscope and analysed using Volocity imaging software. Plates were 
imaged:  immediately  after,  1  h  after  and  every  2  h/d  afterwards,  as  necessary.  All 151 
 
monolayer cultures were maintained at 37ºC, 100% humidity, 5% CO2 and 95% air (~20% 
O2). 
5.2.12 Pre-staining monolayers with PI and Sytox green to assess cell death 
Hippocampal monolayer cultures were stained with PI (5 μl/ml) and Sytox green (0.01 
μl/ml) for 40 min before rinsing 3 times with fresh culture medium. After staining, culture 
medium was aspirated (400 μl) from each well leaving 100 μl of dye containing medium. 
16% Laponite RDS culture medium hydrogels or culture medium were transferred over 
wells and the cultures maintained at 37ºC, 100% humidity, 5% CO2 and 95% air (~20% 
O2). The parameters were as follows: 
 
1.  PI  or  Sytox  stained  monolayers  covered  with  1  mm  16%  RDS  culture  medium 
hydrogel 
2.  Negative control: PI or Sytox stained monolayers with culture medium (no hydrogel)  
3.  Positive control: PI or Sytox stained monolayer cells killed with 4% PFA (15 min 
treatment) covered with 1 mm 16% RDS culture medium gel 
4.  Control:  unstained  monolayers  covered  with  1  mm  16%  RDS  culture  medium 
hydrogel  
 
      Cultures were imaged directly after the addition of hydrogel and followed over time. 
Fluorescence visualisation was performed on an inverted Leica DM IRB microscope and 
analysed using Volocity imaging software.  
5.2.13 Insert cultures 
Hippocampal monolayers grown on culture inserts allow an alternative access route (from 
underneath  the  insert),  potentially  useful  in  determining  cell  viability  and  hydrogel 
biocompatibility under gel cover. A range of culture inserts were investigated for optimal 
cell growth.  
 
1.  Millipore  polytetrafluoroethene  (PTFE)  6-Well  Millicell  Inserts  (0.4  µm  pore)  – 
(Millipore, UK)  
2.  Millipore polyethylene terephthalate (PET) 6-Well Millicell Hanging Inserts  (0.4 µm 
pore) – (Millipore, UK)   
3.  Greiner Lumox PetriPERM 35 hydrophilic culture dishes (adherent surface) – (Sigma 
Aldrich, UK)  152 
 
5.2.14 Optimising hippocampal monolayers on inserts 
Millipore  PTFE  well  inserts  require  coating  for  adherence  of  hippocampal  monolayer 
cultures. A variety of coating techniques were investigated to find one which produced 
optimal cell growth. The parameters were as follows:  
 
1.  Non-treated Millipore PTFE inserts 
2.  Millipore PTFE inserts coated with poly-L-lysine for 1 h (500 μl/well)  
3.  Millipore inserts technical note protocol (see Appendix C, page 233). 
4.  Sigma laminin technical note protocol (Sigma Aldrich, UK) (see Appendix C, page 
233).  
 
      Primary  hippocampal  cell  suspensions  of  100,000  cells/ml  were  transferred  over 
coating-treated  inserts  and  maintained  in  basic  growth  media  (NBA/B27/Glu/1% 
antibiotic/antimycotic) at 37ºC, 100% humidity, 5% CO2 and 95% air (~20% O2). The 
confluence of cultures achieved by the different coatings were compared. 
5.2.15 Layering hydrogels over culture insert hippocampal monolayers 
Similar to  section 5.2.10,  Laponite RDS/XLS culture medium  hydrogels  supplemented 
with  1%  antibiotic/antimycotic  and/or  buffer  (35  mM  HEPES)  and  growth  factors  (20 
ng/ml EGF/FGF) were transferred over insert monolayer cultures at gel thicknesses of ~1 
mm.  A  variety  of  fluorescent  dyes/stains  were  used  to  assess  cell  viability  and  death, 
including  MTG,  MTO,  CM-DiI,  PI  and  Sytox  green,  by  staining  the  hydrogel  from 
underneath. A range of dye combinations were explored:  
 
1.  Hippocampal monolayers were pre-stained with CM-DiI (5 μl/ml) before covered with 
hydrogel and stained from underneath with Sytox green (0.01 μl/ml). 
2.  Hippocampal monolayers were covered with hydrogel and stained from underneath 
with a mixture of MTG (1 μl/ml) and PI (5 μl/ml). 
3.  Hippocampal monolayers were covered with hydrogel and stained from underneath 
with a mixture of MTO (200 nM) and Sytox green (0.01-0.1 μl/ml).   
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Fluorescent  dyes  were  applied  at  different  time  points  i.e.  after  different  lengths  of 
hydrogel exposure, and cultures were also imaged at different times i.e. immediately or a 
few h/d after gel cover. Insert controls included hippocampal monolayers with no hydrogel 
over the top, inserts with no cells with hydrogel over the top, and inserts with no cells or 
hydrogel. All insert cultures were maintained at 37ºC, 100% humidity, 5% CO2 and 95% 
air (~20% O2). 
5.2.16 CM-DiI stained cell seeding and embedding  
Hippocampal  monolayer  cultures  were  pre-stained  with  CM-DiI  (5  μl/ml)  for  40  min, 
washed well in culture medium and dissociated from plates using Trypsin-EDTA (section 
5.2.2.4). Dissociated cells were seeded at 500 μl/well over 1 mm thick Laponite hydrogels 
plated in 24-well multiwell plates. Parameters investigated included: 
 
1.  12% or 16% Laponite RDS/XLS culture medium hydrogels supplemented with 1% 
antibiotic/antimycotic, growth factors (EGF/FGF) and/or buffer (35 mM HEPES).  
2.  12% or 16% Laponite RDS/XLS culture medium hydrogels supplemented with 1% 
antibiotic/antimycotic,  growth  factors  (EGF/FGF),  and  laminin  (5  μl/ml)  (Sigma 
Aldrich, UK) and/or buffer (35 mM HEPES). 
 
      Cell embedding was also attempted using CM-DiI pre-stained dissociated hippocampal 
cells. For a gentler incorporation of cells into the Laponite hydrogel, Laponite powder was 
first made up in half the culture media of the final desired volume, which was subsequently 
gently mixed using a pipette with the other half of the culture medium containing CM-DiI 
stained cells. For example, for a 10 ml final volume of 16% Laponite hydrogel, 16% w/v 
of  Laponite  powder  was  added  to  5  ml  of  culture  media  and  thoroughly  vortexed  to 
disperse  the  powder  evenly.  This  gel  was  then  mixed  with  5  ml  of  culture  medium 
containing cells to give a final 10 ml of 16% Laponite hydrogel containing cells. 
 
      Culture  medium  (500  μl/well)  containing  no  cells  was  transferred  over  control 
hydrogel. Cultures were imaged immediately after cell seeding or embedding and followed 
over time. All seeded or embedded cultures were maintained at 37ºC, 100% humidity, 5% 
CO2 and 95% air (~20% O2). Fluorescent cell visualisation was performed on an inverted 
Leica DM IRB microscope and analysed using Volocity imaging software.  
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5.2.17 Osmolarity of Laponite hydrogels 
The osmolarity of Laponite RDS culture medium hydrogels (Table 5.2.3) was measured 
using an osmometer (Advanced Micro Osmometer Model 3300). 
 
Table 5.2.3 Variations of Laponite RDS culture medium hydrogels tested. 
Non-buffered Laponite RDS culture 
medium hydrogels 
Buffered Laponite RDS culture 
medium hydrogels (35 mM HEPES) 
-  10% Laponite RDS 
-  12% Laponite RDS 
-  14% Laponite RDS 
-  16% Laponite RDS 
-  18% Laponite RDS 
-  20% Laponite RDS 
-  10% Laponite RDS 
-  12% Laponite RDS 
-  14% Laponite RDS 
-  16% Laponite RDS 
-  18% Laponite RDS 
-  20% Laponite RDS 
 
The osmolarity of plain  culture medium  and of the  hydrogels  were measured at  room 






















5.3.1 Seeded or embedded hippocampal cells are difficult to visualise without pre-
staining 
Hippocampal neuronal cells were seeded onto or embedded within 16% Laponite RDS 
culture  medium  hydrogels.  Determination  of  cell  viability  via  visualisation  under  an 
inverted  light  transmission  microscope  (Leica  DM  IRB)  proved  inconclusive  due  to 
difficulties in cell identification. As can be observed in control Laponite hydrogels (with 
no cell seeding or embedding), the hydrogel itself was inhomogeneous and contained many 
natural structures which were quite cell-like in appearance (Fig. 5.3.1). This presented a 
diverse background which made cellular identification complicated in  both  seeded and 



















Figure  5.3.1  Seeded  hippocampal  cells  were  difficult  to  visualise  without  pre-staining.  16% 
Laponite RDS culture medium hydrogels under light transmission with (A) no hippocampal cells 
seeded on top (control) and (B) with hippocampal cells in culture medium seeded on top. The 





      Viability indicators such as DAPI, MTG, PI and Sytox green were added to aid with 
cell visualisation. Unfortunately, fluorescent dye addition resulted in dye-gel binding and 










Figure 5.3.2 Laponite RDS culture medium hydrogels under fluorescence microscopy with (A) PI 
staining and (B) Sytox green staining, which bound and produced high background fluorescence. 
Scale bar, 50 μm.  
5.3.2 Laponite hydrogels are not autofluorescent 
Autofluorescence is a type of endogenous self-induced fluorescence that has no association 
with the fluorophore of interest. To rule out the possibility of autofluorescence as a cause 
of the high background fluorescence observed on fluorescent dye addition, a variety of 
Laponite  hydrogels  (5%  Laponite  RD  water-based,  16%  Laponite  RDS  Neurobasal  A 
medium and 16% Laponite RDS culture medium hydrogels) were exposed to a range of 
fluorescent excitation wavelengths at different intensities. All types of Laponite hydrogel 
showed zero/minimal autofluorescence at excitation intensities/exposure typically used for 
fluorescence dye visualisation (100-500 ms) or higher exposures (500 ms to 1 s) (Fig. 
5.3.3). This suggested that the high background fluorescence, as observed in Fig. 5.3.2, 
























Figure 5.3.3 Laponite RDS culture medium hydrogels under fluorescence microscopy were not 
autofluorescent. Excitation wavelengths are (A) 456 nm, (B) 520 nm and (C) 640 nm respectively. 
No significant fluorescent emission was observed in response to excitation. Scale bar, 50 μm. 
5.3.3 The high pH of Laponite RDS culture medium hydrogels can be corrected 
through the use of HEPES buffer 
The pH indicator phenol red is routinely added to basal growth media as a basic means of 
monitoring media pH. Phenol red shows a colour variation from yellow to red/pink which 
corresponds to a gradual increase in pH. 16% Laponite RDS culture medium hydrogels are 
pink, which indicates a pH above 8. Measurement with a pH meter confirmed the pH of 
16% Laponite RDS culture medium hydrogels as pH 8.6, whilst the pH of culture medium 
(NBA-A/B27/Glu) without Laponite was pH 7.2. As the normal physiological pH range for 
hippocampal cell viability is around pH 7.2-7.6, the Laponite hydrogels were too alkali. 
HEPES buffer was chosen to reduce and control the pH of Laponite hydrogels. The buffer 
was first tested for any effects on Laponite hydrogel formation. The addition of 10 to 45 
mM HEPES to 16% Laponite culture medium hydrogels did not affect gel formation and 
all set within 10 min at room temperature.  
 
      An increase in HEPES concentration resulted in a decrease in the pH of 16% Laponite 
RDS culture medium hydrogels (Fig. 5.3.4). On addition of 25 mM HEPES, the pH of the 
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hydrogels  were  reduced  to  pH  8.0,  a  pH  decrease  of  7%  compared  to  non-buffered 
controls.  However,  the  trend  for  decreasing  pH  with  increasing  HEPES  concentration 
levels off after 30 mM HEPES, where the percentage pH reduction becomes less marked 
with increasing HEPES. A 35 mM concentration of HEPES was chosen for buffering 16% 
Laponite culture medium hydrogels as higher concentrations had no more effect on pH 
reduction. This concentration reduced the pH of the 16% Laponite RDS culture medium 
hydrogels by 9.3% to pH 7.8.  
 
 
Figure 5.3.4 Effect of HEPES buffer concentration on culture medium pH before and after the 
addition of 16% Laponite RDS. An increase in HEPES concentration correlates with a decrease in 
culture  medium  (green  line)  and  hydrogel  (red  line)  pH.  The  effect  of  increasing  HEPES 











5.3.4 Neurospheres can be pre-stained and seeded over or embedded within Laponite 
hydrogels 
To  overcome  the  problem  of  high  background  fluorescence  caused  by  dye  binding  to 
Laponite hydrogel, cells were pre-stained before incorporation. The comparatively large 
size  (100  µm  plus)  of  neurospheres  ensured  easy  cell  visualisation  and  identification. 
Neurospheres pre-stained with DAPI or CM-DiI were embedded within Laponite RDS 









Figure  5.3.5  Laponite  hydrogel  embedded  DAPI  pre-stained  neurosphere  under  (A)  light 
transmission  and  (B)  fluorescence  microscopy.  It  would  have  been  difficult  to  identify  the 
neurosphere if it had not been pre-stained with DAPI. Scale bar, 100 μm. 
 
      Neurospheres  were  also  seeded  over  varying  concentrations  of  Laponite  culture 
medium hydrogel to determine whether hydrogel concentration or vortex time affected 
neurosphere  incorporation  (Table  5.2.2).  Seeded  neurospheres  remained  adhered  to  the 
surface of all Laponite hydrogels, irrespective of gel concentration or vortex time, and did 
not show any visible integration or movement in the hydrogel over time (Fig. 5.3.6A,B). 
The fluorescent  dyes  PI and MTG were used to assess neurosphere survival  by direct 
application  and,  as  expected,  bound  to  the  hydrogel  and  caused  high  background 

























Figure  5.3.6  CM-DiI-stained  neurosphere  seeded  over  10%  Laponite  RDS  culture  medium 
hydrogel after (A) 10 d and (B) 2 wk in culture, under fluorescence microscopy. (B) Direct addition 
of MTG stain to assess cell survival.  There was high background fluorescence due to dye-gel 
binding and no convincing MTG staining was achieved. Scale bar, 100 μm.  
 
      In  both  embedded  and  seeded  neurosphere  cultures,  neurospheres  were  dispersed 
throughout the Laponite hydrogels or spread across the surface at different gel depths, 
which proved difficult for following neurospheres over time. It was also hard to follow the 
response i.e. the movement or cell death of individual cells when focusing on these large 
cell aggregates. Other methods may prove far more appropriate for investigating cell viability.  
5.3.5 Hippocampal monolayers can be followed over time under Laponite hydrogels 
Given the success of pre-staining neurospheres before hydrogel exposure, a similar method 
was  applied  to  dissociated  cells  in  monolayer  culture.  Hippocampal  monolayers  pre-
stained with CM-DiI or MTG were covered by a 1 mm layer of Laponite culture medium 
hydrogel  and  followed  over time to  assess  the biocompatibility of the gel.  Pre-stained 
monolayers and individual cells could be observed easily under the hydrogel (Fig. 5.3.7) 
and a range of influencing factors were investigated (section 5.2.10).  





      Initial observations of Laponite gel covered CM-DiI-stained hippocampal monolayers 
showed no particular differences in appearance to control, however, on careful analysis and 
comparison of monolayers over time, a disparity was observed. Hippocampal monolayers 
are dynamic organisations showing continuous  spatial and morphological changes over 
time, such as the migration of cells and extension of neural processes. On close observation 
of the hydrogel  covered cultures, however, the hippocampal monolayers were static in 
appearance  and  showed  no  spatial  or  morphological  changes  over  the  time  periods 
investigated.  As  well  as  whole  cell  structures,  even  small  neural  processes  remained 
unchanged over time (Fig. 5.3.8).   
 
 
Figure 5.3.8 CM-DiI-stained 7 day old hippocampal monolayers covered with 16% Laponite RDS 
culture medium hydrogel visualised under fluorescence microscopy on (A) day 1, (B) day 2 and 
(C) day 3 since hydrogel cover. Hippocampal monolayers, and even the small processes, remained 
unchanged over time period (arrows). Scale bar, 50 μm. 
Figure  5.3.7  CM-DiI-stained  7  day  old 
hippocampal  monolayer  culture  covered  with 
16% Laponite RDS culture medium hydrogel 
visualised  under  fluorescence  microscopy. 
Individual  cells  and  small  processes  could  be 
easily observed. Scale bar, 100 μm. 
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      MTG-stained  hippocampal  monolayers  covered  with  16%  Laponite  RDS  culture 
medium hydrogels also showed similar results. In comparison to CM-DiI-stained cultures, 
however, MTG proved toxic to control cultures with no hydrogel. Over an investigation 
period of one week, the majority of MTG-stained (on day 0) control monolayers were dead 





      In direct contrast to these results, MTG-stained hippocampal monolayers covered by 
16% Laponite RDS culture medium hydrogels showed no cell death as a result of MTG 
staining.  Similar  to  the  results  observed  with  the  hydrogel  covered  CM-DiI-stained 
monolayers, MTG-stained monolayers showed no spatial or morphological changes over 





Figure 5.3.9 MTG-stained uncovered 6 day old 
hippocampal  monolayers  in  culture  medium 
(NBA-A/B27/Glu)  visualised  under 
fluorescence  microscopy.  On  day  0,  the 
hippocampal  monolayers  were  stained  with 
MTG, but by day 3, the majority of cells were 
dead. At 7 days after MTG application all cells 












Figure 5.3.10 MTG-stained 6 day old hippocampal monolayer covered by 16% Laponite RDS 
culture medium hydrogel visualised over a period of 7 days under fluorescence microscopy. Even 
though  MTG  showed  toxicity  in  control  cultures  with  no  hydrogel  cover,  hydrogel  covered 
monolayers showed no spatial or morphological changes over time and no cell death (arrows). 
Scale bar, 50 μm. 
 
      Many  factors  could  have  contributed  to  the  observations  noted  above,  such  as  the 
culture age, pH or Laponite concentration, so with that taken into account, a range of 
conditions were investigated (section 5.2.10). The same preservation effect, however, was 
observed under all conditions investigated. The incorporation of growth factors or buffer, 
variation  of  Laponite  concentration  (2-16%)  and  type  (RDS  or  XLS)  or  cultures  of  a 
different age, all showed the same static appearance, regardless of fluorescent stain used.  
 
      Both MTG and CM-DiI are live cell stains. Although the majority of cells were live 
before  hydrogel  cover,  it  was  unknown  whether  the  Laponite  covered  hippocampal 
monolayers were alive or dead. Even though the initial fluorescent stain (MTG or CM-DiI) 
remains intact, it is no longer a reliable indicator of cell viability. Attempts at staining 
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hydrogel covered hippocampal monolayers with MTG, Sytox green or PI to assess cell 
viability proved futile due to dye absorption and binding to the hydrogel, leading to high 
background fluorescence and lack of stain diffusion to the monolayers underneath. 
5.3.6 Assessing cell viability using PI and Sytox green 
The  cell  death  markers  PI  and  Sytox  green  were  used  to  assess  the  viability  of  cells 
underneath Laponite hydrogel. The incorporation of PI into Laponite hydrogels or pre-
staining monolayers with PI before gel cover was investigated to determine whether cell 
death  occurred  in  response  to  hydrogel  exposure.  When  PI  was  incorporated  into 
hydrogels, there was a lack of PI staining and no indication of cell death in the underlying 
monolayer. Instead of staining dead or dying cells, it was likely that PI remained tightly 

























Figure 5.3.11 PI was incorporated into Laponite 
gels  to  assess  monolayer  cell  death,  visualised 
one  day  after  hydrogel  application.  (A)  PI 
staining could be observed in control monolayers 
with  no  hydrogel  cover.  (B)  Control  with  PI 
incorporated into hydrogel with no cells. (C) PI 
incorporated  into  hydrogel  over  hippocampal 
monolayer. There was high background staining 
and no convincing PI staining could be observed. 




      In a different approach, hippocampal monolayers were pre-stained with PI or Sytox 
green before gel cover. Although stained monolayers could be visualised under hydrogel, 
there were no changes in cell death staining over time. Control cultures with no gel cover 
showed increased PI staining over time, as expected as a result of cell death, but hydrogel-
covered monolayers instead showed a static response (Fig. 5.3.12), similar to the hydrogel-

























Figure  5.3.12  PI  pre-stained  hippocampal  monolayers.  Monolayers  with  no  hydrogel  cover 
(Control) and monolayers covered in 16% Laponite RDS hydrogel (Gel) at time 0 hours (before gel 
addition), 4 hours (after gel addition), and 1 day (after gel addition). The number of PI stained cells 
(Control 0 hours)  (Gel 0 hours) 
(Control 4 hours) 
(Control 1 day) 
Gel 4 hours 
Gel 1 day 166 
 
(cell  death)  increased  under  control  conditions  but  showed  no  change  under  hydrogel  cover 
(arrows). Scale bar, 100 μm.    
5.3.7 Hippocampal monolayers grown on inserts could be stained from underneath 
Determining the viability of hippocampal monolayers under hydrogel cover was difficult 
because  fluorescents  stains  could  not  reach  the  monolayer  due  to  absorption  by  the 
Laponite hydrogel. To overcome this problem hippocampal monolayers were grown on 
culture inserts with porous membranes, which allowed fluorescent stains to be introduced 
to hydrogel-covered monolayers from underneath.  
5.3.7.1 Optimising hippocampal monolayers on PTFE culture inserts 
Confluent  hippocampal  monolayers  were  achieved  in  one  week  using  both  the  Sigma 
Aldrich laminin technical note protocol or by pre-coating inserts with a mixture of laminin 
and poly-L-lysine. Both treatments were applied at least 24 h before and rinsed before cell 
addition. Insert cultures were supplemented with EGF/FGF/FBS to support cell growth.    
5.3.7.2 Staining hydrogel-covered hippocampal insert cultures 
A variety of fluorescent dyes (MTG, MTO, CM-DiI, PI and Sytox green) were used to 
determine  the  viability  of  Laponite  culture  medium  hydrogel-covered  hippocampal 
monolayers grown on culture inserts. All dyes except MTG (Fig. 5.3.13) were able to stain 
uncovered hippocampal monolayers from  underneath  the inserts,  however, none of the 
hydrogel-covered monolayers were convincingly stained with any fluorescent dye or dye 
combination  (Fig.  5.3.14).  Even  though  the  dyes  could  reach  the  monolayer  from 
underneath, they still bound to the gel to produce high background fluorescence, which 
obscured further analysis. Furthermore, it was difficult to obtain MTG staining in both 
control  insert  cultures  with  no  gel  cover  and  gel-covered  cultures.  Unfortunately,  the 









































Figure 5.3.14 MTO (red) and Sytox green (green)-stained culture insert hippocampal monolayers 
visualised  under  fluorescence  microscopy.  (A  and  B),  Control  (no  hydrogel)  hippocampal 
monolayer stained with (A) MTO and (B) Sytox green. (C and D), (C) MTO- and (D) Sytox green-
stained cultures covered with 12% Laponite RDS culture medium hydrogel. Under gel cover (C 
Figure  5.3.13  Culture  insert 
hippocampal monolayer under light 
transmission  microscopy  with 
combined  MTG/PI  staining.  PI 
(red)  stained  the  dead/dying  cells 
through the porous insert membrane 
when  introduced  from  underneath 
the  insert,  while  MTG  could  not. 
The  respective  image  of  MTG 
(green)  shows  no  staining, 
irrespective  of  insert  type.  Scale 
bar, 100 μm.  
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and D), there was a lack of convincing staining and a lot of unspecific MTO and Sytox binding to 
the gel which produced high background fluorescence. Scale bar, 100 μm.  
5.3.8 Seeded hippocampal cells adhere to Laponite XLS culture medium hydrogels 
In addition to hydrogel cover, cells were also seeded onto Laponite hydrogels to assess gel 
biocompatibility.  Dissociated  CM-DiI  pre-stained  hippocampal  cells  were  seeded  over 
Laponite RDS and XLS hydrogels. Initial observations showed cells floating freely above 
the  gel,  but  with  time,  some  cells  adhered  and  possibly  integrated  into  Laponite  XLS 
culture medium hydrogels. A defined adherence pattern was observed on XLS hydrogels 
and cells remained attached through periods of culture medium change and rinsing (Fig. 
5.3.15B,D). This cell behaviour was not observed on Laponite RDS hydrogels, although a 


















Figure 5.3.15 CM-DiI (red) pre-stained dissociated hippocampal neuronal cells seeded over (A and 
C)  16%  Laponite  RDS  culture  medium  hydrogels  and  (B  and  D)  16%  Laponite  XLS  culture 
medium hydrogels, visualised under fluorescence microscopy. (A and B) show the cultures 17 days 
after seeding, while (C and D) show the Laponite hydrogels after being rinsed with culture medium 
to remove free-floating cells. The dissociated cells adhered randomly to Laponite RDS hydrogels 
but were observed to form a distinct adherence pattern over Laponite XLS hydrogels. Scale bar, 50 
μm. 
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      Although there was a distinct difference in the cell adherence pattern between RDS and 
XLS hydrogels, the concentration of Laponite hydrogel (12% or 16%) and addition of 
laminin (extracellular matrix protein) made no difference to the hydrogel cell adherence 
preferences  observed.  In  addition,  when  the  cultures  were  visualised  under  light 
transmission and fluorescence microscopy, the adherence pattern of cells to Laponite XLS 
hydrogels seemed to follow the network structure of the hydrogel (Fig. 5.3.16). Attempts at 
assessing cell viability using MTG and Sytox green proved unsuccessful as dyes bound to 
the hydrogel.    
 
 
Figure 5.3.16 Overlaid images of fluorescent CM-DiI (red)-stained cells over 16% Laponite XLS 
culture medium hydrogel under light transmission. Cells were observed to adhere to the porous 3D 
network structure of Laponite to form a distinct adherence pattern. Scale bar, 50 μm. 
5.3.9 Laponite culture medium gels have high osmolarity  
The  osmolarity  of  gels  (buffered  and  non-buffered)  were  measured  across  a  range  of 
Laponite concentrations (% w/v) to determine whether this was the cause of the static 
response of cells to Laponite hydrogel cover. Results showed that the osmolarity of culture 
medium  (NBA-A/B27/Glu)  was  ~250  mOsm.  The  addition  of  Laponite,  however, 
increased the osmolarity significantly, which increased even further with the addition of 
higher concentrations of Laponite (Linear regression analysis *p<0.0001). This trend was 
observed in both buffered and non-buffered gels (Fig. 5.3.17). On the whole, buffered 
hydrogels had ~50 mOsm higher osmolarity than non-buffered gels across all Laponite 
concentrations tested. The addition of 16% Laponite RDS produced a hydrogel with an 





Figure 5.3.17 Osmolarity of non-buffered and buffered (35 mM HEPES) Laponite RDS culture 
medium hydrogels. There was a corresponding increase in hydrogel osmolarity as the concentration 


















The biocompatibility of Laponite RDS/XLS culture medium hydrogels for postnatal rat 
hippocampal cells were investigated to explore their potential as synthetic matrices for 3D 
culture.  The  response  of  hippocampal  cells  to  hydrogel  exposure  was  explored  and 
assessed through the use of a range of novel techniques.   
5.4.1 Hippocampal cells must be pre-stained before hydrogel incorporation 
The synthetic hydrophilic clay  Laponite has  a  rich absorptive chemistry which proved 
problematic  for  cell  visualisation  with  fluorescent  dyes.  As  described  in  the  attractive 
theory  for  Laponite  hydrogel  formation,  Laponite  itself  is  comprised  primarily  of  a 
network of disk-shaped, nano-sized monomers which are both positively and negatively 
charged  and  connected  together  by  weak  electrostatic  interactions  and  van  der  Waals 
attractions (Martin et al., 2002). The presence of multiple charges attracts molecules, such 
as  dye  particles,  which  in  turn  remain  bound  to  the  hydrogel  network  structure.  Most 
probably, it is this absorption of dyes which cause the high background fluorescence and 
deter the determination of cell viability. A simple way to overcome this was to pre-stain 
cells and neurospheres before hydrogel incorporation.   
5.4.2 Hippocampal monolayers remain static in response to hydrogel exposure 
Cells  in  culture  are  dynamic  assemblies,  showing  constant  spatial  and  morphological 
changes over time as cells grow and differentiate, with hippocampal monolayers proving 
no exception (Brewer, 1997). In this respect, cells exposed to hydrogel should also be 
expected  to  show  the  same  dynamic  diversity.  Unexpectedly,  however,  hippocampal 
monolayers covered by Laponite culture medium hydrogels showed no dynamic changes 
over  time  and  no  spatial  or  morphological  change,  although  there  could  be  many 
physiological explanations for the static effect observed.  
 
      Over time, as the age of cultures increase, monolayers may become less active as cell 
growth  and  differentiation  peaks.  This  issue  was  investigated  by  covering  cultures  of 
different age under hydrogel, which made no difference to the static effect observed. In 
addition,  even  if  monolayers  became  less  dynamic,  there  are  ongoing  and  continual 
processes,  such  as  cell  migration  and  extension  of  neural  processes,  which  were  not 
observed  in  any  of  the  hydrogel-covered  monolayers.  All  cells  and  cellular  processes 
remained unchanged. The addition of growth factors also made no significant difference, 
which suggested that the hydrogel itself was the main causative factor. Static hippocampal 172 
 
cultures  in  response  to  cover  by  a  range  of  Laponite  RDS/XLS  preparations  (2-16%), 
irrespective of hydrogel formation, supported the fact that it was Laponite itself that was 
not biocompatible. Further investigations, therefore, were made with regards to two basic 
properties of the hydrogel which would contribute to cell survival in culture: the pH and 
osmolarity. The hydrogel pH was initially investigated due to the colour of the phenol red 
indicator in the media, and was corrected through the use of HEPES buffer to reduce the 
pH from 8.6 to 7.8 in 16% Laponite RDS culture medium hydrogels. Buffered hydrogels 
made  no  difference  to  the  static  effect  observed  in  cultures.  On  the  other  hand,  the 
osmolarity (osmoles of solute per litre of solution) of the Laponite hydrogels were very 
high  (~400-450  mOsm  in  16%  Laponite  culture  medium  hydrogel)  compared  to  plain 
culture  medium  (~250  mOsm).  The  hyperosmotic  Laponite  hydrogel  was  not 
physiologically suitable for the survival and cultivation of hippocampal cells, which may 
partly explain the static behaviour observed, as cells were exposed to hyperosmotic stress. 
Cells, however, usually shrink in response to a hyperosmotic environment, which was not 
observed  in  the  hydrogel-covered  cultures  (Kreisman  et  al.,  1995).  The  chemical 
composition of Laponite, which consists of high quantities of chemical compounds such as 
magnesium  oxide  (26%  dry  composition)  and  sodium  oxide  (5.6%  dry  composition), 
contribute to  its  high osmolarity and the presence of these ions  is  central  to  Laponite 
hydrogel  formation  (Mourchid  et  al.,  1995a,  1995b).  Although  the  osmolarity  may  be 
manipulated for enhanced cell survival, the consequence of this on hydrogel formation is 
unknown and provides the basis for further investigation.  
 
      The  viability  of  hippocampal  cells  under  hydrogel  cover  remains  elusive  due  to 
difficulties  in  cell  viability  staining  due  to  dye  absorption  by  the  hydrogel.  Efforts  to 
overcome this through the incorporation of PI into gels and the culturing of cells on inserts 
with porous membranes have proved unsuccessful. Further techniques which may allow 
the determination of cell viability under the hydrogel will need to be explored.   
5.4.3 Laponite XLS may be a more biocompatible alternative to Laponite RDS 
Laponite XLS, the low heavy metal content variation of Laponite RDS, is typically used 
for  cosmetic  applications.  The  basic  chemical  composition  remains  largely  unchanged 
except for the regulation of heavy metal content, with particular focus on minimising the 
contribution from heavy metals such as lead (< 3mg/kg), arsenic (< 1mg/kg), mercury (< 
2mg/kg) and nickel (< 2mg/kg) (Laponite technical bulletin, L246/06e). Heavy metals such 173 
 
as lead and arsenic are well known to be neurotoxic to cells such as hippocampal neurons 
(Yang et al.; 1999; Yang et al.; 2003), although the concentration of heavy metals in the 
final  Laponite  hydrogel  is  negligible  and  was  unlikely  to  have  had  any  significant 
contribution  to  cell  death.  Hippocampal  cells  did  not  show  cell  death  in  response  to 
hydrogel cover, instead, they remained unchanged over time.  
 
      The cells which were seeded over Laponite RDS and Laponite XLS culture medium 
hydrogels showed preferential adherence to XLS hydrogel. This increased adherence may 
be explained by the decreased heavy metal content and overall purer composition of XLS. 
This does not explain, however, why the behaviour of hippocampal monolayers remained 
inactive when Laponite XLS hydrogels were transferred on top. Although Laponite XLS 
may  show  better  compatibility  with  cells,  Laponite  hydrogels,  in  general,  need 
optimisation for improved cell biocompatibility.   
5.4.4 Advantages of a 3D culture of hippocampal cells in silica hydrogel  
Attempts have been made to create silica-based culture matrices from sodium silicate since 
the  1930's.  With  chemically  and  physically  distinct  properties  to  Laponite  (sodium 
magnesium silicate), sodium silicate gel formation requires reaction with hydrogen ions in 
acid  and  heating  for  gel  formation.  The  inorganic  nature  of  sodium  silicate  is  a  great 
advantage, allowing for the free manipulation of nutrients within the gel to control the 
growth of both autotrophic and heterotrophic bacteria (Sterges, 1942), although there have 
been no attempts at cultivating hippocampal neurons in such gels.  
 
      The culture of rat hippocampal and cortical neurons in 3D hydrogel matrices has been 
well  attempted  in  other,  mainly  natural,  hydrogels  such  as  collagen  (Xu  et  al.  2009), 
agarose (O'Connor et al., 2001) and hyaluronic acid (Wei et al., 2010). Xu et al. (2009) 
cultured rat embryonic hippocampal neurons in three different models of collagen hydrogel 
culture. Neurons were either cultured as embedded cells evenly distributed within a 3D 
collagen matrix, at the interface between two layers of collagen called the sandwich model, 
or seeded on the surface of collagen-coated coverslips as a 2D model. Neurons cultured 
within  the  3D  model  demonstrated  improved  survival  compared  to  the  2D  model  and 
extended neuronal processes into the surrounding 3D matrix. Older 3D cultures (14 and 21 
day  old)  also  exhibited  spontaneous  postsynaptic  currents,  presenting  evidence  for 
functional synapse formation (Xu et al., 2009). Functional multi-level 3D hippocampal 174 
 
circuits can be created in collagen hydrogels for applications in neuronal regeneration and 
repair and brain research.   
 
      Commercially  available  hydrogels  which  can  be  used  to  create  3D  matrices  of 
hippocampal cells include BD Matrigel™ basement membrane matrix (BD Biosciences). 
This  heterogeneous  protein  mixture  secreted  by  mouse  tumour  cells  contains  diverse 
structural and adhesive proteins such as laminin and collagen (natural components of the 
extracellular matrix) (Kleinman et al., 1982; 1986), as well as growth factors which help to 
promote neuronal cell growth and differentiation (Biederer & Scheiffele, 2007). In addition 
to being extremely costly, the complex milieu of proteins present in  Matrigel presents 
difficulties  when  performing  experiments  which  require  an  accurate  knowledge  of 
constituents  (Vukicevic  et  al.,  1992).  Although  Laponite  had  not  been  previously 
investigated as a cell culture matrix, its relatively low cost, gentle gelling conditions and 
thixotrophic  properties  provide  advantages  over  many  current  hydrogels.  In  addition, 
similar to sodium silicate (Sterges, 1942), the inorganic nature of Laponite allows for the 
fabrication of a highly controlled cell environment, although unlike bacteria, mammalian 
cells,  and  especially  hippocampal  neurons,  are  much  more  sensitive  to  environmental 
conditions.   
5.4.5 Conclusions 
Although  Laponite  hydrogels  are  attractive  as  3D  culture  matrices  because  of  their 
rheological properties, this will not be possible until they are more biocompatible. The 
high osmolarity of Laponite culture medium hydrogels seems to be the most obvious issue 
and  remains  a  difficult  obstacle  to  overcome.  Although  Laponite  XLS  hydrogels  have 
proved more promising, other ways of determining cell viability within the hydrogels still 
need  to  be  investigated.  Unfortunately,  due  to  time  and  physical  constraints,  Laponite 
hydrogels could not be further optimised for cell survival, although it remains a potential 



































































Chapter 6 - General discussion 
6.1 Cellular mechanisms underlying NPY-mediated neuroproliferation 
It has been proposed that NPY-releasing interneurons in the dentate hilus release NPY onto 
progenitors  within  the  SGZ  to  regulate  their  proliferation  and  adult  hippocampal 
neurogenesis (Gray, 2008). I have confirmed previous observations (Howell et al., 2003) 
that NPY exerts a purely proliferative effect on hippocampal cultures, but the question 
remained as to how NPY mediates this increase in proliferation. Through combining the 
observations  identified  so  far,  the  key  mediators  of  this  proliferative  effect  can  be 
organised into a systematic signalling pathway.   
 
      The neuroproliferative effect was mediated via the NPY Y1 receptor, whereupon NPY-
binding resulted, presumably, in the activation of nNOS, possibly via Gi/Go G proteins 
(Limbird, 1988). Indeed, signalling between GPCRs, such as the Y1 receptor, and nNOS 
may be possible through GPCR-mediated mechanisms. In the cholecystokinin-mediated 
proliferation of Chinese hamster ovary cells, for example, the cholecystokinin A GPCR 
activated  nNOS  via  the  G-protein  βγ  subunit  and  the  tyrosine  phosphatase  SHP-2 
(Cordelier et al., 1999). NOS activation converts the amino acid L-arginine into citrulline 
and  NO  (Alderton  et  al.,  2001),  for  which  I  have  shown  a  significant  increase  in 
intracellular  NO/N2O3  production  upon  NPY  addition.  This  NO  mediates  further 
intracellular signalling mechanisms which ultimately results in cell proliferation. Imaging 
studies using DAF-FM DA showed that, even before a NPY or PBS pulse, hippocampal 
cells had some endogenous NO/N2O3 activity. It is unlikely, however, that this background 
level of NO was involved in mediating basal proliferative processes, as pharmacological 
analysis using L-NAME showed that it had little effect on basal cell proliferation. On the 
contrary, both sGC and PKG were associated with maintaining basal proliferation rates, 
which may be due to NO-independent sGC activation (Ignarro et al., 1982; Stasch et al., 
2001) which is less efficient than NO at promoting cGMP synthesis. Moreover, many of 
the physiological effects of NO are concentration dependent and an increase in endogenous 
(basal) NO levels,  as  a result of NPY stimulation or  L-arginine supplementation, may 
initiate proliferative processes which would otherwise not occur if NO levels were low.  
 
      The targets immediately downstream of NO were identified as sGC and the second 
messenger cGMP, which in turn, activated PKG. PKG activation typically leads to the 
phosphorylation  of  serine  and  threonine  residues  on  protein  targets  which  (indirectly) 178 
 
regulate the activity of downstream targets such as ERK 1/2 (Francis & Corbin, 1999). As 
well as confirming the involvement of ERK 1/2, I have also shown that ERK 1/2 activation 
by  NPY  was  solely  mediated  via  NOS/NO  mechanisms.  ERK  1/2  are  involved  in 
mediating further pathways involved in regulating the expression of genes controlling cell 
proliferation and differentiation (Cano & Mahadevan, 1995;  Lopez-Ilasaca, 1998) (Fig. 
6.1).  The  signalling  mechanisms  downstream  of  ERK  1/2,  such  as  the  activation  of 





Figure  6.1  Schematic  diagram  of  the  intracellular  mechanisms  underlying  NPY-mediated 
neuroproliferation. NPY released by interneurons of the dentate hilus acts on NPY Y1 receptors in 
the subgranular zone (SGZ) to initiate a neuroproliferative effect. The Y1 GPCR activates neuronal 
nitric oxide synthase (nNOS) which synthesises NO from L-arginine. The target of NO is soluble 
guanylate  cyclase  (sGC),  which  converts  GTP  into  cGMP.  cGMP  activates  cGMP-dependent 
protein kinase (PKG), which in turn leads to the activation of a range of protein targets or kinase 
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regulating  the  expression of  genes involved  in  controlling  cell  proliferation  and  differentiation 
(adapted from Alvaro et al., 2008).  
 
      NO  synthesised  by  nNOS  in  response  to  NPY  was  most  likely  intracellular  and 
mediated its proliferative effect, while extracellular NO was antiproliferative, a finding 
consistent with the dual role of nNOS-derived NO recently demonstrated by Luo et al. 
(2010). My study significantly extends these findings by identifying NPY as a possible 
mediator of intracellular NO-induced proliferation. While high level concentrations and 
sustained NO release is commonly associated with anti-proliferative effects (Cardenas et 
al., 2005), a low level and localised release of NO, in response to NPY for example, may 
be involved in mediating proliferative pathways. This dual role is a common characteristic 
of NO and may be enforced by the differential subcellular compartmentalisation of nNOS, 
for example, to the nuclei of neural stem cells or to the cytoplasm of neurons as proposed 
by  Luo  et  al.  (2010),  a  trend  also  observed  during  the  nNOS  immunostaining  of 
hippocampal cultures in my study (Fig. 3.3.6), or possibly, the existence of the nNOS 
splice  variants  such  as  nNOSα,  nNOSβ  and  nNOSγ  (Corso-Diaz  &  Krukoff,  2010; 
Alderton  et  al.,  2001).  Although  the  involvement  of  NO  was  previously  suggested  to 
mediate the proliferative effect of NPY on retinal neural cells by Alvaro et al. (2008), my 
results are the first to suggest that intracellular NO produced by nNOS signals the complete 
Y1 receptor-mediated proliferative effect of NPY on hippocampal nestin
+ precursor cells, 
while extracellular NO had the opposite antiproliferative effect. 
6.2 Levels of NO in in vitro culture 
There are many influential factors in tissue culture which can affect levels of NO, one of 
which is the oxygen (O2) concentration. The synthesis of NO by NOS occurs via two 
monooxygenation reactions and the rate of NO synthesis is related to the concentration of 
O2. nNOS (Km = 350 µM), the most likely mediator of the neuroproliferative effect of 
NPY, is more sensitive to physiological levels of O2 than iNOS (Km = 130 µM) or eNOS 
(Km = 4 µM) (Stuehr et al., 2004). In tissue culture, cell monolayers are cultured under air 
equilibrated levels of O2 (210 µM O2) (Hall & Garthwaite, 2009), which is about 10-fold 
higher than levels normally present within the brain in vivo (20 µM O2) (Dings et al., 
1998). In this hyperoxic environment in vitro the production of NO will be significantly 
increased (Hall & Garthwaite, 2009), and in addition to this, high O2 levels can cause 
oxidative stress  (Coyle  & Puttfarcken, 1993).  Although increased oxidative stress  as  a 180 
 
result of high O2 levels is not likely a major issue in in vitro hippocampal cultures, as cells 
proliferated well under basal conditions and overall cell death was low (~10%), the effect 
of  increased  NO  production  on  cultures  is  unknown.  The  effect  of  O2  levels  on 
hippocampal  cultures  and  NO  signalling  should  be  addressed  in  the  future,  as  it  has 
important consequences for a vast number of studies.  
 
      Similar  to  high  O2,  certain  chemical  components  of  culture  media  have  also  been 
demonstrated to react with and influence levels of NO in vitro. In aqueous solution, NO 
can be simply inactivated by an autoxidation reaction with O2 (Ford et al., 1993), however, 
the study by Keynes et al. (2003) identified HEPES buffer and, under laboratory lighting, 
the vitamin riboflavin, as NO-consuming components which are present within a variety of 
culture media. NO produced by the donor, DETA/NONOate, was reduced in the presence 
of these two components, which probably occurs via the generation of superoxide anions 














Figure 6.2 Interactions of NO with riboflavin and HEPES in culture media (adapted from Keynes et 
al., 2003). Superoxide anion (O2
-) generated from riboflavin reacts with NO to form peroxynitrite 
(ONOO
-), which can be cytotoxic. In turn, ONOO
- can oxidise HEPES, which, upon subsequent 
reaction with molecular oxygen (O2), generates more O2
-.      
 
      Neurobasal A, the culture medium used in this study, contains both HEPES (10.92 



















Keynes  et  al's  (2003) study, where 0.1-0.2 mg/L riboflavin  and 12.5-200 mM  HEPES 
significantly  reduced  the  generated  NO  (~1  µM)  from  300  µM  DETA/NONOate,  the 
amount of riboflavin present in Neurobasal A media is relatively high and may have acted 
as  a  significant  NO-consumer  when  cultures  were  exposed  to  laboratory  lighting.  The 
influence of these factors limits the reliability of any NO studies conducted in vitro, and 
are issues which were considered during data interpretation.  
6.3 NPY-mediated neuroproliferation in vivo 
This  study  has  identified  the  importance  of  NO  mechanisms  in  mediating  the 
neuroproliferative  effect  of  NPY  on  hippocampal  cultures  in  vitro.  Would  these 
mechanisms, however, still hold true in vivo? Although the proliferative effect of NPY for 
hippocampal neurogenesis has been well demonstrated  in vivo (Decressac et al., 2011; 
Howell et al., 2007), no attempts have yet been made to decipher any of the underlying 
mechanisms. Indeed, the next step in this study would be to confirm my findings in vivo. 
With  nNOS  identified  as  a  possible  mediator  of  the  neuroproliferative  effect  of  NPY, 
hippocampal precursor cell proliferation in response to exogenous NPY application could 
be  assessed  in  vivo  using  nNOS  knockout  mice  (Packer  et  al.,  2003).  This  will  be 
challenging, however, given the highly complex, wide-ranging and bifunctional effects of 
NO in vivo and difficulties in specifically targeting the intracellular nNOS and Y1 receptors 
of neural stem cells in the hippocampal SGZ. Nevertheless, in vitro hippocampal cultures 
could at least be derived from nNOS knockout mice for further confirming the importance 
of  NO  in  mediating  the  effect  of  NPY.  On  the  other  hand,  Cre/LoxP-mediated 
recombination using nestin-Cre transgenic mice (Dubois et al., 2006; Sclafani et al., 2006) 
is another possibility which could be used for the specific deletion of nNOS in nestin 
expressing  precursor  cells,  as  the  NOS  subtypes  are  encoded  for  by  distinct  genes 
(Alderton et al., 2001).  
6.4 Is NO a common mediator of NPY and the NPY Y receptors? 
Of the four NPY receptor subtypes functional in humans (Y1, Y2, Y4 and Y5) (Michel et al., 
1998), all four are expressed (albeit at different levels) in the hippocampus (Kopp et al., 
2002; Gustafson et al., 1997; Wolak et al., 2003; Dumont et al., 1998). Coupled to G-
proteins of the Gi/Go family (Limbird, 1988), the NPY receptors act through a variety of 
signalling pathways to exert diverse physiological effects (Michel et al., 1998). Although 
this and Alvaro et al's study (2008) have been the first to demonstrate the involvement of 
NO  mechanisms  in  mediating  the  neuroproliferative  effect  of  NPY,  NO  has  been 182 
 
implicated in mediating other aspects of NPY action, especially via the NPY Y1 receptor. 
For  instance,  NO  has  been  shown  to  mediate  the  effect  of  NPY  on  neurovascular 
regulation through the Y1 receptor. In the vascular smooth muscle of peripheral blood 
vessels, NPY normally acts as a sympathetic neurotransmitter which facilitates adrenaline-
evoked vasoconstriction via the Y1 receptor (Wahlestedt, 1990). On the other hand, NPY 
has also been shown to mediate vasodilatory responses via the Y1 receptor, but this time by 
acting  through  NO  mechanisms.  Nilsson  et  al.  (2000)  showed  that  the  NPY-mediated 
dilation of small human subcutaneous arteries was significantly inhibited by the presence 
of the Y1 receptor antagonist BIBP3226 and the NOS inhibitor L-NAME, supporting the 
involvement of NO in mediating NPY Y1-mediated vasodilation. Similarly, noradrenalin 
and NPY binding to the α2 adrenoreceptor and Y1 receptor on endothelial cells stimulates 
eNOS and NO production which promotes the vasodilator response (Hodges et al., 2009; 
Vanhoutte & Miller, 1989). Heat-induced vasodilation, for example, is abolished with both 
the presynaptic sympathetic blockade of cutaneous vasoconstrictor nerves with bretylium 
tosylate  and/or  L-NAME  application,  further  supporting  the  requirement  for  NO 
production in mediating the neurovascular effects of NPY (Hodges et al., 2008). In fact, 
the  release  of  catecholamines  from  NPY-stimulated  adrenal  chromaffin  cells  has  been 
shown to occur via the Y1 receptor and involves the activation of NOS/NO mechanisms 
(Rosmaninho-Salgado et al., 2007). In addition to the Y1 receptor, NO processes have also 
been shown to mediate the vasodilatory effect of NPY in cerebral vessels by acting through 
the Y2 receptor (You et al., 2001).  
 
      NPY has been shown to induce angiogenesis in ischemic tissues via NO-dependent 
pathways  (Zukowska  et  al.,  2003). NPY itself  exerts a proliferative  effect  on vascular 
smooth  muscle  cells  (VSMC)  (Pons  et  al.,  2003;  Zukowska-Grojec  et  al.,  1998a)  and 
endothelial cells (Zukowska-Grojec et al., 1998b), which, during hindlimb ischemia (due 
to vessel occlusion), is released from perivascular sympathetic nerves and endothelial cells 
(Zukowska-Grojec & Wahlestedt, 1993; Zukowska et al., 2003). Ischemia upregulates the 
expression of the Y2/Y5 receptors (Zukowska-Grojec et al., 1998a; Lee et al., 2003) and 
dipeptidyl-peptidase IV (DPPIV), a peptidase which forms the Y2/Y5 agonist, NPY 3-36 
(Mentlein et al., 1993; Ghersi et al., 2001). The failure of NPY-mediated aortic sprouting 
in mice null for eNOS (Lee et al., 2003) has led to the hypothesis that stimulation of the 
Y2/Y5 receptors results in eNOS activation and the production of NO, which mediates the 183 
 
angiogenic effects of NPY (Zukowska et al., 2003). In fact, NO itself has also been shown 
to exhibit angiogenic effects of its own (Ziche & Morbidelli, 2000). 
 
      In the CNS, the NPY Y1 receptor has been shown to modulate NO levels during stroke 
in rats (Chen et al., 2002). Using a middle cerebral artery occlusion (MCAO) stroke model, 
Chen et al. (2002) showed that the intracerebroventricular injection of NPY or a Y1 agonist 
increased the infarct volume, a Y2 agonist had no effect, and the Y1 receptor antagonist 
BIBP3226  reduced  the  infarct  volume.  Using  electron  paramagnetic  resonance 
spectroscopy to measure NO levels, MCAO was found to increase the relative brain NO 
concentration to 131.94 ± 7.99%, while NPY treatment increased this further to 250.94 ± 
50.48%. BIBP3226, however, significantly reduced the relative brain NO concentration to 
69.63 ± 8.84% (Chen et al., 2002). This study suggests that Y1-mediated NO generation 
during cerebral ischemia mediates ischemic damage via NO overproduction (Malinski et 
al., 1993; Matsui et al., 1999). To the contrary, however, ischemic injury has also been 
associated with increased adult neurogenesis (Lichtenwalner & Parent, 2006). The first to 
describe this effect was Liu et al. (1998a), who observed a 12-fold increase in the number 
of BrdU
+ cells in the dentate SGZ after transient global ischemia in the adult gerbil. The 
proliferative  effect  of  ischemia  on  adult  hippocampal  neurogenesis  has  also  been 
demonstrated in rats (Jin et al., 2001) and mice (Takagi et al., 1999), occurs after a latent 
period of about 1-2 weeks and is transient in its effects (Liu et al., 1998a; Lichtenwalner & 
Parent, 2006). Indeed, contrary to the role of NO in mediating ischemic damage, Zhang et 
al. (2001) have shown that the administration of the NO donor DETA/NONOate increased 
cell  proliferation  and  neurogenesis  in  the  dentate  gyrus  of  rats  under  both  basal  and 
ischemic  conditions.  Cortical  levels  of  cGMP  were  significantly  increased  and  the 
administration  of  DETA/NONOate  considerably  improved  the  neurological  outcome 
during  recovery  from  ischemic  damage  mediated  via  MCAO  (Zhang  et  al.,  2001). 
Although the mechanisms underlying these processes are complex, this illustrates again the 
dual role of NO and how a single molecule of NO can be controlled to exert a range of 
diverse physiological effects. In this instance, the NOS subtype producing NO and the 
levels of NO are probably the main determinators. nNOS probably mediates the NO injury 
in response to ischemia by producing high levels of NO, since as described previously, 
nNOS knockout mice show reduced infarct size in response to transient focal cerebral 
ischemia (Sun et al., 2005). eNOS and iNOS, on the other hand, have been shown to be 
important in mediating basal (Reif et al., 2004) and ischemia-induced (Zhu et al., 2003) 184 
 
neurogenesis, respectively. As well as ischemia, a significant increase in NO production is 
also associated with epileptic seizures (Bashkatova et al., 2000; Kaneko et al., 2002) and 
Jiang et al. (2004) have shown that administration of the relatively non-selective nNOS 
inhibitor, 7-nitroindazole, significantly reduced the number of BrdU
+ cells in the dentate 
gyrus  3,  7  and  14  days  after  pentylenetrazol-induced  seizures  in  rats.  This  possible 
involvement of nNOS in initiating hippocampal neurogenesis after seizures (Jiang et al., 
2004) and the fact that NPY itself is necessary for seizure-induced hippocampal precursor 
cell proliferation (Howell et al., 2007) suggests that nNOS-derived NO may potentially 
mediate the proliferative effect of NPY in response to seizure activity in vivo, although 
further verification of this is required. Nevertheless, the conclusion from these studies is 
that NO may be a more common mediator of the effects of NPY than first thought.   
6.5 The NO-cGMP-PKG pathway and synaptic plasticity 
NO  mediates  a  broad  variety  of  physiological  processes  in  the  CNS  (Garthwaite  & 
Boulton, 1995) which, due to practical reasons, cannot be fully covered in this discussion. 
However,  the  NO-cGMP-PKG  pathway,  which  was  found  to  mediate  the 
neuroproliferative  effect  of  NPY  in  this  study,  is  involved  in  regulating  some  key 
neurological processes such as synaptic plasticity. Synaptic plasticity, a process whereby 
the strength of connections between neurons is manipulated in response to various factors, 
seems to be necessary for learning and memory (Martin et al., 2000). In a study by Ota et 
al.  (2008),  the  NO-cGMP-PKG  signalling  pathway  was  found  to  be  involved  in  the 
regulation of synaptic plasticity and fear memory consolidation in the lateral amygdala 
(LA)  of  the  rat  (Ota  et  al.,  2008).  The  intra-LA  infusion  of  a  PKG  inhibitor  or  PKG 
activator, impaired or enhanced, respectively, fear memory consolidation in behavioural 
experiments, while slice electrophysiology experiments showed that the application of 8-
Br-cGMP or the sGC activator YC-1 enhanced long-term potentiation (LTP), a form of 
synaptic plasticity whereby synaptic transmission efficacy is enhanced in the long-term, at 
thalamic  inputs  to  the  LA  (Ota  et  al.,  2008).  As  well  as  the  involvement  of  NO 
mechanisms, the inhibition of the YC-1-induced LTP enhancement in the LA by U0126 
suggested the involvement of ERK 1/2 mechanisms (Ota et al., 2008). In fact, the NO-
cGMP-PKG pathway promotes fear memory consolidation, in part, by mediating ERK 1/2-
driven gene transcription (Ota et al., 2010). Similarly, NO plays an important role in LTP 
in the hippocampus (Bohme et al., 1991; Doyle et al., 1996), which some studies have 
shown is mediated via cGMP-PKG processes (Boulton et al., 1995). Zhuo et al. (1994) 185 
 
showed that the induction of LTP in the CA1 region of hippocampal slices was blocked by 
the  inhibition  of  sGC  or  PKG,  while  cGMP  analogues  or  PKG  activators  produced 
activity-dependent  long-lasting  enhancement  of  the  excitatory  postsynaptic  potential. 
Likewise,  Monfort  et  al.  (2004)  showed  that  the  activation  of  sGC,  PKG  and  cGMP-
degrading phosphodiesterase was essential for the proper induction of NMDA receptor-
dependent LTP in the CA1 region of the hippocampus. In summary, cGMP and PKG are 
major mediators of NO in fundamental processes of the CNS.   
6.6 Considerations on the dual nature of NO 
At a cellular level, the NO-cGMP-PKG pathway has been implicated in the regulation of 
apoptosis and survival in neural cells (Fiscus, 2002). As briefly mentioned previously, the 
cell type, cell source, duration of exposure, timing of synthesis and the concentration of 
NO  are  major  factors  contributing  to  its  seemingly  dual  role  (Cardenas  et  al.,  2005). 
Indeed, with regards to cell survival, NO can also have both an apoptotic/necrotic (toxic) 
effect, or antiapoptotic (protective) effect depending on the circumstances (Beckman & 
Koppenol, 1996; Fiscus, 2002). NO at relatively low (submicromolar) concentrations is 
usually correlated with mediating its protective effects and the activation of sGC leading to 
cGMP  synthesis  (Bobba  et  al.,  2007;  Fiscus,  2002).  On  the  other  hand,  excess  NO 
production, such as in response to ischemia, is neurotoxic and can lead to cellular damage 
by inducing oxidative stress (Bobba et al., 2007). The oxidative stress and damage initiated 
by, for example, peroxynitrite, a reactive species formed as result of NO reaction with 
superoxide  anion,  can  ultimately  result  in  cell  apoptosis  or  necrosis  (Beckman  & 
Koppenol, 1996; Estévez et al., 1998a). Although the cGMP-PKG pathway contributes to 
the proapoptotic actions of NO in certain cell types, such as vascular smooth muscle cells 
(Pollman et al., 1996) and vascular endothelial cells (Suenobu et al., 1999), cGMP has 
been shown to mediate the neuroprotective or antiapoptotic effects of NO in mammalian 
neural cells such as motor neurons (Estévez et al., 1998b), dorsal root ganglion neurons 
(Thippeswamy  &  Morris,  1997)  and  cerebellar  granule  neurons  (Bobba  et  al.,  2007). 
Indeed, the addition of extracellular NO (through the application of NO donors) protected 
serum-deprived PC12 cells (Kim et al., 1999), as well as nerve growth factor-deprived 
sympathetic  neurons  (Farinelli  et  al.,  1996),  from  cell  death  in  vitro.  Of  particular 
significance,  however,  is  that  the  neuroprotective  effects  of  the  NO  donors  (sodium 
nitroprusside or SNAP) were only observed with low concentrations (below 100 µM) of 
the donor (Farinelli et al., 1996; Kim et al., 1999). It is possible that low concentrations of 186 
 
NO activate sGC and cGMP production, which contributes to its neuroprotective effects, 
while  higher  concentrations  of  NO  may  elicit  toxic  effects  through  the  formation  of 
reactive species (Fiscus, 2002). These findings support my observations regarding the dual 
role of NO in regulating the proliferation of hippocampal cells, especially of the nestin
+ 
precursor  cell  population.  I  have  shown  that  intracellular  NO  probably  mediates  the 
proliferative effect of NPY, which was perhaps low level and short-lived, while the long-
term application of extracellular NO through the use of the NO donor DETA/NONOate, 
which has a half-life of around 22 h (Keefer et al., 1996), was antiproliferative. Similarly, 
inhibition  of  cell  proliferation  occurred  at  higher  concentrations  (100  µM)  of 
DETA/NONOate, and showed further inhibition with increased donor concentration (200 
µM).  In  fact,  Carreira  et  al.  (2010)  had  previously  reported  a  dual  effect  of 
DETA/NONOate, depending on the concentration, on the proliferation of neural stem cell 
cultures derived from the mouse SVZ. While a low concentration of DETA/NONOate (10 
µM)  increased  cell  proliferation,  higher  concentrations  (100  µM)  inhibited  cell 
proliferation (Carreira et al., 2010). This increased cell proliferation in response to low 
levels of NO donor was blocked by inhibiting the MAPK pathway with U0126 (Carreira et 
al., 2010), supporting the involvement of ERK 1/2 in mediating the proliferative aspect of 
NO  identified  in  my  own  investigations.  Indeed,  as  mentioned  previously, 
DETA/NONOate was used at quite high concentrations within my own investigations and 
exerted a negative effect on neural proliferation. In reality, a biphasic effect of extracellular 
NO may have been observed if the concentration range I examined was not so limited. 
Lower concentrations of DETA/NONOate may have exerted proliferative effects similar to 
that  of  the  intracellular  NO  pathway  identified,  and  remains  a  topic  for  further 
investigation. As well as neural proliferation, low doses of DETA/NONOate (0.1 and 0.4 
µM) have also been shown to promote (Chen et al., 2006), while high doses (50 µM) 
inhibited (Luo et al., 2010), neuronal differentiation and neurite outgrowth. Although the 
context may be slightly different i.e. cell proliferation compared to cell survival, the ability 
to manipulate the effects of NO through regulating its properties (i.e. concentration) and 
the positive effects of the NO-cGMP-PKG pathway are well demonstrated in both cases.  
6.7 Is the neuroproliferative effect of NPY on the SVZ mediated via NO? 
As in the SGZ, NPY exerts a neuroproliferative effect on SVZ cells which has been shown 
to be mediated via the NPY Y1 receptor and the ERK 1/2 pathway in mice (Agasse et al., 
2008).  As  well  as  enhancing  neurogenesis,  NPY  has  also  been  shown  to  increase  the 187 
 
chemokinetic  activity  of  cells  in  the  rat  SVZ  (Thiriet  et  al.,  2011).  Unlike  the  SGZ, 
however,  the  stress-activated  protein  kinase/c-Jun  NH2-terminal  kinase  (SAPK/JNK) 
pathway has also been implicated in mediating the action of NPY in the SVZ (Agasse et 
al., 2008). Like the ERK 1/2 pathway, the SAPK/JNKs are MAPKs involved in mediating 
neural proliferation and differentiation (Agasse et al., 2008). Other than the involvement of 
the MAPKs, no other mechanisms underlying the neuroproliferative effect of NPY on SVZ 
cells  is  known,  which  raises  the  question  over  whether  NO  mechanisms  may  also  be 
involved. Indeed, the localisation of nNOS to the SVZ, olfactory and rostral migratory 
stream of adult male mice was demonstrated previously by Moreno-Lopez et al. (2000), 
however, nNOS was never found co-localised to, only intermingled with, PSA-NCAM
+ 
precursor cells (neuroblasts). Although this might suggest against the direct involvement of 
intracellular NO in mediating the effects of NPY on SVZ precursor cells, the anatomical 
proximity of the nNOS
+ neurons nevertheless supports the findings that NO, regardless of 
NPY, influences adult neurogenesis in the SVZ (Moreno-Lopez et al., 2000). On the other 
hand, contradictory to the findings by Moreno-Lopez et al., Torroglosa et al. (2007) have 
shown the expression of both nNOS and eNOS, as well as the intracellular production of 
NO,  in  neurosphere  cultures  derived  from  the  SVZ  of  adult  mice.  Further 
immunocytochemical studies confirming these findings would prove beneficial, as well as 
exploring the nNOS expression by other cell types and looking at the expression of the 
other NOS subtypes in the SVZ. The question of whether NO is involved in mediating the 
effect  of  NPY  on  SVZ  precursor  cells,  and  if  it  is,  how,  remains  a  topic  for  further 
investigation.  
6.8 Pathological relevance  
The potential in furthering our understanding of the mechanisms by which the proliferation 
of  endogenous  neural  stem/precursor  cells  are  controlled  lies  with  the  prospect  for 
manipulating these cells for therapeutic purposes. Of particular relevance are disorders 
afflicting  the  hippocampus,  including  stress  and  depression,  and  neurodegenerative 
diseases such as Alzheimer's disease (AD) and temporal lobe epilepsy (TLE). Progressive 
neuronal degeneration and cell death, for example, is associated with AD, as well as a 
disruption of neurogenesis in the SVZ and hippocampus of mouse models of AD by the 
main constituent of amyloid plaques, β-amyloid peptide (Aβ) (Haughey et al., 2002). In 
human  AD  sufferers,  however,  Jin  et  al.  (2004)  have  shown  that  there  is  enhanced 
neurogenesis in the hippocampus, as demonstrated by an increase in the expression of 188 
 
neurogenic  markers  and  the  number  of  expressing  cells.  Much  like  the  enhanced 
neurogenesis  observed  in  response  to  ischemia  (Liu  et  al.,  1998a),  these  observations 
suggest  the  presence  of  an  intrinsic  mechanism  whereby  the  brain  attempts  to  restore 
function to areas of neuronal damage or loss. This enhanced neurogenesis in response to 
AD, however, is insufficient in restoring function and is still associated with ongoing cell 
loss (Jin et al., 2004). Similarly, the loss of hilar and hippocampal interneurons, including 
NPY-immunoreactive interneurons (de Lanerolle et al., 1989; Chan-Palay et al., 1986), is a 
common feature of TLE, all of which contribute to cognitive decline (Gray, 2008). Much 
like the response to AD and ischemia, an increase in hippocampal neurogenesis is observed 
in response to seizure activity (Parent et al., 1997) and in experimental TLE (Parent et al., 
2006). The loss of hippocampal volume and neuronal cell death is also associated with the 
pathogenesis of stress and depression, although in this case there is decreased neurogenesis 
(Lee et al., 2002; Lucassen et al., 2006; Gould & Tanapat, 1999; Malberg et al., 2000). In 
retrospect, the prominent cell loss associated with the progression of these hippocampal 
disorders  suggest  the  possibility  of  replacing  or  protecting  the  deteriorating  neuronal 
population through the control of neural stem/precursor cells. 
 
      The therapeutic potential of neural stem/precursor cells could be harnessed in a number 
of  ways  as  a  means  to  ameliorate  or  rescue  damaged  areas  of  the  hippocampus.  The 
transplantation of neural stem/precursor cells into injured areas of the brain, for example, is 
one therapeutic strategy, which could also potentially be combined with gene therapy to 
generate genetically manipulated stem cells in vitro which will express therapeutic gene 
products when transplanted in vivo (Shihabuddin et al., 1999). In a transgenic mouse model 
of  AD,  for  example,  Blurton-Jones  et  al.  (2009)  found  that  the  transplantation  of 
hippocampal  neural  stem  cells  improved  cognition  by  rescuing  spatial  learning  and 
memory deficits. Alternatively, a different strategy relies on the endogenous ability for 
neurogenesis in the adult brain. The possibility of isolating multipotent stem cells from 
both neurogenic and non-neurogenic regions of the adult mammalian CNS suggests that in 
non-neurogenic regions, adult neurogenesis may be suppressed by a lack of permissiveness 
in the surrounding environment and/or a deficiency in factors which support differentiation 
(Shihabuddin  et  al.,  2000).  In  fact,  adult  spinal  cord  stem  cells  have  been  shown  to 
generate neurons after being transplanted into the adult dentate gyrus (Shihabuddin et al., 
2000). The existence of these endogenous stem/precursor cells could be recruited as an in 
situ source for replacing cells lost during pathological events by manipulating the factors in 189 
 
their  surrounding  environment  (Shihabuddin  et  al.,  1999).  To  harness  this  limitless 
potential to full effect, however, the events underlying the control of neural stem/precursor 
cell  proliferation  and  differentiation  must  be  fully  understood  and  appreciated.  In  this 
respect, NPY is particularly relevant. Decreased levels of NPY have been detected in the 
CSF of AD (Nilsson et al., 2001) and depressed (Widerlöv et al., 1988) patients, while the 
effect of NPY on increasing hippocampal neurogenesis has been implicated in the action of 
antidepressants (Malberg et al., 2000; Redrobe et al., 2002a). Similarly, NPY is important 
in  mediating  the  increase  in  precursor  cell  proliferation  and  neurogenesis  in  the 
hippocampus  in  response  to  seizure  activity  (Howell  et  al.,  2007).  Understanding  the 
central role in which NPY plays in mediating the proliferation of neural stem/precursor 
cells and in modulating levels of adult hippocampal neurogenesis will prove invaluable for 
the development of pharmacological mediators of repair or for ameliorating damage in 
response to a variety of pathological conditions.  
 
      Adult neurogenesis, however, is a tightly regulated process which can be influenced by 
a multitude of factors and increased hippocampal neurogenesis does not necessarily equate 
to  functional  repair.  The  increased  hippocampal  neurogenesis  in  response  to  seizure 
activity in adult rats, for example, is accompanied by abnormal network re-organisation 
and the formation of aberrant neural connections by the new granule cells (Parent et al., 
1997).  Likewise,  pathological  conditions  which  result  in  cell  loss  and  reduced 
neurogenesis also change the structure and connectivity of the dentate gyrus, and thus have 
impacts on its physiological function (Gould & Tanapat, 1999). The correct mechanisms 
must be in place in order for adult neurogenesis to occur functionally. It is only through 
studying these processes  in  depth  may we be  able to  direct  the correct  desired  effect. 
Indeed,  I  have  demonstrated  not  only  the  proliferative  effect  of  NO  mechanisms  in 
mediating the effect of NPY, but also its antiproliferative effect, on neural precursor cells 
from the hippocampus. The Janus-faced role of NO in mediating both neuroproliferative or 
neuroinhibitory,  and  neurodegenerative  or  neuroprotective,  effects  serves  not  only  to 
illustrate  the  complexity  by  which  physiological  and  pathophysiological  processes  are 
regulated,  but  also  highlights  the  conflicting  factors  which  must  be  considered  when 
developing potential therapeutic treatments.     190 
 
6.9 3D hydrogel stem cell cultures 
Attempts were made to develop 3D cultures of hippocampal cells in a novel synthetic silica 
hydrogel in an effort to explore the response and interaction of cultures to NPY in an in 
vitro  environment  which  was  more  representative  of  in  vivo  conditions.  Studying  the 
proliferative response of neural precursor cells to external factors in 3D hydrogel cultures 
will not only further expand our understanding of the processes controlling this effect, but 
forms a means by which neural stem/precursor cells may be transplanted into injured areas 
of the CNS and their proliferation or differentiation manipulated for therapeutic effect. 
Indeed, although Laponite hydrogels still require further optimisation for improving its 
biocompatibility, much interest on the use of hydrogels in 3D cultures has been on the 
cultivation of stem cells. Stem cells are promising candidates in regenerative medicine and 
tissue engineering due to their potential to differentiate into a variety of specialised cell 
types to replace existing tissues (Shihabuddin et al., 1999). In order to fulfil this potential, 
however, there must be more efficient ways of handling, manipulating and controlling the 
differentiation of these stem cells in vitro, and most importantly, in vivo (i.e. inside the 
stem cell recipient). In this aspect, hydrogels are superior candidates for much the same 
reasons that they make ideal 3D matrices for cell culture. In fact, hydrogels may even help 
stem cells to renew and differentiate by mimicking the natural ECM.  
 
      Li et al. (2006) demonstrated the short-term self-renewal of human embryonic stem 
cells  (hESCs)  in  a  completely  synthetic  hydrogel  ECM  composed  of  a  semi-
interpenetrating polymer network. In this polymer hydrogel, cell adhesion ligand density 
and  matrix  stiffness  was  independently  manipulated.  hESCs  adhered  to  the  hydrogel 
surface, retained viability and morphological aspects and expressed markers representative 
of undifferentiated hESCs in the short term (Li et al., 2006). The large scale expansion of 
undifferentiated hESCs is a challenge and major drawback for the use of stem cells in 
regenerative  medicine.  The  advantages  of  growing  hESCs  on  artificial  extracellular 
matrices, in comparison to more conventional cell-based feeder systems for the large scale 
expansion of undifferentiated stem cells, is the ease of scale up and reduced pathogen 
transmission  risk  (Li  et  al.,  2006).  Similarly,  bioactive  hydrogel  scaffolds  have  been 
created to control the vascular differentiation of hESCs. Ferreira et al. (2007) developed a 
new methodology for enhancing the differentiation of hESCs into the vascular lineage via 
encapsulation in a bioactive dextran-based hydrogel matrix with either insoluble (Arg-Gly-
Asp  sequences)  or  soluble  factors  (vascular  endothelial  growth  factor)  for  promoting 191 
 
vascular  differentiation.  After  10  days,  fluorescence  activated  cell  sorting  (FACS)  and 
techniques  in  immunostaining  were  used  to  determine  the  percentage  expression  of 
vascular  markers  such  as  KDR/flk-1  (VEGF  receptor).  These  dextran-based  hydrogels 
were shown to support hESC differentiation, with a 22-fold increase in VEGF receptor 
KDR/flk-1  expression  compared  to  spontaneously  differentiated  embryoid  bodies  (cell 
culture  used  for  assessing  stem  cell  differentiation  potential)  (Ferreira  et  al.,  2007). 
Through  the  use  of  different  3D  hydrogel  matrices  incorporating  specific  bioactive 
molecules, a primitive control of stem cell differentiation may be achieved (Nisbet et al., 
2008).  
 
      As  well  as  hESCs,  neural  stem  cells  (NSCs)  have  also  been  incorporated  into  3D 
hydrogel matrices. Watanabe et al. (2007) established a 3D culture of NSCs in a collagen 
type-1  gel.  The  focus  of  their  study  was  to  produce  a  hydrogel  scaffold  for  the 
transplantation  of  NSCs  into  injured  spinal  cord  to  promote  functional  recovery.  This 
required a scaffold which was biocompatible, entrap NSCs within a cavity and act as a 
support for neurite extension. NSCs derived from embryonic rat striatum were grown in a 
3D collagen hydrogel and subjected to a viability and migration assay to determine the 
optimal  cell  density  and  collagen  concentration.  The  viability  rate  increased  with  an 
increase in NSC density and a decrease in collagen concentration. Under these optimal 3D 
collagen  hydrogel  conditions,  the NSCs  differentiated into neurons (40.1%), astrocytes 
(53.1%) and oligodendrocytes (5.3%) (Watanabe et al., 2007). Similarly, in a different 
strategy to develop a hydrogel scaffold for the repair of spinal cord injury by Nisbet et al. 
(2009), mouse NSCs and primary cortical neurons were cultured in a 3D thermoresponsive 
xyloglucan hydrogel which was optimised to provide similar mechanical characteristics to 
spinal  cord  and  functionalised  through  immobilising  poly-D-lysine  to  promote  neural 
adhesion and neurite outgrowth. As well as supporting neuronal growth and differentiation, 
this  functionalisation  enabled  the  cell  diameter,  migration,  neurite  density  and  growth 
direction to be manipulated (Nisbet et al., 2009). Leipzig et al. (2011) also directed the 
neuronal  differentiation  of  adult  mouse  NSCs  encapsulated  in  a  3D  methacrylamide 
chitosan  hydrogel  through  the  immobilisation  of  proliferative  factors  (pro-neural  rat 
interferon-γ). As well as conventional methods such as cell entrapment, a novel method for 
controlling NSC differentiation by Ilkhanizadeh et al. (2007) involved using  the inkjet 
printing of macromolecules on hydrogels to steer NSC differentiation. Biologically active 
molecules  fibroblast  growth  factor-2  (FGF2),  fetal  bovine  serum  (FBS)  and  ciliary 192 
 
neurotrophic factor (CNTF) were printed onto polyacrylamide-based hydrogels using an 
inkjet printer and seeded with primary fetal NSCs. While NSCs seeded onto FGF2 printed 
hydrogel  remained  undifferentiated,  NSCs  on  FBS  and  CNTF  printed  areas  displayed 
markers for smooth muscle or astrocytic differentiation, respectively. These results were 
coherent with the known effects of FGF2, CNTF and FBS on NSCs (Ilkhanizadeh et al., 
2007). The use of hydrogels  as 3D scaffolds for stem cells lie not only in its clinical 
applications but also as tools for studying the mechanisms underlying stem cell renewal 
and differentiation.  
6.10 Conclusion 
The  ubiquitous  neuropeptide,  NPY,  exerts  a  neuroproliferative  effect  on  postnatal  rat 
hippocampal cultures which was most likely mediated via intracellular NO production and 
signalled  via  a  nNOS-cGMP-PKG  and  ERK  1/2  signalling  pathway.  The  bifunctional 
nature  of  NO  was  demonstrated  by  its  conflicting  effects  on  neural  precursor  cell 
proliferation. While the literature on the effects of NO signalling on adult neurogenesis in 
vivo is complex and conflicting, the NPY Y1 receptor has been identified as a key target to 
selectively  promote  NO-mediated  neural  stem/precursor  cell  proliferation  as  a  possible 
therapeutic intervention for promoting hippocampal neurogenesis. Notably, this study has 


























































































Figure A.1The NO donor, DETA/NONOate (NOC18) had no effect on cell death in hippocampal 
cultures. Hippocampal cells were cultured under control conditions (NBA-A/B27/glutamine) or 50, 
100  or  200  µM  DETA/NONOate  for  3  DIV  before  cell  death  was  assessed  by  PI  and  DAPI 
staining. The (A) total cell counts and (B) percentage of dead/dying cells were unchanged in the 
presence of DETA/NONOate, regardless of the concentration. Data represent mean ± SEM based 
on a sample that represents at least 7 wells per condition from two different experiments. One-way 
ANOVA with Dunnett’s multiple comparison test, compared to control condition. *p < 0.05. None 
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Appendix B - Laponite: A synthetic silica hydrogel 
B.1 Introduction 
The  rheological  and  handling  properties  of  Laponite,  a  thixotropic  hydrogel,  was 
investigated in order to determine, and optimise, its potential as a 3D cell culture matrix.  
B.1.1 Hydrogels 
Hydrogels  were  one  of  the  first  biomaterials  developed  for  use  in  the  human  body 
(Kopecek,  2007).  Hydroxyethyl  methacrylate  (HEMA),  a  hydrogel  first  described  by 
Wichterle  and  Lim  (1960),  was  later  used  for  constructing  contact  lenses.  A  range  of 
natural, synthetic and semi-synthetic hydrogels have been explored for use as the scaffold 
material in 3D cultures. The vast range of available hydrogels and their extensive physical 
properties  are  promising  for  creating  highly  adapted  3D  cell  cultures  for  an  array  of 
applications. 
B.1.2 Types of hydrogel 
Hydrogels fall into three main classes depending on the nature of the polymer used for 
synthesis:  synthetic,  natural  or  semi-synthetic  combination  hydrogels  (Hoffman,  2002; 
Drury & Mooney, 2003). A select few from each class is listed in table B.1.1.  
 
Table B.1.1 Polymers used to synthesise hydrogels (Drury & Mooney, 2003; Lee & Mooney, 
2001). 
Natural polymers and derivatives: 
-  Anionic polymers: alginic acid, pectin, chondroitin sulphate. 
-  Cationic polymers: chitosan, polylysine 
-  Amphipathic polymers: collagen, fibrin 
-  Neutral polymers: dextran, agarose 
Synthetic polymers: 
-  Polyesters: PEG-PLA-PEG, PLA-PEG-PLA (PEG: poly(ethylene glycol), 
PLA: poly(lactic acid)), PEO (poly(ethylene oxide) 
-  Other polymers: PEG-bis-(PLA-acrylate), P(biscarboxy-phenoxy-
phosphazene) 
-  Silica hydrogels: Laponite RD 
Synthetic and natural combination polymers: 
-  P(PEG-co-peptides), collagen-acrylate, alginate-acrylate 
 
      Depending on the nature of the hydrogel network, hydrogels can be further classified 
into  two  groups,  physical/reversible  hydrogels  and  chemical/permanent  hydrogels. 
Physical or reversible hydrogel networks are held together by molecular entanglements 200 
 
and/or secondary forces such as H-bonding, ionic or hydrophobic forces (Hoffman, 2002). 
These  hydrogels  are  not  chemically  stable  and  transient  network  defects  can  occur  in 
response to changes in temperature, pH, ionic strength, shear stress or specific solutes, 
lending to their reversible nature. Depending on the specific hydrogel, response to different 
factors may lead to network disruption and hydrogel breakdown, or network formation and 
hydrogel formation. One such physical hydrogel is calcium alginate, where a multivalent 
ion of opposite charge is combined with a polyelectrolyte for hydrogel formation (Kikuchi 
et al., 1997). Conversely, chemical or permanent hydrogels contain covalently-crosslinked 
polymer networks which are much stronger and resilient to breakage (Hoffman, 2002). 
These  hydrogels  reach  an  equilibrium  swelling  level  in  aqueous  solution  which  is 
determined by the crosslink density. Hyaluronic acid is a chemical hydrogel formed by 
crosslinking hyaluronic acid with any of a variety of hydrazide derivatives such as adipic 
dihydrazide (ADH) (Lee & Mooney, 2001; Prestwich, 1998).  
B.1.3 Methods for synthesising hydrogels 
There are many varieties of hydrogel, and as such, are synthesised via a range of methods. 
With regards to physical gels, changes in physical factors such as temperature or pH can 
lead  to  hydrogel  formation.  PEO-PPO-PEO  (PEO:  poly(ethylene  oxide),  PPO: 
poly(propylene  oxide))  triblock  copolymers  form  hydrogels  through  an  increase  in 
temperature (Fusco et al., 2006), while on the contrary, agarose gels require cooling for gel 
formation (Thompson et al., 1985). Meanwhile, PEO and PAAc (polyacrylic acid) form H-
bonded gels in aqueous solution after a reduction in pH (Nho et al., 2004). In contrast, 
chemical gels require cross-linking of polymers. These polymers can be cross-linked in the 
solid state or in solution with chemical crosslinkers, multi-functional reactive compounds 
or  radiation.  Monomers  can  also  be  copolymerised  with  chemical  crosslinkers  or 
multifunctional macromers (Drury & Mooney 2003; Lee & Mooney, 2001).  
B.1.4 Hydrogel applications 
Hydrogels are promising materials currently used in a range of biomedical applications due 
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Figure B.1.1 Current and potential applications of hydrogels (adapted from Kopecek, 2007). 
 
      3D hydrogel matrices which are highly hydrated and provide cells with a place for 
adherence, proliferation and differentiation are highly appealing, especially as scaffolds for 
cell delivery or the possibility of creating transplantable ‘bioartificial’ organs or tissues 
(Khademhosseini & Langer, 2007). When considering the use of either synthetic or natural 
hydrogels, however, both classes have their merits and drawbacks. Synthetic hydrogels 
have more controllable and reproducible properties than natural hydrogels, but may be less 
biologically compatible. For example, PLG (poly(lactide-co-glycolide)), a Food and Drug 
Administration  (FDA)  approved  scaffold  material,  is  mechanically  strong  and 
hydrolytically degradable, but the hydrophobic nature and synthesis methods makes it hard 
to produce matrices containing viable cells (Gunatillake & Adhikari, 2003). On the other 
hand, natural hydrogels are usually favoured over their synthetic counterparts because of 
their biocompatibility. Natural hydrogels are often composed of molecules derived from 
and/or  have  macromolecular  properties  which  are  similar  to  the  natural  ECM  and  so 
usually interact more favourably in vivo than synthetic hydrogels. For instance, collagen, 
an abundant structural protein in the mammalian ECM (Alberts et al., 2002), is one of the 
most  widely  used  hydrogels  for  3D  matrices.  Naturally  existing  metalloproteases 
(especially collagenase) and serine proteases degrade collagen, allowing for local control 
of degradation by cells in the engineered tissue (Drury & Mooney, 2003).  202 
 
B.1.5 Laponite 
Laponite, or hydrous sodium magnesium silicate, is a colloidal synthetic layered silicate 
(Avery  &  Ramsey,  1986)  often  used  as  a  speciality  additive  which  improves  the 
performance  of  a  wide  range  of  industrial  and  household  products  through  controlling 
viscosity and flow properties (Cummins, 2007; Rockwood Clay Additives Ltd.). While 
Laponite dispersions are capable of forming gels which can suspend solid particles, it is 
also  sensitive  to  shear  stress.  It  is  a  thixotropic  physical  hydrogel  which  changes  its 
rheological properties in response to shear stress, exhibiting high viscosity at low shear 
rates,  low  viscosity  at  high  shear  rates  and  progressive  restructuring  after  shear 
(Willenbacher, 1996; Martin et al., 2002). This thixotropic behaviour underlies the many 
applications of Laponite. 
 
      The dispersed primary particle of Laponite is a disk-like clay particle with a thickness 
of 0.92 nm and diameter of 25 nm (Fig. B.1.2) (Avery & Ramsey, 1986; Thompson & 
Butterworth, 1992). The particle disk is ionised in aqueous solution with the disk face 
possessing a negative charge, typically of about 50-55 mmol.100g-1, while the disk rim 
may  be  negatively  or  positively  charged  depending  on  pH,  but  is  typically  positively 
charged due to the absorption of hydroxyl groups (Kroon et al., 1998; Mongondry et al., 








Figure B.1.2 Laponite addition to water. Laponite powder added to aqueous solution initially form 
aggregated particle stacks, followed by dispersal into individual stacks. The sodium ions between 
each Laponite layer are hydrated by water, which results in a swelling of the stack structure and 
separation into primary particle disks (redrawn from Rockwood Clay Additives Ltd.).  
 
      When dispersed, a narrow band of solubilised sodium ions are held between Laponite 
disks. Through electrostatic interactions, the solubilised sodium ions are drawn towards the 
Laponite crystal surface; while on the other hand, osmotic pressure from the surrounding 
aqueous solution pulls the sodium ions away. This forms an equilibrium where sodium 
ions are retained in a diffuse region on both sides of the Laponite particle disks, known as 
electrical double layers (Tawari et al., 2001) (Fig. B.1.3). Thus, when two Laponite particle 
disks  approach,  they  repel  each  other  due  to  mutual  positive  charge  resulting  in  low 







Figure  B.1.3  Dispersed  Laponite  primary  particle  disk.  The  electrostatic  attraction  from  the 
negative charge on the surface of the Laponite platelet forms an equilibrium with the osmotic 
pressure drawing the sodium ion away from the platelet, forming a diffuse region where sodium 
ions are held (redrawn from Rockwood Clay Additives Ltd.).  
 
      If  polar  compounds  (such  as  salts  and  surfactants)  are  added  during  Laponite 
dispersion, the osmotic pressure drawing the sodium ions away from the particle surface is 
reduced, which in turn causes a reduction in the electrical double layer. Weaker positive 
charges localised on the Laponite crystal edges can then interact with the negative surface 
of adjacent Laponite crystals. These interactions between Laponite crystals can result in 
the formation of a connected hydrogel network (Mongondry et al., 2005; Mourchid et al., 
1995a; Nicolai & Cocard, 2001). 
B.1.6 Laponite Phase diagram 
The phase diagram first proposed by Mourchid et al. in 1995 illustrates the transition of 
Laponite  dispersions  from  a  sol  to  gel  phase  as  a  function  of  the  salt  and  Laponite 
concentration (Fig. B.1.4) (Mourchid et al., 1995a; Mourchid et al., 1995b; Mourchid et al., 
1998).  205 
 
 
Figure B.1.4 State diagram of Laponite dispersions. The x-axis represents the solid fraction or 
concentration of Laponite (g/L) while the y-axis represents the salt concentration (mM). The sol to 
gel transition line in the middle divides the two states of Laponite dispersions. Flocculation of 
Laponite dispersions occur at high salt concentrations (Cs > 20 mM) (redrawn from Mongondry et 
al., 2005).  
 
      If Laponite dispersions showed a measurable storage shear modulus or viscoelastic 
solid-like  behaviour,  the  dispersions  are  considered  in  gel  state.  Gel-like  behaviour 
develops slowly and is time-dependent (Mongondry et al., 2005). The time it takes for 
Laponite  dispersions  to  reach  gel-like  behaviour  increases  strongly  with  decreasing 
Laponite  and  salt  concentration.  An  increase  in  salt  concentration  (ionic  strength), 
however, shifts the transition and allows for lower Laponite concentrations to reach a gel-
like state (Mourchid et  al., 1995a). Gel fragility increases  with a decrease in  Laponite 
concentration and increase in ionic strength (Nicolai & Cocard, 2001). The mechanisms 
dictating the transition from sol to gel are not fully understood. 
B.1.7 Laponite hydrogel formation – The attractive and repulsive theories 
Two  opposing  theories  exist  for  the  mechanism  of  Laponite  hydrogel  formation,  the 
attractive  theory  and  repulsive  theory.  The  attractive  theory  suggests  that  attractive 
interactions  between  Laponite  particles  result  in  aggregation  and  the  formation  of  a 
connected network or ‘house of cards’ structure (Fig. B.1.5) (van Olphen, 1962). In the 
‘house of cards’ theory, attractive interactions between the negatively charged face and 
positively  charged  rim  of  Laponite  particles  result  in  a  gathering  of  particles  in 206 
 
microdomains  which  associate  to  form  large  fractal  superaggregated  structures  held 
together  by  weak  electrostatic  forces  and  weak  van  der  Waals  attractions.  When  the 
connection network is macroscopic, a gel state is obtained (Martin et al., 2002). A gel state 
is  a  colloidal  system  described  as  a  porous  network  of  interconnected  nanoparticles 
spanning a liquid medium. Instead of a homogenous distribution of particles, hydrogels 
usually contain areas of high density dispersed within a low density hydrogel network 
(Ramsay & Lindner, 1993; Willenbacher, 1996).  
 
 
Figure B.1.5 House of cards structure. Individual Laponite particles interact through the negatively 
charged faces and positively charged edges to form a macroscopic gel network (redrawn from 
Rockwood Clay Additives Ltd.).  
 
      Several aspects of the rheology of Laponite support the attractive gel formation theory. 
As  the  bonds  holding  the  structure  together  are  ionic,  temperature  does  not  affect  the 
viscosity of the hydrogel, instead, the ‘house of cards’ structure is easily disrupted under 
application of shear stress which breaks the weak ionic and van der Waal interactions, 
lending to the hydrogel's reversible characteristics (Mourchid et al., 1995a). In addition, 
restructuring after stress requires time as the particles must reorientate and interact with 
other particles (Ramsay & Lindner, 1993). Dynamic light scattering studies on Laponite 
particle  aggregation  have  shown  an  increase  in  aggregation  rates  with  increasing 
electrolyte concentration due to the screening of electrostatic repulsion between particles 
and a decrease in  the energy barrier (Mongondry et  al.,  2005). On the other hand, an 
increase in pH, which favours deprotonation and reduces the positive charge of the disk 
rim, causes an overall decrease in particle aggregation (Tawari et al., 2001). In a separate 
study using time- and ensemble-averaged light scattering, gel formation was shown to be 207 
 
preceded by aggregation (Nicolai & Cocard, 2000). Laponite particles were shown to form 
fractal  clusters  through  aggregation  which  grow  in  size  until  they  sediment  at  low 
concentrations (since they are too weak to resist gravity) or fill up the space and form a gel 
with increasing viscosity at higher concentrations through the growth of aggregates until 
the network spans the whole volume (Nicolai & Cocard, 2000). This slow aggregation 
process is induced by electrostatic repulsion screening. Although concentration and ionic 
strength do not determine aggregate structure, the aggregation rate increases significantly 
with  increasing  ionic  strength  due  to  a  reduction  in  electrostatic  repulsion  (Nicolai  & 
Cocard,  2000).  Dynamic  light  scattering  studies  on  large  aggregates  show  that  these 
aggregates are not rigid. The angle between the positive edge of one particle and negative 
face of another, which may be close to 90°, fluctuates (Mongondry et al., 2005).  
 
      Other  studies  have  shown  that  the  attractive  interactions  can  be  weakened  by  the 
addition of peptisers (salts) which bind to the positively charged disk rim and obstruct their 
interaction with the negatively charged disk face. When peptisers (such as tetrasodium 
diphosphate) are present, the Laponite network forms slowly and restructuring after shear 
is much delayed with an extended fluid state (Martin et al., 2002). The presence of these 
positive  charges  on  the  edge  of  Laponite  disks  seem  to  be  necessary  for  inducing 
aggregation and gelation (Mongondry et al., 2005). By delicately manipulating the balance 
between repulsive and attractive interactions, the behaviour of Laponite dispersions can be 
controlled,  which  form  the  basis  for  diverse  formulations  of  Laponite  with  unique 
properties. The theory of attractive interaction, aggregation and the formation of a ‘house 
of cards’ structure is favoured by biomaterial scientists. 
 
      In contrast to the attractive theory, the repulsive or glass formation theory suggests that 
interparticle repulsive interactions lead to a glassy state (a disordered solid phase) instead 
of a gel state (presence of an ordered network) and aggregation does not occur except at 
high ionic strength (salt concentration > 10mM) (Kroon et al., 1998; Bonn et al., 1999). In 
this case, the lack of free volume means that each particle is unable to move because every 
location  surrounding  it  is  already  occupied.  These  long-range  electrostatic  repulsions 
between double layers were originally suggested by Norrish (1954). During light and x-ray 
scattering  studies,  even  though  the  reorientation  of  charged  Laponite  particles  were 
observed during gelation, the formation of hydrogel did not occur via aggregation to form 
larger clusters (Kroon et al., 1998). Static light scattering and rheometric studies also show 208 
 
no evidence of an organisation of colloidal particles with increased viscosity (Bonn et al., 
1995).  Gel-like  behaviour,  however,  occurs  even  at  low  Laponite  concentrations  and 
occurs more rapidly when salt is added, which contradicts the presence of strong repulsive 
interactions supported by the glass formation theory (Levitz et al., 2000).  
 
      Both mechanisms may have equally important roles in Laponite gelation, depending on 
factors  such  as  ionic  strength  and  Laponite  concentration.  At  low  ionic  strengths  the 
electrostatic  interactions  are  long-range  type,  possibly  interparticle  repulsions,  while  at 
moderate ionic strengths the electrostatic interactions are short range, typical of attractive 
interactions.  Particles  tend  to  aggregate  spontaneously  under  these  circumstances  and 
possibly form microdomains which may become interconnected (Nicolai & Cocard, 2001). 
Concentrated  dispersions  would  form  hydrogels  relatively  quickly  or  successfully 
compared to less concentrated dispersions (Martin et al., 2002). On the whole, the precise 
mechanism of Laponite solid phase formation and network structure is still undefined and 
many studies are continually conducted into the two theories. One possible reason for this 
may be due to the sensitivity of Laponite to sample preparation procedures, which makes 
result comparison difficult between separate groups (Cummins, 2007).  
B.1.8 The aims of this chapter 
Laponite hydrogels were assessed in its ability to form distinct hydrogel layers and sectors, 
which  would  have  been  important  for  constructing  multilayered  or  multi-sectored  3D 
cultures, as well as optimisation for supporting cell growth by exploring its response to 











B.2.1 Methodology and experimental aim 
A variety of different Laponite formulations exist, some of which are listed in table B.2.1. 
The aim of this chapter was to explore the properties of the Laponite hydrogel, focusing 
initially on the conventional Laponite formulation, Laponite RD (rapid diffusion). After 
determination  of  a  suitable  working  concentration  of  Laponite  RD,  its  handling  and 
manipulation as a potential 3D cell culture material was explored before it was optimised 
for supporting cell survival. All investigations were carried out at room temperature (20-
25°C). 
 
Table B.2.1 Formulations of Laponite (from Southern Clay Products, inc., Rockwood Additives 
Ltd.) 
Laponite formulation  Description 
Laponite RD  
(rapid diffusion) 
Highly thixotropic hydrogels produced at 
concentrations of 2% or greater in water 
Laponite RDS  
(rapid diffusion sol) 
At 10% concentration in water, these will remain free 
flowing for 24 hours. On addition of small quantities of 
electrolyte, highly thixotropic hydrogels are formed 
rapidly. 
Laponite XLG   Low heavy metals content version of RD 
Laponite XLS  Low heavy metals content version of RDS 
Laponite JS  At 18% concentration in water, these will remain free 
flowing for at least 1 month. 
Laponite B  Highly thixotropic hydrogels produced at 
concentrations of 2% or greater in water 
 
B.2.2 Laponite RDS and Laponite XLS hydrogel formation - Non-sterile conditions 
The Laponite RDS/XLS powder (courtesy of Mr Patrick Jenness, Rockwood Additives 
Ltd.) was added to water or solution (i.e. NBA-A/B27/Glu medium) and quickly vortexed 
for at least 10 s to ensure thorough powder dispersion. Depending on the concentration 
(percentage weight/volume or % w/v) and type of Laponite (RD or XLG), setting times 
differed remarkably. The hydrogels were considered set if they remained undisturbed by 
physical inversion.  
 
      In accordance with the manufacturer’s instructions, a 2% dispersion of Laponite RD in 
water  was  the  minimum  concentration  required  to  produce  a  thixotropic  hydrogel.  A 
Laponite RD hydrogel concentration of 5% dispersion in water was used for handling and 210 
 
manipulation studies as the hydrogels produced set quickly and were less fragile than 2% 
Laponite dispersions.  
 
      Gel thixotrophy (in response to shear stress) was determined by passing the hydrogel 
through a syringe fitted with a 0.8 x 40 mm hypodermic needle and observing its response. 
In response to the high shear stress from enforcement through the needle, the viscosity of 
the gel is reduced and the gel flows. After removal of shear stress, the hydrogel slowly 
reforms and becomes more viscous over time, eventually returning to its original gelled 
state. 
B.2.3 Handling and Manipulation of Laponite hydrogels – Layering 
The layering of hydrogels ultimately provides a platform upon which a complex 3D cell 
culture system consisting of different niches could be created. Laponite RD preparations at 
5% concentration dispersion in water were pre-stained with one of a range of dyes for 
better  visualisation,  including  Phenolphthalein  (anionic)  (Sigma  Aldrich,  UK),  Litmus 
(Sigma  Aldrich,  UK),  Rhodamine  6G  (cationic)  (Sigma  Aldrich,  UK)  and  Eosin  Y 
(anionic) (Sigma Aldrich, UK) or not stained (clear). Prepared hydrogels were transferred 
via pipette to a cuvette where the gels were layered. The hydrogels were allowed to set 
completely  before  the  addition  of  another  layer  and  layered  gels  were  centrifuged  to 
determine whether the layers remained separated.  
B.2.4 Layering hydrogels in multiwell plates 
6-, 12- and 24-well multiwell plates are frequently used for conventional cell culture and 
would be a good foundation for the formation of multilayered 3D cultures. In order to form 
these multilayered complexes,  however,  Laponite  hydrogels  must first  be able  to  form 
distinct layers within these plates. A range of Laponite RD (% w/v) preparations were pre-
stained  with  one  of  a  range  of  dyes  (1-2  drops)  including  Phenolphthalein  (anionic), 
Litmus, Rhodamine 6G (cationic) and Eosin Y (anionic) or not stained (clear). Hydrogels 
were transferred via pipette to multiwell (6-well, 12-well and 24-well) plates where the 
hydrogels were layered. Thicknesses of the hydrogel were calculated using the formula: π 
x radius





      Attempts at layering hydrogels in multiwell plates, however, proved difficult because 
of the formation of a meniscus inside each well and the inability to obtain flat gel layers. 
Flat gel layers were important for generating a distinct multi-tiered 3D cell culture system. 
Attempts  at  obtaining  flat  hydrogels  and  to  reduce  meniscus  formation  included 
centrifugation, modifying the percentage Laponite RD, and the use of non surface-treated 
hydrophobic plates. 
B.2.4.1 Centrifugation to obtain flat hydrogel layers 
A range of concentrations of Laponite RD (% w/v) preparations were pre-stained with one 
of a range of dyes and transferred via pipette to multiwell (6-well, 12-well and 24-well) 
plates where the hydrogels were layered. The plates were then centrifuged (5177 Sorvall 
Legend RT Centrifuge) at 4600rpm (3760g) for 10 min with the aid of plate adaptors. 
B.2.4.2 Modifying the percentage of Laponite RD to obtain flat hydrogel layers 
The  Laponite  concentration  of  hydrogel  may  affect  meniscus  formation.  A  range  of 
concentrations of Laponite RD (1%, 2%, 3%, 4%, 5% and 6% w/v) preparations in water 
were pre-stained with Phenolphthalein, gels transferred via pipette to multiwell (6-well, 
12-well and 24-well) plates, and layers created to determine the effect of Laponite RD 
percentage (w/v) on the size of the meniscus.  
B.2.4.3 Non surface-treated hydrophobic (polystyrene) multiwell plates to reduce 
meniscus formation 
A range of concentrations of Laponite RD (% w/v) preparations were pre-stained with one 
of a range of dyes and transferred via pipette to non surface-treated hydrophobic multiwell 
(6-well and 24-well) plates where the hydrogels were layered. 
B.2.5 Hydrogel Injection  
The ability to form structures other than layers were investigated by injecting Laponite RD 
hydrogels into layered gels. 5% Laponite RD (w/v) dispersions in water were pre-stained 
with  Rhodamine  6G  or  not  stained  (clear).  Unset  stained  hydrogels  were  quickly 
transferred to 10 ml syringes and allowed to set, while clear gels were layered in 6-well 
plates.  Stained  Laponite  hydrogels  were  injected  into  set  and  semi-set  clear  Laponite 
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B.2.6 Hydrogel transfer  
3D  cultures  may  need  to  be  removed  from  multiwell  culture  plates  for  further 
investigations.  To  test  this  idea,  Polytetrafluoroethylene  (PTFE)  or  Teflon  membrane 
(Millipore, UK) was cut to size and layered on the bottom of petri-dishes and multiwell 
plates. 5% Laponite RD (w/v) dispersions in water were pre-stained with Rhodamine 6G or 
not stained (clear) and transferred to the PTFE-layered petri-dishes or multiwell plates. 
After setting, PTFE coated instruments (i.e. scalpel and tweezers) could be used to remove 
the hydrogel slabs from the plates and dishes.  
B.2.7 Laponite culture medium hydrogels 
In  order  to  optimise  Laponite  hydrogels  for  cell  growth,  culture  medium  must  be 
incorporated. The culture medium for hippocampal cells consists of Neurobasal A medium 
(Life Technologies, UK) supplemented with 2% B27 (Life Technologies, UK) and 0.5 mM 
Glutamine (Sigma Aldrich, UK).  
B.2.7.1 Laponite RD culture medium hydrogels 
In order to obtain a better idea of the hydrogel formation dynamics in culture medium, a 
range of Laponite RD dispersions (% w/v) were made up with varying concentrations of 
culture medium diluted in distilled water (table B.2.2) in glass vials (for gel visualisation). 
The vial lids were screwed on tightly to prevent gel desiccation and hydrogel formation 
was assessed.  
 
Table B.2.2 Laponite dispersions in varying concentrations of culture medium diluted in  
distilled water.  
Culture medium dilution 
(in distilled water) 
Laponite RD (w/v) 

















      The possibility of developing 100% (neat) culture medium Laponite RD hydrogels was 
explored to maximise the chances cell survival. Laponite RD at a range of concentrations 
(10%, 15%, 16%, 17%, 18%, 19%, 20%, 25%) was dispersed in neat culture medium to 
assess  hydrogel  formation.  Setting  times  were  recorded  and  thixotropic  properties 
investigated by passing through a syringe.  
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B.2.8 Laponite RDS, JS and B hydrogels 
Other formulations of Laponite, such as RDS (rapid diffusion sol), JS and B (courtesy of 
Mr  Patrick  Jenness,  Rockwood  Additives  Ltd.),  were  tested  for  hydrogel  formation  in 
distilled water and culture medium. The Laponite RDS/JS/B powder was added to water or 
medium (NBA-A/B27/Glu medium) at varying concentrations (% w/v) and vortexed for at 
least 10 s to ensure thorough powder dispersion.  
B.2.9 Laponite RDS culture medium hydrogels 
A  range  of  Laponite  RDS  concentrations  (2.5%,  5%,  10%,  15%  and  20%  w/v)  were 
dispersed in 100% culture medium and hydrogel formation assessed. Setting times were 
recorded and thixotropic properties investigated by passing through a syringe.   
B.2.9.1 Layering Laponite RDS culture medium hydrogels in multiwell plates 
16% Laponite RDS preparations in 100% culture medium were prepared and layered in 
non surface-treated 6- and 24-well multiwell plates to verify that handling properties were 





















B.3.1 Hydrogel setting time decreased with increased Laponite concentration 
In an inverse relationship, an increase in Laponite RD concentration (% w/v) was directly 
linked to a decrease in setting time. The setting time for Laponite dispersions at 2%, the 
minimum required for hydrogel formation, was around 2 h, however, Laponite dispersions 
above 5% all set within 10 min. The higher the percentage of Laponite the quicker the 
hydrogel set (Fig. B.3.1). This increase in Laponite concentration was also associated with 
an observed increase in hydrogel opacity (Fig. B.3.2).   
 
 
Figure B.3.1 An increase in Laponite RD concentration was directly linked to a decrease in setting 

















B.3.2 Thixotropic Laponite hydrogels 
Laponite hydrogels were passed through a syringe to determine its thixotropic properties in 
response  to  shear  stress.  While  low  concentrations  of  Laponite  (5%)  demonstrated  a 
thixotropic response, higher concentrations of Laponite (15%) were not thixotropic. The 
5% Laponite hydrogel had a low, almost fluid, viscosity when enforced through the needle, 
before  returning  to  its  gel  state  once  the  stress  was  removed  (Fig.  B.3.3A  and  B).  In 
contrast, the viscosity of the 15% Laponite hydrogel remained unchanged when exposed to 



















Figure  B.3.3  Laponite  hydrogels  were  passed  through  a  syringe  to  determine  its  thixotropic 
response to shear stress. 5% Laponite hydrogels exhibited a thixotropic response, as demonstrated 
by  (A)  a  decrease  in  viscosity  and  (B)  reformation  of  a  gel  state  over  time.  15%  Laponite 
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Figure  B.3.4  Laponite  hydrogels  layered  in 
plastic  cuvettes  stained  with  either 
phenolphthalein  (pink),  litmus  (purple)  or 
unstained.  
Figure  B.3.5  The  formation  of  flat 
Laponite  hydrogel  layers  were 
hindered by the presence of a meniscus 
(arrows). 
B.3.3 Laponite hydrogels could be manipulated by layering  
The ability to layer Laponite  hydrogels would permit the formation of complex multi-
layered  or  -sectored  3D  cultures.  To  determine  whether  Laponite  hydrogels  could  be 
layered  on  top  of  one  another,  alternating  layers  of  stained  and  non-stained  Laponite 
hydrogel  layers  were  created  in  clear  plastic  cuvettes  (Fig.  B.3.4).  It  was  possible  to 
manipulate the layer thicknesses (1 mm to 1 cm) by changing the volume of gel and the 
layers remained distinct from each other. 
 
 
B.3.4 Hydrogel layering in multiwell plates was hindered by meniscus formation 
As a vessel for creating 3D cultures, hydrogel layering was attempted in multiwell plates. 
Layer  formation,  however,  was  hindered  by  meniscus  formation  (1.9  -  2  mm  size 
meniscus) (Fig. B.3.5) and the inability to obtain flat gel layers, which were essential for 
creating multilayered 3D hydrogel culture constructs. Attempts to obtain flat gel layers and 
reduce  meniscus  formation  included  centrifugation,  modifying  the  percentage  Laponite 








B.3.4.1 Flat gel layers could be obtained by centrifugation but layers were slanted 
With the use of plate adaptors, plated Laponite hydrogels were centrifuged at 4600 rpm for 
10 min in an attempt to flatten the layers using centrifugal force. Although flat gel layers 217 
 
were achieved after centrifugation, layers were slanted at an angle and not horizontal, most 
likely due to the centrifugal force the hydrogel was exposed to (Fig. B.3.6).  
 
 
Figure B.3.6 Slanted phenolphthalein-stained Laponite hydrogels after centrifugation. Gels are flat 
but slanted at an angle (dotted lines) due to centrifugal force.  
 
      The angle of the hydrogels increased as they became further away from the centre of 






Figure B.3.7 The angle of the hydrogel layers (°) increased the further they were away from the 
centre of the plate. Wells 1 and 4 are situated on the outside of the plate, while wells 2 and 3 are in 
the centre.    
B.3.4.2 The meniscus decreased with an increase in Laponite concentration 
In a different approach to minimising the meniscus of hydrogel layers, a range of Laponite 
RD concentrations (1%, 2%, 3%, 4%, 5% and 6% w/v) were investigated for any potential 
effects on meniscus size. An increase in  Laponite concentration was associated with a 218 
 
visual  decrease  in  the  meniscus  height  (Fig.  B.3.8),  which  was  quantified  by  directly 
measuring the size of the meniscus. There was, on average, about a 0.2 mm reduction with 
every  1%  increase  in  Laponite  RD  concentration,  and  a  significant  decrease  in  the 
meniscus size was observed with higher Laponite concentrations (4-6%) when compared 
to 1% dispersions (One-way ANOVA with Dunnett's post-hoc test, p<0.05, F=80.78 and 
d.f.=17) (Fig. B.3.9).  
 
  
Figure B.3.8. 1% to 6% (w/v) Laponite RD concentration hydrogels layered in a multiwell 
plate. The meniscus was reduced with increasing Laponite concentration (arrow). 
 
 
Figure B.3.9 The meniscus height of hydrogel layers decreased with an increase in Laponite RD 
concentration. Data represent mean ± SEM based on a sample from three separate experiments. 
One-way  ANOVA  with  Dunnett’s  multiple  comparison  test,  compared  to  1%  Laponite  RD 
dispersion. *p < 0.05.   
B.3.4.3 Flat hydrogel layers could be achieved by layering in non surface-treated 
hydrophobic multiwell plates 
To overcome the formation of a meniscus, Laponite hydrogels were layered in non surface-
treated (polystyrene) multiwell plates. While tissue culture-treated multiwell plates (i.e. 
with a cell-attractive coating) are hydrophilic, thus attracting water, non surface-treated 
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multiwell plates are hydrophobic and repel water. In these hydrophobic plates Laponite 
hydrogel  meniscus  formation  was  significantly  reduced  (Fig.  B.3.10),  allowing  the 







Figure B.3.10 Flat Laponite hydrogel layers could be formed in hydrophobic multiwell plates. (A) 
Hydrogel layer in surface-treated (hydrophilic) well with prominent meniscus (arrow) and (B) 
hydrogel layer in non surface-treated (hydrophobic) well with minimal meniscus formation.     
 
      From a meniscus size of about 1.9-2.0 mm in surface-treated (hydrophilic) plates, the 
meniscus was reduced to below 0.5 mm in non surface-treated (hydrophobic) plates. After 
resolving the meniscus problem and being able to achieve flat gel layers, alternating layers 
of stained and non-stained Laponite hydrogel layers could be created in 6- and 24-well non 
surface-treated  hydrophobic  multiwell  plates  (Fig.  B.3.11).  A  range  of  hydrogel  layer 













Figure B.3.11 Laponite hydrogel layering in multiwell plates. (A) 2 mm thick Laponite hydrogel 
layers in a 6-well multiwell plate. (B) Hydrogels could be layered at an angle which occupies half a 
well. C) 1 mm thick Laponite hydrogel layers in a 24-well multiwell plate.  
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Figure  B.3.12  Laponite  injection.  (A) 
Gels  could  be  injected  as  capsules 
directly onto plates before covered with 
gel or (B) gels could be injected directly 
into  semi-set  gels.  (C)  Side  view  of 
injected  capsules.  (D)  Side  view  of 
stained gel layers with gel capsules on 
top and covered with clear gel.  
B.3.5 Laponite gels could be injected into semi-set Laponite hydrogels 
In order to create a multi-sectored 3D culture, other ways of handling Laponite hydrogels 
were explored. As Laponite hydrogels are thixotropic when exposed to shear stress, gels 
could easily be injected through a needle into other hydrogel preparations, but only when 
the  preparations  were  semi-set,  as  gel  injection  into  set  hydrogels  resulted  in  gel 
displacement and cracked surfaces. Injected Laponite hydrogel capsules retained their form 















B.3.6 Laponite hydrogels could be transferred out of plates 
In  case  3D  hydrogel  culture  removal  from  multiwell  plates  was  required  for  further 
investigations,  the  possibility  of  transferring  whole  gel  constructs  out  of  wells  was 
explored. Hydrogels could be successfully transferred out of multiwell plates and petri-
dishes if the bottom of the wells/dishes were pre-layered with PTFE/Teflon membranes 
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Figure  B.3.13  Clear  Laponite  hydrogel  block 
transferred out of a petri-dish and inverted.   
 





B.3.6 Laponite RD-based culture medium hydrogels are not suitable for use as cell 
culture matrices 
As Laponite hydrogels will ultimately be used for the culture of hippocampal cells in vitro, 
culture medium-based hydrogels needed to be developed. The gel formation dynamics in 
culture medium were first investigated. Laponite RD was added at different concentrations 
(% w/v) to varying dilutions of culture medium. On addition, Laponite RD either dispersed 
and formed a hydrogel, or flocculated (solute comes out of solution and aggregates) to 
varying degrees to form a pellet at the bottom of the vial. The presence of culture medium 
directed this flocculation effect as the higher the ratio of culture medium to water, the more 
likely  Laponite  was  to  flocculate  (Fig.  B.3.14).  The  flocculated  pellet  also  became 
progressively more compact with an increase in the amount of culture medium. 
 
 
Figure  B.3.14  Laponite  flocculation  increased  with  increasing  culture  medium  concentration. 
Laponite (5% w/v) was added to a range of culture medium dilutions (25%, 30%, 40%, 50% and 
75% culture medium diluted in water, to 100% culture medium neat, noted on vial caps). There 
was partial gel formation in 25% culture medium, but as the concentration of culture medium 
increased, gel flocculation became more pronounced (pellet).    
 
      Flocculation at higher culture medium concentrations could be overcome, to a certain 
extent, by further increasing the concentration of Laponite (Fig. B.3.15). 
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Figure  B.3.15  Larger  amounts  of  Laponite  RD  were  required  for  hydrogel  formation  as  the 
concentration of the culture medium increased. Laponite RD dispersions in culture media resulted 
in either hydrogel formation (  ) or flocculation. The black line represents the boundary between 
hydrogel formation and flocculation.     
 
      After exploring the gel formation dynamics, the formation of culture medium-based 
Laponite  hydrogels  were  investigated.  As  a  means  to  maximise  the  chances  of  cell 
survival, hydrogels were developed by dispersing Laponite RD in 100% culture medium. 
The  aim  was  create  a  thixotropic  Laponite  hydrogel  using  the  lowest  possible 
concentration  of  Laponite  dispersed  in  100%  culture  medium.  From  the  gel  formation 
dynamics graph above (Fig. B.3.15), a Laponite concentration of around 18% would be 
sufficient for hydrogel formation in 100% culture medium, which was explored along with 
a range of other Laponite concentrations. Indeed, 18% Laponite RD was the minimum 
concentration  required  for  hydrogel  formation  in  100%  culture  medium.  These  18% 
Laponite  RD  dispersions  typically  set  in  5  minutes,  while  significant  flocculation  was 
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Figure B.3.16 Laponite RD hydrogel formation in 100% culture medium. A range of Laponite RD 
concentrations (2.5%, 5%, 10%, 15%, 18% and 20%, noted on vial caps) were dispersed in 100% 
culture  medium.  18%  Laponite  RD  was  the  minimum  concentration  required  for  hydrogel 
formation. Any Laponite concentrations below 18% resulted in gel flocculation. 
 
      The 18% Laponite RD culture medium hydrogels, however, had a gritty texture and 
were not thixotropic (Fig. B.3.17), most likely due to the high concentrations of Laponite 
required  for  hydrogel  formation  in  100%  culture  medium.  The  18%  Laponite  RD 











Figure B.3.17 18% Laponite RD culture medium hydrogels were not thixotropic in response to 
application  of  shear  stress.  (A)  18%  Laponite  RD  culture  medium  hydrogels  did  not  exhibit 
decreased  viscosity  in  response  to  shear  stress  application  and  (B)  hydrogels  were  of  a  gritty 
texture.  
 
      The properties of 18% Laponite RD culture medium hydrogels were not desirable for 
creating 3D cultures and so other Laponite formulations were explored. 
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B.3.7 Laponite RDS, JS and B hydrogels 
Other  Laponite  formulations  were  explored  for  their  potential  in  forming  thixotropic 
hydrogels in 100% culture medium. Their properties were first confirmed by dispersion in 
water  before  adding  to  culture  medium.  Laponite  RDS,  JS  and  B  formulations  were 
dispersed at 5% concentration in distilled water. As expected, Laponite RDS and JS did not 
form hydrogels and remained as sols (stable dispersion of solid in liquid), while Laponite 
B formed hydrogels. On addition to 100% culture medium, however, 15% Laponite RDS 
formed clear hydrogels while Laponite JS and B flocculated from solution. These results 
support Laponite RDS as a potential alternative to Laponite RD in the development of 
culture medium-based hydrogels for 3D cultures.  
B.3.8 Laponite RDS-based culture medium hydrogels have greater potential as 3D 
cell culture matrices 
The lowest Laponite RDS concentration (% w/v) required for forming culture medium-
based  Laponite  RDS  hydrogels  was  investigated  by  dispersing  varying  concentrations 
(2.5%, 5%, 10%, 15% and 20%) of Laponite RDS in 100% culture medium and assessing 
gel formation. While Laponite RDS concentrations below 15% flocculated from solution 
and did not gel, concentrations above 15% formed clear hydrogels. 16%, instead of 15%, 
Laponite RDS was determined as the minimum concentration required for 100% hydrogel 
formation as, on closer inspection, 15% dispersions had a thin layer of culture medium on 
top and were not 100% set (Fig. B.3.18). 16% Laponite RDS dispersions set within 5 
minutes of preparation and setting times decreased as the concentration of Laponite RDS 
increased. 20% dispersions, for example, set within a minute of preparation.  
 
 
Figure  B.3.18  Laponite  RDS  dispersions  in  100%  culture  medium.  A  range  of  Laponite  RD 
concentrations (2.5%, 5%, 10%, 15%, 16% and 20%, noted on vial caps) were dispersed in 100% 
culture medium. 16% Laponite RDS was the minimum concentration required for 100% hydrogel 
formation. Any Laponite concentrations below 16% resulted in either flocculation or incomplete 
hydrogel formation. 
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      16%  Laponite  RDS  produced  clear,  thixotropic  culture  medium  hydrogels  which 
exhibited low viscosity in response to shear stress (from passing through a 0.8 mm needle) 
(Fig. B.3.19A) and progressive restructuring after shear (Fig. B.3.19B). Similarly, 16% 
Laponite XLS, the low heavy metal content formulation of RDS, was also able to produce 
thixotropic  culture  medium  hydrogels  (Fig.  B.3.19C).  16%  Laponite  RDS/XLS  culture 
medium hydrogels are viscous enough to be able to hold their shape and support any cells 


















Figure B.3.19 16% Laponite RDS/XLS culture medium hydrogels. (A) 16% Laponite RDS culture 
medium hydrogels were thixotropic when passed through a needle, exhibiting decreased viscosity 
on application of shear stress and (B) reformation of a gel of high viscosity once the shear stress 
was removed. (C) 16% Laponite RDS and XLS culture medium hydrogels are the same except for 
the low heavy metal content of XLS. (D) 16% Laponite RDS culture medium hydrogel in a 6-well 
plate. 
B.3.9 Laponite RDS culture medium hydrogels can be layered in multiwell plates 
The  handling  properties  of  16%  Laponite  RDS  culture  medium  hydrogels  were 
investigated by layering in multiwell plates. Hydrogels formed flat layers which remained 
intact when covered with culture medium to prevent gel desiccation (Fig. B.3.20). 
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Figure B.3.20 16% Laponite RDS culture medium hydrogels layered in multiwell plates remained 































Much current emphasis in research on novel 3D culture matrices is focused primarily on a 
select few hydrogels, such as the natural collagen and fibrin hydrogels and the synthetic 
poly(ethylene glycol) and poly(propylene glycol) block copolymers (Drury & Mooney, 
2003).  Laponite  has  not  been  previously  described  as  a  cell  culture  matrix  but  it's 
intriguing rheological properties, such as thixotrophy (Martin et al., 2002), allow for the 
creation of complex multilayered 3D constructs. The key finding of this work has been the 
development of thixotropic culture medium-based Laponite hydrogels.  
B.4.1 Multilayered 3D hydrogel complexes can be created with Laponite  
In an effort to mimic the complex 3D structural organisation of cells in the ECM in in vitro 
cultures, hydrogels prove superior to other biomaterials because their properties are very 
similar to the natural ECM (Tibbitt & Anseth, 2009). The aqueous environment allows for 
the efficient diffusion of molecules, while the ability to withstand compressive forces is 
representative of the mechanical aspects of the ECM. In fact, due to the vast range of 
hydrogels  currently  available,  many  aspects  of  the  natural  ECM,  whether  it  is  the 
structural, mechanical or molecular recognition properties, can be imitated in some form or 
another to varying degrees of success (Hubbell, 2003). It is these adaptable characteristics 
of  hydrogels  which  allow  for  the  creation  of  a  variety  of  specialised  3D  cultures.  In 
particular, the thixotropic characteristic of Laponite hydrogels allow for the construction of 
complex multilayered hydrogel matrices which are highly advantageous in 3D cultures. 
 
      Initial attempts at creating multilayered Laponite hydrogel complexes was hindered by 
the formation of a meniscus, which obstructed the formation of flat hydrogel layers. The 
solution  to  this  problem was  the use of non surface-treated polystyrene culture plates. 
Conventional polystyrene culture plates treated for tissue culture use have a hydrophilic 
well coating  for promoting cell adhesion; however, the  Laponite hydrogels  themselves 
were also hydrophilic in nature. This presentation of hydrophilic forces led to an attraction 
between the well surface and the hydrogel, leading to the formation of a meniscus. On the 
other  hand,  non  surface-treated  polystyrene  plates  have  a  well  surface  which  is 
hydrophobic  in  nature.  The  hydrophilic  Laponite  hydrogel  was  not  attracted  to  the 
hydrophobic well surface, allowing the formation of a flat hydrogel layer. Subsequently, 
multilayered Laponite hydrogels consisting of distinct multiple layers (1-2mm thick) could 
be constructed. Once the first gel layer was set, additional layers could be easily transferred 228 
 
on top, with the new layer of hydrogel binding to the previous layer (Fig. B.3.11). As well 
as multilayering, Laponite hydrogel injection could be utilised to create distinct zones of 
hydrogel of any shape or volume during structural design (Fig. B.3.12). 
 
      The clear advantage of being able to construct multilayered/sectored hydrogel matrices 
lies  within  the  possibility  of  varying  the  composition  of  each  layer.  By  incorporating 
varying  cell  types  (co-cultures)  and/or  pharmacological  reagents  i.e.  growth  factors  or 
drugs,  specific  cell  interactions  and  pharmacological  responses  could  be  easily 
investigated. The presence of a boundary between layers/zones allows for investigations 
into the effect of environmental changes on cell response (Liebmann et al., 2007).  
 
      In fact, the ability to control the three-dimensional structure of hydrogel matrices could 
be used to mimic the natural structure of in vivo tissues, especially those characterised by 
defined  cell  and  tissue  organisation,  such  as  the  skin,  liver  and  kidney.  The  defined 
organisation  of  cells  is  often  necessary  for  cellular  communication  during  cell 
differentiation  and  tissue  formation.  Once  such  attempt  was  the  construction  of  a 
multilayered culture of  human skin  fibroblasts  and keratinocytes by  Lee et al.  (2009), 
which aimed at mirroring skin layers. A 3D freeform fabrication technique, which involved 
using  a  robotic  platform  to  print  collagen  hydrogel  precursor  and  cells,  was  used  to 
engineer  the  biomimetic  multilayered  culture  (Lee  et  al.,  2009).  Each  printed  layer  of 
collagen  hydrogel  precursor  was  suspended  with  cells,  which  was  subsequently  cross-
linked to form a hydrogel before the next layer was printed. This printing process was 
repeated to construct distinct layers of inner fibroblasts and outer keratinocytes, which 
demonstrated  high  viability  within  the  layers.  This  type  of  tissue-reconstruction  using 
collagen  hydrogel  has  potential  applications  in  skin  wound  repair  as  skin  grafts  or  as 
artificial tissue assays in pharmacological studies (Lee et al.. 2009). By being able to co-
culture  different  cell  types  in  a  structurally  organised  3D  in  vitro  environment,  more 
realistically  representative  cell-cell  interactions  and  motility  may  be  studied  (Elisseeff, 
2008).   
B.4.2 Laponite RDS culture medium hydrogels have greater potential as cell culture 
matrices 
To  determine  the  suitability  of  Laponite  hydrogels  as  a  cell  culture  matrix,  cells  will 
eventually be cultured within the hydrogels. Hippocampal neuronal cells, however, cannot 229 
 
be cultured in water-based Laponite hydrogels alone, which prompted the development of 
culture  medium-based  Laponite  hydrogels.  The  growth  media  conventionally  used  for 
culturing hippocampal neurons is Neurobasal A medium supplemented with the growth 
supplement B27 and glutamine (Brewer et al., 1993), which made this the media of choice 
for developing culture medium-based Laponite hydrogels. 
 
      Laponite is a material with highly sensitive chemical properties which influence the 
rheological response. Especially well described is the relationship between the Laponite 
concentration  and  the  concentration  of  added  salt  (ionic  strength),  as  illustrated  in  the 
Laponite phase diagram (Fig. B.1.4; Mourchid et al., 1995a, 1995b). Laponite flocculates 
out of solution when the dispersion media has an ionic strength surpassing the upper limit 
of  20  mM  salt  concentration,  irrespective  of  Laponite  concentration  (Mourchid  et  al., 
1995a, 1995b). Indeed, this sensitivity of Laponite has led to the development of a wide 
range of Laponite formulations with diverse properties.         
 
      The standard Laponite formulation, Laponite RD (rapid diffusion), was used for the 
layering  and  handling  studies  as  described  above.  Laponite  RD  easily  forms  highly 
thixotropic  hydrogels  in  water  at  2%  (w/v)  concentrations  or  above  and  was  first 
investigated for hydrogel formation in culture media. Preliminary attempts at Laponite RD 
hydrogel  formation,  however, were obstructed  by  gel  flocculation.  The increased ionic 
strength of culture media compared to water is the most likely explanation for Laponite 
flocculation.  A  solution  of  high  ionic  strength  will  dramatically  reduce  the  electrical 
double layers and electrostatic repulsion between Laponite particle disks. This, coupled 
with dominating van der Waals attractions, promotes particle aggregation (Bonn et al., 
1999). An increase in the ionic strength of the dispersion media will result in an increase in 
fractal aggregate size until they sediment due to the effect of gravity. Differences in the 
size of the flocculation pellet, which became smaller and denser with an increase in culture 
media  concentration,  may  be  due  to  a  reduction  in  steric  hindrance  due  to  the  tighter 
compaction of aggregates (Nicolai  & Cocard, 2001). This flocculation and compaction 
may  explain  the  unexpected  consistency  of  18%  Laponite  RD  100%  culture  medium 
hydrogels, which exhibited a gritty texture and no thixotrophy. The high ionic strength of 
full media may have caused much of the Laponite to flocculate, aggregate and grow in size 
within the hydrogel to produce the consistency observed.   
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      Other  Laponite  formulations  were  investigated  for  hydrogel  forming  potential  in 
culture medium. Only Laponite RDS (rapid diffusion sol) and its low heavy metal content 
formulation (XLS), was successful at forming clear, thixotropic hydrogels in 100% culture 
medium. Laponite RDS dispersions in 100% culture medium produced clear thixotropic 
hydrogels at 16%, which could also be layered like water-based Laponite RD hydrogels. 
Unlike  Laponite  RD  culture  medium  hydrogels,  however,  Laponite  RDS  dispersions 
showed no flocculation at 18% concentration in full media. This difference in property is 
most likely due to  the addition  of inorganic polyphosphate peptisers to  Laponite RDS 
(Rockwood Additives Ltd.; Martin et al., 2002). These peptisers are attracted to and bind to 
the positive charge on the rim of Laponite disks, which interferes with the establishment of 
electrostatic interactions during hydrogel formation. Thus, Laponite RDS dispersions in 
water remain as free-flowing sols (dispersions of low viscosity), until the addition of small 
quantities of electrolyte, which result in the rapid formation of thixotropic hydrogels. In 
effect, referring back to the Laponite phase diagram (Mourchid et al., 1995a, 1995b), the 
upper limit  of ionic strength  where flocculation occurs is  effectively  raised. The ionic 
threshold for Laponite RDS flocculation was higher compared to that of Laponite RD, 
which allowed for its free flowing sol state at 10% concentration in water and the ability to 
form hydrogels in solutions of high ionic strength such as culture media.          
B.4.3 Conclusions 
Laponite is a novel hydrogel with appealing rheological and handling properties which 
underpin its use in a range of applications. Laponite has not been previously investigated 
as a cell culture matrix, however, its relatively low cost, gentle gelling conditions and 
thixotropic properties may prove advantageous over many other conventional hydrogels. 
The  ability  to  construct  multilayered/zoned  3D  matrices  with  Laponite  hydrogels  is 
promising for creating in vitro cultures more representative of in vivo environments, whilst 
the capacity for hydrogel formation in full culture media would be essential for supporting 
cell survival. In conclusion, Laponite shows potential as a novel alternative to existing 
hydrogels used in 3D culture and further investigations are necessary to determine the 































































A) Laminin Coating (amended from TN2004EN00 Millipore Technical Guide, 
Millipore) 
1.  Dilute the laminin 1:10 in NBA-A medium and vortex until the laminin is 
solubilised. 
2.  Place the 30 mm inserts into a 6-well cell culture plate. 
3.  Using a sterile pipette, add 700 μl of laminin/NBA-A mixture to each of the 30 mm 
inserts. 
4.  Gently shake the cell culture plate to coat. 
5.  Air-dry inserts overnight in a laminar flow hood. Leave the cell culture plate cover 
ajar to allow airflow and prevent condensation. 




B) Laminin Coating (amended from Sigma Aldrich product L2020 Product 
Information Guide) 
1.  Slowly thaw the laminin solution at 2-8 °C to avoid the formation of a gel. 
2.  Place the 30 mm inserts into a 6-well cell culture plate. 
3.  Dilute laminin in sterile water (5 μl/ml) and coat culture surface with a minimal 
volume (500 μl/well). 
4.  Incubate at 37 °C for at least 24 h. 
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